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Abstract 
Adverse pregnancy outcomes such as preterm birth and low birth weight are major causes of 
maternal and neonatal morbidity and mortality. Increasing evidence points to an association 
between periodontal disease and adverse pregnancy outcomes and thus a better understanding 
of the nature of this association will assist in treatment planning to reduce adverse pregnancy 
outcomes. Among the Gram-negative anaerobic bacteria frequently associated with 
periodontal disease are Treponema denticola, Tannerella forsythia and Porphyromonas 
gingivalis which may be detected in plaque using the BANA test (N-benzoyl-DL-arginine-2-
naphthylamide). 
The aim of this study was to investigate the effect of periodontal disease on pregnancy 
outcomes and evaluate the use of BANA as a screening test for the risk of adverse pregnancy 
outcomes.  
This study complied with the Declaration of Helsinki (2013) and included 443 pregnant 
women attending ante-natal clinics in KwaZulu Natal. At first visit, maternal oral health 
status was assessed by the measurement of periodontal indices and BANA testing of dental 
plaque from the same teeth. Patient demography and medical history were obtained by means 
of a questionnaire and all data compared with pregnancy outcomes. 
While controlling for other factors, significant differences were found between the 
distributions of periodontal disease at BANA-negative and BANA-positive sites and between 
infant birth weight and maternal periodontal index scores such as plaque index and gingival 
index.  The birth weight and gestational age at delivery of infants born of BANA-positive 
periodontally diseased mothers were significantly lower than those born of BANA-negative 
mothers with no periodontal disease. We may conclude that the presence of periodontal 
disease during pregnancy has a significant association with negative pregnancy outcomes and 
suggest that the risk for adverse pregnancy outcomes may be reduced by monitoring the oral 
health status of women during pregnancy. 
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CHAPTER 1: INTRODUCTION 
 
The impact of oral health on life quality is in relation to socio-demographic factors, age group 
and social class background and in some cases it is in relation to housing, medication 
adherence and access to care and food (Kenagy et al., 2003).It is widely accepted that general 
health or disease status affects oral health.  However the possibility that oral health or the oral 
cavity (as a portal of entry with access to the bloodstream and respiratory system) can cause 
alterations in general health seems less recognized (Offenbacher et al., 2001; Kinane and 
Bouchard, 2008). 
 
Periodontal disease is one of the most common chronic disorders of infectious origin known 
in humans, with a reported prevalence varying between 10 and 60% in adults, depending on 
diagnostic criteria (Albandar and Rams, 2000). Periodontal disease refers to gingivitis (an 
inflammatory condition of the soft tissues surrounding a tooth or the gingivae) and 
periodontitis (involving the destruction of such supporting structures as the periodontal 
ligament, bone, cementum, or soft tissues) (Kinane and Bouchard, 2008). The two most 
prevalent and most investigated periodontal diseases are dental plaque-induced gingivitis and 
chronic periodontitis (Tatakis and Kumar, 2005; Preshaw, 2008). Commonly accepted 
clinical measures of periodontal disease are clinical attachment level (CAL): the distance 
between the cementoenamel junction and clinical pocket base, and probing depth (PD): the 
distance from the gingival margin to the apical part of the pocket (Preshaw, 2008; Tatakis and 
Kumar, 2005).  
 
Periodontal disease is initiated by the overgrowth of certain bacterial species, with a majority 
of Gram-negative, anaerobic bacteria growing in subgingival sites. The host response to 
periodontal pathogens causes persistent inflammation and the destruction of periodontal 
tissues that support teeth leading to clinical manifestations of disease (Kornman et al., 2000). 
A limited number of cultivable species are associated with periodontal disease (Loesche, 
1993) and may include Aggregatibacter (formally called Actinobacillus) 
actinomycetemcomitans, Porphyromonas gingivalis, Prevotella intermedia, Tannerella 
forsythia, Campylobacter rectus, Eubacterium nodatum, Peptostreptococcus micros, 
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Streptococcus intermedius and Treponema species. The bacterial numbers associated with 
disease are up to 10 times larger than those associated with health (Lovegrove, 2004). 
 
These periodontopathogens share the ability to penetrate the gingival epithelium, such that 
their endotoxins, immunologically active compounds, and cytotoxic enzymes and molecules 
are presented directly to the host's inflammatory cells. This ability may be what distinguishes 
these Gram-negative species from the plethora of other Gram-negative species that inhabit 
the subgingival plaque (Loesche, 1993; Lovegrove, 2004). Criteria for defining periodontal 
pathogens have been developed and include association, elimination, host response, virulence 
factors, animal studies and risk assessment reasons (Lovegrove, 2004). Research has 
indicated that A. actinomycetemcomitans produces a leukotoxin, and the immunologic 
response of the host to this antigen may explain the unique pattern of tooth involvement in 
localized juvenile periodontitis. Both P. gingivalis and T. denticola have been identified to 
have a trypsin-like enzyme that could be a virulence factor (Loesche, 1993; Lovegrove, 
2004). There has been an increase in research evidence suggesting associations between 
periodontal disease and increased risk of systemic diseases such as atherosclerosis, 
myocardial infarction, stroke, diabetes mellitus, and adverse pregnancy outcomes (Garcia, 
2001; Offenbacher et al., 2001). 
 
Periodontal disease may contribute to adverse pregnancy outcomes because of a chronic oral 
inflammatory bacterial infection. In a study by McCormick (2003) and Bobetsis (2006), 
pregnant hamsters infected with P. gingivalis at doses insufficient to induce either fever or 
wasting, produced litters with significantly reduced foetal weight, accompanied by a 
proportional rise in tumour necrosis factor alpha  (McCormick, 2003; Bobetsis, 2006). In 
humans, adverse pregnancy outcomes that have been linked to periodontal disease include: 
preterm birth, low birth weight, miscarriage or early pregnancy loss, and pre-eclampsia 
(Appendix 1). Pre-eclampsia and preterm births are major causes of maternal and perinatal 
morbidity and mortality (McCormick 2003; Bobetsis, 2006). 
 
The specific aetiologies and pathogeneses of these adverse pregnancy outcomes are still 
unclear, as few risk factors have been clearly identified as early predictors or modifiable risk 
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factors for purposes of determining intervention strategies (Kinane and Bouchard, 2008). 
Confirmation of periodontal disease as an independent risk factor for adverse pregnancy 
outcomes would be of great public health importance because periodontal disease is both 
preventable and curable (Offenbacher et al., 2006). Periodontal treatment during pregnancy is 
regarded as safe for both the mother and the child  (Offenbacher et al., 2006; Jeffcoat et al., 
2003),  thereby preventing  or reducing the occurrences of adverse pregnancy outcomes as 
well as maternal and perinatal morbidity and mortality (Offenbacher et al., 2006; Jeffcoat et 
al., 2003).  
 
The “red complex” (Porphyromonas gingivalis, Tannerella forsythia, and Treponema 
denticola), has consistently been associated with periodontal infections (Kinane, 2001; 
Loesche et al., 1987; Offenbacher et al., 2009). Bayingana, (2005), examined the prevalence 
of T. denticola, T. forsythia, and P. gingivalis in subginginval plaque samples from pregnant 
women to establish the prevalence of the red complex using N-benzoyl-DL-arginine-2-
naphthylamide (BANA) and PCR and proposed the use of BANA as a screening test for 
mothers at risk of pre-term delivery or low birth weight. The present study, conducted under 
field conditions, is a more detailed study trying to correlate a treatment plan with BANA+ 
results in order to prevent/reduce the risk of adverse pregnancy outcomes. Further 
understanding of the nature of this association between periodontal disease and adverse 
pregnancy outcomes will assist in better maternal treatment planning in an attempt to reduce 
adverse pregnancy outcomes. 
 
Therefore, the aim of this study was to investigate the effect of the presence of pregnancy-
associated periodontal disease and a positive BANA test result on pregnancy outcomes.  
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CHAPTER 2: LITERATURE REVIEW 
 
2.1. Introduction 
This chapter critically reviews the literature on periodontal disease and adverse pregnancy 
outcomes in an attempt to update information and provide a current assessment of the state of 
the science in this area. 
 
2.2. Definition and Classification of Periodontal disease  
Periodontal diseases are a group of infectious diseases that cause inflammation and 
destruction to the tissues surrounding and supporting the teeth (Jared and Boggess, 2008) and 
may vary from inflammation of the gingivae alone (gingivitis) to severe inflammation of the 
periodontal ligament (periodontitis) as a result of a non-specific proliferation of the normal 
gingival crevice microbiota due to poor oral hygiene (Marsh and Martin, 1992). Plaque 
bacteria may produce disease directly, by invasion of the tissues, or indirectly via bacterial 
toxins (Marsh and Martin, 1992). 
In the early stage of periodontal disease, the gingiva becomes red, swollen and bleed easily 
resulting in false pocket formation (Marsh and Martin, 1992; Mokeem et al., 2004).  At this 
stage (gingivitis), the disease is still reversible and can usually be eliminated by improved 
oral hygiene practise (Mokeem et al., 2004; Jared and Boggess, 2008). If chronic gingivitis is 
not treated, bacterial poisons from the plaque penetrate the deeper tissues and destroy the 
periodontal ligament and alveolar bone (Mokeem et al., 2004). This advanced stage of 
periodontal disease is known as periodontitis.  In periodontitis, the junctional epithelial tissue 
at the base of the gingival crevice migrates down the tooth resulting in deepening of the 
gingival pocket and true periodontal pocket formation (Levision, 1997). Serious damage to 
the gingiva and alveolar bone as well as destruction of the periodontal ligament and 
cementum results in tooth loss (Marsh and Martin, 1992; Mokeem et al., 2004; Jared and 
Boggess, 2008). 
Periodontal diseases can be considered silent infections that have periods of exacerbation and 
remission that often go undiagnosed until irreparable damage occurs to the teeth and oral 
structures (Jared and Boggess, 2008). Gingivitis and mild periodontitis affect the majority of 
people and severe periodontitis affects approximately 10-15% of the population (Preshaw, 
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2004). Chronic destructive periodontal disease occurs in a small proportion of most 
populations, regardless of locality or socioeconomic status (Cuttress, 1986) but more than 
23% of women between the ages of 30 and 54 years are affected with periodontal disease 
(Holmlund et al., 2006; Sparh et al., 2006). The classification of periodontal diseases is still 
far from being resolved. Disease may be classified according to age (e.g. pre pubertal, 
juvenile, and adult) rate of progress (chronic, acute, and rapid) and distribution of lesions 
(localised and generalised) (Holmlund et al., 2006; Sparh et al., 2006).  
 
2.3. Risk factors for periodontal disease 
The nature of the host response is determined primarily by genetic factors and environmental 
and acquired factors such as smoking (Preshaw, 2004; Baelum and Lopez, 2003). The host 
response is essentially protective in nature, but both under-activity (hypo-responsiveness) and 
over-activity (hyper-responsiveness) of aspects of the host response can result in enhanced 
tissue destruction (Preshaw, 2004).  
Significant differences were recognised for race, gender, diabetes, education, smoking, and 
body mass index among categories of increasing severity of periodontal disease (Page and 
Kornman, 1997;  Baelum and Lopez, 2003). Of all the subject-level factors, race, gender, and 
the presence of diabetes were the strongest contributors to disease expression with 
predisposition based on individual exposures being critical to how the disease is expressed 
(Page and Kornman, 1997; Armitage, 2004; Baelum and Lopez, 2003). 
Offenbacher et al (2008) suggest that based on new data, the clinical characteristics of some 
complex diseases, such as periodontal disease, are influenced by the genetic and epigenetic 
contributions to clinical phenotype. Although the genetic basis for periodontal disease is 
considered imperative for setting an inflammatory capacity for an individual and thus, a 
threshold for severity, there is evidence to suggest an epigenetic component is involved as 
well (Page and Kornman 1997; Armitage 2004; Baelum and Lopez 2003). This is supported 
by factors long associated with periodontitis including bacterial accumulations, smoking, and 
diabetes and are known to produce strong epigenetic changes in tissue behaviour 
(Offenbacher et al., 2008; Al-Zahrani et al., 2003). As such, the clinical presentation of 
disease, or clinical phenotype, is typically based on clinical features of inflammation, such as 
redness, oedema, and bleeding on probing (BOP), and loss of supporting tissue, as evidenced 
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by probing depth (PD), attachment level, and alveolar bone loss (Page and Kornman, 1997; 
Armitage, 2004; Baelum and Lopez, 2003). 
Baelum and Lopez (2003) state that “periodontal disease is a syndrome that comes in all 
sizes,” suggesting that there are no clear demarcations between health and disease or between 
conditions. However, biologic data indicates that there are dramatic differences between 
individuals with very similar clinical presentations or patients with identical clinical 
presentations who may respond differently to the same therapy (Page and Kornman, 1997; 
Armitage, 2004; Baelum and Lopez, 2003). According to Page and Kornman, (1997) in 
addition to biologic phenotype, important subject-level variables that shape the host response 
to an organism may contribute to the clinical phenotype. These subject-level factors include 
smoking, obesity, and diabetes and increase the risk for progression of gingivitis to advanced 
stages of periodontal disease (Al-Zahrani et al., 2003; Page et al., 2003).  A relatively small 
proportion of all bacterial species is consistently found within diseased tissue sites 
(Schenkein, 2002; Offenbacher et al., 2007).  It is suggested that defining the multiple factors 
that contribute to the clinical presentation of the different types of periodontal disease, should 
make it possible to develop more consistent diagnostic categories and treatment modalities 
for the different types of periodontitis (Page and Kornman, 1997; Feinberg, 2007; 
Offenbacher et al., 2007).  This allows for a more accurate prognosis, providing more insight 
into the ideal customized treatment for a given individual (Page and Kornman, 1997; 
Feinberg, 2007; Offenbacher et al., 2007). 
 
2.4. Microbiology of periodontal disease 
Periodontal disease can further be described as a chronic inflammatory response to the tooth-
associated microbial biofilm which is  plaque (Pihlstrom et al., 2005) that induces 
inflammation of the adjacent tissues and causes local tissue destruction and loss of the tooth 
attachment such as ligament and bone (Offenbacher et al., 2009 ; Jared and Boggess, 
2008).Thorpe (2006) points out that although no evidence exists of an underlying relationship 
between gingivitis and calculus build up, many studies nevertheless report a high prevalence 
or increased severity of periodontal disease associated with poor oral hygiene or nutritional 
status. In the absence of adequate oral hygiene, periodontal bacteria accumulate in the 
gingival crevice of the teeth to form an organized complex structure known as a bacterial 
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biofilm (Jason et al., 2006; Sparh et al., 2006). The bacterial biofilms begin on the crown 
(supragingival), extend onto root surfaces under the gumline (subgingival) and penetrate into 
the root surfaces. They can become mineralized as hard deposits termed calculus 
(Offenbacher et al., 2009). The bacterial biofilm increases in virulence as it matures (Jason et 
al., 2006; Sparh et al., 2006) and manifests with the excretion of a protective and adhesive 
matrix (Thomas and Nakaishi, 2006). This bacterial matrix contains Gram-negative anaerobic 
and microaerophilic bacteria that colonize on the tooth structures (Philstrom et al., 2005), and 
initiates a systemic inflammatory and immune response (Slade et al., 2003). This can cause 
bone loss and the migration of the junctional epithelium, resulting in periodontal pocketing 
and periodontal disease (Thomas and Nakaishi, 2006; Sparh et al., 2006). Several bacteria, 
predominantly Gram-negative, anaerobic, and microaerophilic bacteria that colonize the 
subgingival area are responsible for initiating and sustaining the periodontal infection 
(Mokeem et al., 2004; Thomas and Nakaishi, 2006).  Rosebury (1962) introduced the concept 
of an amphibiotic state to describe those infections attributed to the overgrowth of bacterial 
species that are normally present in the indigenous flora, but at low levels (Flemmig et al., 
1996; Mombelli et al., 1996; Loesche, 1999). Certain changes in or on the mucous 
membranes allow these species to be selected for, and as a result of this overgrowth, they 
cause an endogenous infection1, resulting in clinical disease (Flemmig et al., 1996; Mombelli 
et al., 1996; Loesche, 1999). An additional selection factor for periodontopathic bacteria 
would be their ability to utilize nutrients that are available because of tissue inflammation 
(Loesche, 1993b). Host products such as haemin, menadione, progesterone, estradiol, 
acetylmuramic acid, spermine, alpha-2 globulin, and ceruloplasmin seem to be essential 
growth factors for P. gingivalis, T. forsythia (formally B. forsythus), T.denticola, and P. 
intermedia (Loesche, 1993a; Loesche, 1999).  Pathogenic bacteria though constantly present, 
are not the only cause of periodontitis (Thomas and Nakaishi, 2006; Philstrom et al., 2005) 
and the host defence mechanism plays an integral role in the pathogenesis of periodontal 
disease (Mokeem et al., 2004; Jared and Boggess, 2008). 
                                                          
1Medical examples of endogenous infections would be the several types of diarrhoea diseases that occur because 
of malnutrition, vaginal infections due to yeast, super infections that follow the usage of antibiotics, e.g., a 
Clostridium difficile infection after the use of Clindamycin (Flemmig et al., 1996; Mombelli et al., 1996; 
Loesche, 1999). Dental caries would be an endogenous infection due to the selection of the mutants’ 
streptococci by frequent sucrose ingestion (Loesche, 1993a; Loesche, 1999).  
 
 
 
 
 
8 
 
Tissue destruction in periodontitis is mainly due to the activation of the host’s immune cells 
by the microbial cell wall component, lipopolysaccharide. The lipopolysaccharide stimulates 
the production of host-derived enzymes, cytokines, and other pro-inflammatory mediators 
resulting in connective tissue destruction (Offenbacher et al., 1996; Lopez et al., 2002). This 
biologic process, including the characteristics of the biofilm and of the host inflammatory and 
immune responses, tend to vary among individuals, despite producing a similar clinical 
picture or diagnostic category (Page and Kornman, 1997;  Offenbacher et al., 2007).The host 
response to the bacterial invasion regulates the severity of the disease by activating the 
immune system to mediate the disease process (Philstrom et al., 2005; Thomas and Nakaishi, 
2006). The host’s response to the pathogenic bacteria modulates how the disease is initiated 
and progresses as evidenced by the fact that gingivitis does not always progress into 
periodontitis (Philstrom et al., 2005; Thomas and Nakaishi, 2006). 
Eighty per cent of individuals with periodontal disease have at least one risk factor that 
increases their susceptibility to the infectious process and subsequent tissue damage 
(Philstrom et al., 2005; Thomas and Nakaishi 2006). Often, multiple factors are present such 
as stress, poor dietary habits with high sugar intake, smoking and tobacco use, obesity, age, 
and poor dental hygiene have been identified as risk factors contributing  to the development 
of periodontal disease (Philstrom et al., 2005; Holmlund et al., 2006; Thomas and Nakaishi 
2006; Jared, and Boggess, 2008). Grinding teeth, genetic and other family factors, medical 
diseases such as diabetes, cancer, or AIDS, defective dental restorations, medication use, and 
conditions that change oestrogen and progesterone levels such as puberty, pregnancy and 
menopause have been identified as other major risk factors for periodontal disease (Philstrom 
et al., 2005; Jared and Boggess, 2008). 
 
2.4.1. Non-specific Plaque Hypothesis 
The Non-specific Plaque Hypothesis states that any plaque accumulation, regardless of its 
microbial make-up may cause disease (Loesche, 1976). For that reason, for adequate 
debridement of the tooth root surfaces with deep pockets, the pockets need to be eliminated 
surgically so that the patient can practice good oral hygiene on these newly accessible tooth 
root surfaces (Goodson, 1994; Loesche 1999; Offenbacher et al., 2009). Post-operative 
infections are prevented by the use of systemic antimicrobials and if the patient cannot 
maintain clean tooth root surfaces after the surgical approach, and the diseased pockets 
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return, then systemic antimicrobials are used in a rescue or salvage mode (Goodson, 1994; 
Loesche 1999; Offenbacher et al., 2009). Thus, in the Non-specific Plaque Paradigm, there 
would appear to be no contra-indications for the use of antimicrobial agents, if this use 
coincides with the surgical procedures, or is conducted if surgery fails (Goodson, 1994; 
Loesche 1999; Offenbacher et al., 2009). The established treatments are based on the non-
specific plaque overgrowth paradigm, which, if therapy is maintained on a periodic basis for 
a lifetime, can provide satisfactory results for about 80% of periodontal patients (Loesche, 
1999).  
 
2.4.2. Specific Plaque Hypothesis 
The Specific Plaque paradigm, in contrast, focuses on quality rather than quantity of plaque, 
by associating specific microbial species with disease and recommends that the short-term 
usage of antimicrobial agents, in combination with debridement, should precede any surgical 
intervention (Loesche, 1999; Offenbacher et al., 2009). This approach would require that one 
identifies the periodontopathic microbiota prior to any treatment and then use the appropriate 
antimicrobial agent (Loesche, 1999; Offenbacher et al., 2009). Numerous studies have 
implicated the overgrowth of anaerobic species as being statistically associated with 
advanced forms of periodontal disease. This would indicate the short-term usage of 
antimicrobial agents such as metronidazole and doxycycline directed against anaerobic 
members of bacteria (Offenbacher et al., 2009). 
Both paradigms are antimicrobial, in that debridement is used to limit the numbers of bacteria 
that accumulate on the tooth surfaces. However, they differ in the treatment of patients with 
advanced disease (Loesche, 1999; Offenbacher et al., 2009). The two paradigms use the same 
modules of treatment but differ in the process of the sequencing of these modules. Studies on 
the microbial aetiology of most forms of periodontal disease have shown that advanced forms 
of periodontal disease can be successfully treated by short-term usage of metronidazole and 
doxycycline (Loesche, 1999; Offenbacher et al., 2009). 
 
2.4.3. Bacterial species implicated in the aetiology of periodontal disease 
Periodontal disease is an infectious disease caused mainly by anaerobic Gram-negative 
bacteria. Socransky and his colleagues (1998) divided these bacteria into microbial 
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complexes or clusters and assigned to each a colour for the convenience of discussion. The 
“blue,” green,” “yellow” and “purple” clusters include mainly bacteria that colonize the 
periodontal sulcus in the early stages of dental plaque formation. Organisms of the “orange” 
cluster (Campylobacter rectus, Fusobacterium nucleatum, Peptostreptococcus micros, 
Prevotella intermedia and Prevotella nigrescence) appear and provide the necessary habitat 
for the subsequent colonization and establishment of the more aggressive bacteria of the 
“red” cluster (Porphyromonas gingivalis, Tannerella forsythia and Treponema denticola). As 
the biofilm matures, it becomes more pathogenic (Madianos et al., 2001; Socransky et al., 
1998; Loesche and Grossman, 2001). Although the exact role of each of these bacterial 
species in the progression of periodontal disease is not fully understood, it is clear that the 
presence of a large group of bacteria is necessary for the overall pathogenic effect (Madianos 
et al., 2001; Socransky et al., 1998; Offenbacher et al., 2006). Progression of the periodontal 
disease causes the host’s immune system to respond by producing antibodies against the 
various bacterial species (Madianos et al., 2001; Offenbacher et al., 2006). Virulence factors 
include lipopolysaccharide (LPS) that may cause direct destruction to the periodontal tissues 
or stimulate the host local inflammatory response which even though intended to eliminate 
the infection, may lead to further loss of periodontal structures (Al-Shammari et al., 2006). 
Further consequences can be that bacteria and/or their shed virulence factors may enter the 
bloodstream, disseminate throughout the body and trigger the induction of systemic 
inflammatory responses with or without entopic infections (Thomas and Nakaishi ,2006; Al-
Shammari et al., 2006).  
 
2.4.4. The use of BANA as a diagnostic tool for periodontal disease. 
DNA probes, cultural procedures, microscopic measures, and immunological techniques have 
been used to detect P. gingivalis, T. forsythia, and T. denticola in dental plaque (Loesche et 
al., 1987; Aimetti et al., 2007; Komiya et al., 2010; Andrade et al., 2010). 
The “red complex”  (P. gingivalis, T. forsythia, and T. denticola), has  consistently been 
associated with periodontal infections (Kinane, 2001; Loesche et al., 1987; Offenbacher et 
al., 2009) and is known to possess a trypsin-like enzyme that can hydrolyse the synthetic 
trypsin substrate, BANA (Loesche, 1986). BANA is a rapid and effective diagnostic aid and 
has shown to correlate well with the clinical indices used to diagnose periodontal disease 
(Loeshe et al., 1997a, b; Grisi et al., 2001).  BANA is able to detect between 10 3 - 10 5 
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targets/ sample (Loesche et al., 1992; Tran et al., 1999) which is the same range as 
immunoassays and nucleic acid probes. The commercially available BANA test (Oral B, 
Perioscan TM) is a modification of the BANA hydrolysis test adapted from the trypsin - like 
enzyme of the API - ZYM Kit (Laughon et al., 1982; Loeshe et al., 1990).  SK-013 
(carbobenzoxy -glycil -arginine -3.5 -dibromo -4-hydroxy arginine) has also been used for 
the detection of peptidase activity of T. denticola, P. gingivalis and T. forsythia in plaque 
samples (Ishihara., et al 1991).  However, BANA appears to be more frequently employed. 
Other species such as Bacterionema matruchotti, Rothia dentocariosa, Rothia 
(Stomatococcus) mucilaginous and some Capnocytophaga species are known to be BANA 
positive, but these species have not consistently been associated with periodontal disease 
(Scannapieco, 2005; Loesche et al., 1987). 
According to Loesche et al (1992) in the detection of P. gingivalis, T forsythia and T. 
denticola, the BANA test had a 92% sensitivity and 70% specificity when compared with 
DNA probes and polyclonal immunological reagents. The BANA Test had a sensitivity of 
95%, when compared with checkerboard DNA-DNA hybridization using highly specific 
whole genomic DNA probes to P. gingivalis, T. forsythia, and T. denticola.Loesche et al., 
(1987), Andrade et al., (2010) and Africa et al., (2009) suggest that the BANA test could be 
used as a surrogate for DNA probes in the detection of these bacterial species in plaque 
samples. Smoking is a well-documented risk factor for periodontal disease (Hujoel et al., 
2002) and is associated with significant proportional and absolute overgrowth of 
periodontopathic bacterial species in the subgingival plaque (Hujoel et al., 2002; Offenbacher 
et al., 2009). Plaques from smokers are 11 times more likely to be BANA positive compared 
to plaques from individuals who have never smoked and are less likely to respond to 
debridement/surgical procedures (Hujoel et al., 2002; Offenbacher et al., 2009).  Andrade et 
al., (2010) reported that the BANA test was most effective for the detection of these 
organisms when their levels in the subgingival plaque were high during the initial diagnosis 
of chronic periodontitis. Teeth that do not respond to scaling and rootplaning remain 
colonized by the BANA positive species, P gingivalis, T. forsythia and T. denticola 
(Nishihara and Koneke, 2004; Offenbacher et al., 2009; Scannapieco, 2005). Elderly veterans 
who were dentate and whose plaques were BANA-positive, were twice as likely to have a 
diagnosis of coronary heart disease, as were elderly dentate veterans whose plaques were 
BANA-negative (Loesche et al., 1998a; Loesche, 1999). 
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2.5. Periodontal Disease and Systemic Conditions 
Periodontal pathogens and their virulence factors have the ability to disseminate and induce 
both local and systemic inflammatory responses in the host. This has led to the hypothesis 
that periodontal disease may have effects beyond the periodontal tissues themselves 
(Azarpazhooh et al., 2006).  Miller first reported this concept in 1891 when he published the 
theory of “focal infection” (Miller, 1891).  According to Miller’s theory, oral foci of infection 
were considered responsible for a number of regional and systemic diseases, such as 
tonsillitis, pneumonia, endocarditic and septicaemia however, the lack of scientific evidence 
condemned this theory to dormancy (Azarpazhooh et al., 2006). The "Focal Infection 
Theory" proposed by Hunter (1910) concurred that bacteria and their products from local 
infections could be disseminated throughout the body and cause diseases in other organs 
(Billings, 1912). This was supported by other studies which suggested that systemic spread of 
endotoxins in periodontal disease may be associated with adverse pregnancy outcomes 
(Dasanayake et al., 2001; Jeffcoat et al., 2001; Offenbacher et al., 2001). In contrast, 
Davenport and co-workers (2002) reported no association, and a systematic review reported 
limited evidence that periodontitis is associated with increased risk for preterm low birth 
weight (Madianos et al., 2002). 
Despite these discrepancies, oral health and its relationship to systemic health is important to 
society because up to 90% of the worldwide population is affected by either gingivitis or 
periodontitis (Philstrom et al., 2005), with reports indicating that up to 30% of the general 
population has a genetic predisposition to periodontitis (Albandar et al., 1999). The systemic 
importance of periodontal disease has been highlighted by the recent progress in 
identification and characterization of periodontal pathogens, as well as the characterisation of 
potential systemic mechanisms of action of bacterial products and inflammatory cytokines 
(Mokeem et al., 2004), thus pointing to the association periodontal disease with an increased 
risk for cardiovascular disease, (Spahr et al., 2006; Holmlund et al., 2006) diabetes, (Jason et 
al., 2006; Al-Shammari et al., 2006) community and hospital acquired respiratory infections, 
(Azarpazhooh et al., 2006) and adverse pregnancy outcomes (Beck et al., 2005; Bogies et al., 
2006; Lopez et al., 2002). According to Dasanayake et al (2003), individuals with periodontal 
disease have approximately 1.5 – 1.9 increased odds for developing cardiovascular disease 
and after adjusting for many known risk factors for heart disease, this association was found 
to be statistically significant (Beck et al., 1996; Loesche and Lopatin, 1998; Loesche, 
1999).There also appears to be a bidirectional relationship between periodontal disease and 
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diabetes, with a 2-3 fold-increased risk for diabetes among individuals with tooth loss 
(Azarpazhooh and Leake, 2006; Dasanayake et al., 2003).   
Teeth and periodontium may serve as a reservoir and may also contribute to respiratory 
infections with poor oral hygiene such as dental decay increasing the odds for pneumonia 2- 
to 9-fold (Azarpazhooh and Leake, 2006; Dasanayake et al., 2003).   
Treatment of periodontal infection may reduce the risk of other systemic conditions. In a 
randomized clinical trial to estimate the effect of periodontal therapy on traditional and novel 
risk factors for cardiovascular disease and on markers of inflammation, D’Aiuto et al  (2006), 
found that therapy reduced inflammatory cytokines, blood pressure, and cardiovascular risk 
scores (D’Aiuto et al., 2006).  Faria-Almeida et al (2006) found that periodontal treatment of 
type 2 diabetic patients resulted in improved diabetic control (lower HbA1c levels) and 
treatment of mechanically ventilated patients with a daily oral hygiene regime consisting of a 
0.12% chlorhexidine gluconate mouthwash reduced the risk for nosocomial pneumonia 
(Genuit et al.,2001; Koeman et al.,2006). 
 
2.6. Pregnancy-associated periodontal disease  
During pregnancy, changes in hormone levels promote an inflammatory response that 
increases the risk of developing gingivitis and periodontitis (Jared and Boggess, 2008). 
Because of varying hormone levels without any changes in the plaque levels, 50%-70% of all 
women will develop gingivitis during their pregnancy, commonly referred to as pregnancy 
gingivitis (Hasegawa et al., 2003; Leon et al., 2007; Barak et al., 2007). This type of 
gingivitis is typically seen between the second and eighth month of pregnancy (Hasegawa et 
al., 2003;   Barak et al., 2007).   
Increased levels of the hormones progesterone and oestrogen can have an effect on the small 
blood vessels of the gingiva, making it more permeable (Jensen et al., 1981; Barak et al., 
2003). This increases the mother’s susceptibility to oral infections, allowing pathogenic 
bacteria to proliferate and contribute to inflammation in the gingiva (Offenbacher et al., 1998; 
Hasegawa et al., 2003). This hyper-inflammatory state increases the sensitivity of the gingiva 
to the pathogenic bacteria found in dental biofilm. Females often see these changes during 
other periods of their life when hormones are fluctuating, such as puberty, menstruation, 
pregnancy, and again at menopause (Jensen et al., 1981; Barak et al., 2003). During 
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pregnancy, the ratio of bacterial anaerobes to aerobes and the proportions of Bacteroides 
melaninogenicus, Prevotella intermedia (Bacteroides intermedius) and Porphyromonas 
gingivalis (Bacteroides gingivalis) were found to increase (Kornman and Loesche, 1980). 
Pregnant women were established to have a level of Bacteroides species 55 times higher than 
that of non-pregnant women (Jensen et al., 1981; Barak et al., 2007).  
Maternal infection with periodontal pathogens has a deleterious effect on foetal growth and 
viability. According to (Offenbacher et al., 2006) a hypothetical model of the association 
between maternal periodontal inflammation and foetal development may be proposed. 
Periodontal bacteria and their virulence factors, found in the periodontal pockets, induce a 
local periodontal host immune response that includes mainly the production of inflammatory 
cytokines such as IL-1, PGE2, TNF-α and antibodies against the bacteria. If this immune 
response and the neutrophils are not capable of keeping the infection localized (such as low 
maternal IgG response to bacteria), then the bacteria and/or their virulence factors and the 
inflammatory cytokines may gain access systemically via the blood circulation (Offenbacher 
et al., 2006). This would be evidenced clinically by signs of bleeding on probing and 
increased pocketing during pregnancy (Offenbacher et al., 2006).  The presence of the 
bacteria in the blood circulation will trigger the host to elicit a second round of inflammatory 
response, systemic this time, mainly by the production of more inflammatory cytokines and 
acute-phase reactants such as C-reactive protein from the liver (Offenbacher et al., 2006).  
Eventually, bacteria and/or their virulence factors and inflammatory cytokines appear to 
reach the placenta, as about 40 % of all pregnancies are associated with some foetal IgM 
antibody response to organisms of maternal oral origin (Offenbacher et al., 2006). This will 
create another site of bacterial challenge and possibly placental infection, leading to a new 
inflammatory response, localized at the foetal-placental interface this time, with the 
production of more inflammatory cytokines (Offenbacher et al., 2006). As in periodontal 
tissues, these cytokines, although produced with the intention to combat the infection, may 
also cause tissue destruction (Offenbacher et al., 2006). Because the structural integrity of the 
placenta is vital for the normal exchange of nutrients between the mother and the foetus, this 
placental tissue damage may contribute to impaired foetal growth, which may lead to low 
birth weight (LBW) (Offenbacher et al., 2006). In addition, structural damage in the placenta 
may disrupt the normal blood flow between the mother and the foetus, affecting the maternal 
blood pressure and leading to preeclampsia. The increase in the production of inflammatory 
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cytokines such as IL-1β and PGE2 also may contribute to preterm rupture of the membranes 
and uterine contraction and lead to miscarriage or preterm delivery (Offenbacher et al., 2006).  
Finally, periodontal bacteria and/or their virulence factors and inflammatory cytokines may 
cross the placenta and enter the foetal circulation. There, they may trigger a new foetal-host 
immune response, as evidenced by the observed elevated levels of foetal IgM to periodontal 
pathogens. If the foetus cannot control the infection, the bacteria and/or their virulence 
factors may gain access to various tissues and initiate local inflammatory responses and, 
consequently, structural damage to the foetal tissues and organ systems. Depending on the 
extent of this damage, the newborn may or may not survive the perinatal period. However, 
survivors may possess deficiencies that may compromise their quality of life, even 
throughout adulthood (Offenbacher et al., 2006).  
 
2.7. Adverse pregnancy outcomes defined 
This study uses terminology from the World Health Organization International Statistical 
Classification of Diseases and Related Health Problems to ensure consistency with 
universally accepted definitions (WHO, 2005).  A list of terms and their definitions are in 
appendix 6.   
 
2.7. 1.  Neonatal Low birth weight (LBW) 
Low birth weight (LBW), is a significant public health issue in both developed and 
developing countries (Kramer et al., 1998; Barros et al., 2001). This obstetric complication is 
usually a direct result of pre-term labour, in which case it is referred to as pre-term delivery 
(less than 37 weeks) of low birth weight infants (PLBW) (WHO, 1984) . The prevalence of 
LBW in the United States is about 7.3% and in the United Kingdom, 6%. In Africa, the 
average LBW is around 12% and around 15% in Asia (Williams et al., 2000).  
Various factors have been associated with the delivery of PLBW infants and maternal risk 
factors including age, height, weight, socioeconomic status, ethnicity, smoking, nutritional 
status and stress (Nordstrom et al., 1996).  In addition, birth intervals, previous 
complications, pre- and ante-natal care, maternal hypertension, generalized infections, 
localized infections of the genital and urinary system, and cervical incompetence may also be 
important (Lamont, 1998; Walker et al., 1998).  However, a significant proportion of LBW is 
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of unknown aetiology and infection is considered a major factor in these cases (Barros et al., 
1992). 
Infant mortality has fallen in many parts of the world (Lee et al., 1995) but there has been 
little or no success in preventing LBW and in some developing countries with reliable 
national or regional birth registration, preterm birth appears to be on the rise (Silva et al., 
1998; Barros et al., 2001), as has also been reported from most developed countries (Joseph 
et al., 1998; Kramer et al., 1998).   
 
2.7.2. Pre-term labour and pre-term premature rupture of membranes  
Pre-term labour and premature rupture of foetal membranes (PPROM) are frequently 
associated with pre-term birth (Goldenberg et al., 2008). PPROM is associated with 30–40% 
of pre-term deliveries, complicates 2–5% of all pregnancies, and has been found to be the 
most common identifiable cause of preterm delivery (Menon and Fortunato, 2007). Although 
the exact cause(s) of pre-term labour are unclear, the following conditions have been 
associated with pre-term labour, cervical incompetence, or pre-term membrane rupture: 
premature activation of the foetal and maternal hypothalamus–pituitary–adrenal axis (e.g. 
mediated by maternal or foetal stress), systemic or ascending bacterial vaginal infections, 
decidual haemorrhage, uterine distortion, and uteroplacental insufficiency (Moutquin, 2003; 
Schneider et al., 2006). Early PPROM appears to be associated with underlying pathologic 
processes, most likely due to inflammation and/or foetal membrane infection (Simhan and 
Canavan, 2005) and clinical factors such as low socioeconomic status, low body mass index, 
tobacco use, pre-term labour history, urinary tract infection, vaginal bleeding at any time in 
pregnancy, and amniocentesis (Schneider et al.,2006). 
 
2.7.3. Preterm birth  
Preterm birth has a severe socioeconomic impact and is a major problem for modern 
obstetrics due to its increasing frequency and the accompanying expense (Pararas et al., 
2006). Several maternal characteristics related to preterm birth have been identified (Pararas 
et al., 2006; Katz et al., 2009).  The aetiology (see section 2.9 below) in most cases, however, 
remains inadequately understood (Pararas et al., 2006) but infection is considered as a risk 
factor for preterm delivery (Pararas et al., 2006; Katz et al., 2009). Various microorganisms 
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have been linked to the pathogenesis of preterm birth (Pararas et al., 2006 ; Katz et al., 2009) 
and these microbes may reach the amniotic cavity and foetus by ascending from the vagina 
and cervix, by haematogenous distribution through the placenta, migration from the 
abdominal cavity through the fallopian tubes, or through invasive medical procedures 
(Pararas et al., 2006). Very pre-term birth occurs in only a small proportion of the infant 
population, its societal and personal health impact is considerable because of its 
disproportionately high perinatal morbidity, mortality, and need for costly medical care 
(Wimmer and Pihlstrom, 2008).  
Preterm birth is a critical priority in healthcare throughout the world because of medical, 
social, and economic reasons (Shennan and Bewley, 2006) however, interventions to prevent 
pre-term birth have proven to be almost universally ineffective (Shennan and Bewley, 2006; 
Wimmer and Pihlstrom, 2008). 
 
2.8. Cost of infant morbidity due to preterm birth 
Maternal infections have long been recognized as increasing the risk for pregnancy 
complications such as preterm birth and preeclampsia and Jared and Boggess (2008) point 
out that adverse pregnancy statistics could have a major impact on health care policy because 
they often form the basis for international comparisons and assessment of health care funding 
needs. It is also important because it is the foremost cause of death in the first month, causing 
up to 70% of all perinatal deaths (Andrews et al., 2000; Raju, 2008). Prematurity is 
responsible for almost 50% of all neurological complications in newborns, and leads to 
lifelong complications in health, including but not limited to visual problems, developmental 
delays, gross and fine motor delays, deafness, and poor coping skills (Andrews et al., 2000; 
Raju, 2008). These complications increase the health care dollars spent on each child and on 
average, the medical cost alone for a preterm birth is 10 times greater than the medical costs 
for a full-term birth (Andrews et al., 2000; Raju, 2008).  
In 2005, the nationwide cost of preterm birth in the United States was more than $26.2 billion 
for health care and lost productivity (Jared and Boggess, 2008). Although there have been 
advances in technology to help save the infants who are born premature or low birth weight, 
there are problems associated with these conditions which persist throughout life (Andrews et 
al., 2000; Raju, 2008; Jared and Boggess, 2008). Preterm infants are at an increased risk for a 
number of serious health complications, including chronic lung disease, severe brain injury, 
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motor and sensory impairment, learning difficulties and behavioural problems (Wimmer and 
Pihlstrom, 2008). First-year mortality rates are significantly higher for preterm infants and 
these children often require significantly greater family practitioner services, education 
services and social services than infants born at term or normal birth weight (Stavros et al., 
2003), and thus the economic impact associated with the perinatal period, as well as 
throughout life, can be substantial (OECD, 2001). On average, a preterm infant costs $51,600 
more than the average cost for full-term infants in the first year of life  with additional long-
term costs often continuing  over the individual’s lifetime (Behrman et al., 2006) . 
Globally, over 4 million babies die within the first 4 weeks of life and a third of these are 
secondary to pre-term birth (Lawn et al., 2005). Infant death rates appear to be highest in 
Africa and South Asia (WHO, 2006), with Liberia and Mauritania having the highest known 
rate of infant death in the world (104 and 111 respectively, per 1000 live births). Among 
industrialized nations, Japan, the United Kingdom, and the United States have a rate of nearly 
seven deaths per 1000 infants within the first 4 weeks of life (WHO, 2006). In the United 
States, pre-term birth is the second leading cause of neonatal mortality (ACOG Practice 
Bulletin 2001, 2003, WHO 2006). The US preterm birth (under 37 weeks) rate rose to12.8% 
in 2006, an increase of 21% since 1990 and the rate of low birth weight (under 2500 g) rose 
to 8.3% in 2006, an increase of 19% since 1990 (Martinet et al., 2007). There are also 
indications that pre-term birth is increasing in other countries with the risks of infant 
morbidity and mortality being greater with increased prematurity, especially when birth 
occurs before 34 weeks (Strebel and Bucher, 1994; Tracy et al., 2007). 
Tracy et al (2007) reported an increasing trend for live pre-term birth among low-risk 
Australian women (5.9% in 1994 to 6.6% in 2003) and Langhoff-Roos et al., (2006) reported 
that pre-term deliveries in Denmark increased by 22% (5.2–6.3%) from 1995 to 2005. The 
incidence of spontaneous pre-term deliveries increased mostly among precipitous women at 
low risk (Tracy et al., 2007).  
Complicated pregnancies impose a risk not only to the mother, but also, and primarily, to the 
offspring. The majority of very preterm infants (born at less than 32 weeks’ gestation) enter 
the neonatal intensive care unit (NICU) owing to an increased risk of perinatal mortality, 
especially due to  respiratory problems (asthma, lower respiratory infections, broncho 
pulmonary dysplasia, impaired lung development and function, chronic lung disease) 
(Michalowicz et al., 2006; Offenbacher et al., 2006).  Fortunately, new modalities in perinatal 
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care, such as the use of lung surfactant treatments and maternal receipt of steroid injections to 
hasten foetal lung development, have improved the survival rates of preterm infants 
(Michalowicz et al., 2006; Offenbacher et al., 2006). However, preterm and LBW infants 
who survive the neonatal period also face a higher risk of developing neuro developmental 
problems (cerebral palsy, blindness, and deafness), behavioural problems (attention deficit 
hyperactivity disorder), learning problems, cardiovascular disease and metabolic 
abnormalities (obesity, type 2 diabetes mellitus) (Michalowicz et al., 2006; Offenbacher et 
al.,2006).  The resulting obstetric complications are not only a significant health care expense 
(estimated at more than $5.5 billion annually), but also affect the wellbeing of the affected 
infants throughout life (Offenbacher et al., 2006). However, not all of the contributing factors 
have been identified, and more than 25 per cent of all complicated pregnancies occur without 
any known reason.  With   periodontal diseases being both preventable and treatable, it would 
be of significant public health interest in pregnancy if a cause-effect relationship with preterm 
birth could be demonstrated (Michalowicz et al., 2006). 
Neurological disorders, such as cerebral palsy, which is often found with mental disability, 
epilepsy, and cognitive impairment, are of special concern for survivors of pre-term birth 
(Hack et al., 1994). Up to 40% of surviving infants with birth weight to 750g have modest to 
severe disabilities (Hack et al., 1994), while pre-school and school-age children born pre-
term, may have cognitive and behavioural disorders.  School-age children with very low birth 
weight (VLBW, under 1500 g) have higher rates of grade repetition and need for special 
education than term-born infants (Taylor et al., 2000).   Research on adolescent outcomes of 
VLBW infants suggests that its sequelae persist over time (Saigal et al.,2000b) with the 
impact and burden of extremely low birth weight (ELBW, under 1000 g) adversely affecting 
families (Taylor et al., 2001). Compared with parents of term infants,  parents of ELBW 
infants reported more marital stress (Saigal et al., 2000a) while parents of young children 
with VLBW reported more financial, social, and family stress (Cronin et al., 1995).  
 
2.9. Causes of pre-term birth 
According to Schneider et al., (2006) the main reported causes of adverse pregnancy 
outcomes are maternal infection and placental, foetal, or uterine pathosis.  Maternal infection 
and placental pathosis appear to be the most important causal factors, but each can cause pre-
term labour, premature pre-term membrane rupture, or result in medically induced pregnancy 
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interruption. Increasingly, very pre-term birth occurs with multiple pregnancies (Blondel et 
al., 2006) and is often a result of assisted reproductive technology (Mukhopadhaya and 
Arulkumaran 2007; Reddy et al., 2007; Schieve et al., 2007). Prominent risk factors for pre-
term birth include history of previous preterm birth, demographic characteristics, periodontal 
disease, and behavioural factors such as tobacco use (Goldenberg et al., 2008).  
Demographic factors associated with pre-term birth include, ethnicity, extremes of maternal 
age, low socioeconomic status, and low pre-pregnancy weight (MacDorman et al., 2007). 
Preterm labour and pre-term birth have also been associated with stressful life situations such 
as domestic violence; close family death; insecurity over food, home or partner; work and 
home environment (Eskenazi et al., 2007, Precht et al., 2007).  A higher risk of spontaneous 
pre-term delivery has been associated with genetically driven excessive amniotic fluid IL-Ib 
or with a disturbance of bioavailability of this cytokine, which is central to the pro-
inflammatory reaction to infectious stimulants (Witkin et al., 2003; Genc et al., 2004). The 
foetus also has a role in pre-term birth by recognising a hostile intrauterine environment and 
precipitating labour by the premature activation of the foetal–placental parturition pathway 
(Annells et al., 2004; Boggess et al., 2005; Gardosi, 2005). 
Uterine bacterial infections2 can occur between the maternal tissues and the foetal 
membranes (i.e. in the choriodecidual space), in the foetal membranes (the amnion and 
chorion), the placenta, the amniotic fluid, and the foetus (Goldenberg et al.,2000 ; Romero et 
al., 2006; Goldenberg et al., 2008). Intrauterine infectious organisms are believed to originate 
primarily from ascending the vaginal tract, and secondarily, haematogenously from other 
parts of the body (Goldenberg et al., 2000). Therefore, it is plausible that microbes 
originating from the oral cavity may be transmitted to the uterus. It is also possible that other 
oral microorganism besides periodontal pathogens could cause intrauterine infections 
(Morency et al., 2006; Han et al., 2006). Ascending vaginal or systemic infections are 
considered frequent causes of pre-term birth with or without-term premature rupture of 
membranes (Hillier et al., 1995; Goldenberg et al., 1998; Hill, 1998; Flynn et al., 1999). 
Increased concentration of endotoxin in cervical mucus (Platz-Christensen et al., 1993; 
Mattsby-Baltzer et al., 1998), vaginal fluid (Sjoberg and Hakansson 1991; Platz-Christensen 
et al., 1993) and microbial invasion of a sterile compartment such as the amniotic cavity 
(Romero et al., 1987a, b) is an indication of an increased Gram-negative microbiota such has 
                                                          
2 Infection of the foetal membranes is termed chorioamnionitis; infection of the umbilical cord is funisitis; and 
infection of the amniotic fluid is called amnionitis (Goldenberg et al., 2000). 
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been reported in women with bacterial vaginosis (Romero et al., 2004) which,  if occurring 
early in pregnancy, appears to be a particularly strong risk factor for pre-term delivery and 
spontaneous abortion (Leitich et al., 2003a).   However, recent evidence suggests that the 
majority of pre-term births are caused by bacterial infections of the chorioamnion, in which 
the infecting organisms originate in the vagina (Goldenberg et al., 2002).  A significant 
association has been reported between the detection of microbial DNA (Streptococcus ssp. 
and Fusobacterium nucleatum) and previous pregnancy complications including pre-term 
delivery and premature rupture of membranes (Bearfield et al., 2002).  According to Smith et 
al., (2007) maternal infection is more likely to be associated with spontaneous very pre-term 
births in women with socio-economic deprivation.  
Whether or not the endometrial cavity is normally sterile remains unanswered, although the 
traditional view holds that it is sterile (Horowitz et al., 1995). However, several studies such 
as Cowling et al. (1992), Moller et al. (1995), Espinoza et al. (2006), have reported 
microbiological colonization in the uterine cavity and there is controversy regarding the most 
effective microbiological sampling procedures, which pathways of infection exist, and where 
the microorganisms are likely to be located. Ansbacher et al. (1967), Duff et al. (1983), 
Espinoza et al. (2006) point out that in addition to the presence or absence of 
microorganisms, it is important to characterise the host response that microorganisms elicit 
under physiologic and pathologic circumstances (Costerton et al., 2003; Romero et al., 2004; 
Swidsinski et al., 2005).  
Bacteria activate cell-mediated immunological responses, that can induce host production of 
proinflammatory cytokines, including interleukin-1 (IL-1), IL-6, tumour necrosis factor-α 
(TNF-α), and prostaglandins. Bacterial endotoxins such as lipopolysaccharides are a 
component of the cell wall of Gram-negative bacteria (Narahara and Johnston, 1993; Smith et 
al., 2007) and may precipitate pre-term labour if they reach the foeto-placental unit (Gibbs et 
al., 1992; Smith et al., 2007). 
In an attempt to test the hypothesis that the risk for pre-term birth is increased by oral 
microorganism colonization of the uterine environment and/or the initiation of a foetal or 
maternal immune response by these bacteria, Boggess et al., (2005) collected 640 umbilical 
cord blood specimens and assayed cord serum levels of C-reactive protein, IL-1b, IL-6, and 
TNF-α, prostaglandin E2 (PGE2), 8-isoprostane, and the presence of foetal IgM antibody 
against selected oral pathogens. The joint effects of foetal IgM seropositivity and detectable 
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C-reactive protein, high 8-isoprostane, PGE2 or TNF-α resulted in significantly increased risk 
for pre-term birth. They concluded that foetal exposure to oral pathogens evidenced by an 
IgM response is associated with preterm birth, and the risk for pre-term birth is greatest 
among foetuses that also demonstrate an inflammatory response (Boggess et al., 2005). The 
method of dissemination of oral pathogens is unclear in this investigation and foetal exposure 
may occur because of systemic dissemination or these organisms may ascend from the vagina 
possibly following oral-vaginal translocation (Boggess et al., 2005).   Boggess et al., (2005) 
further state that the foetal immune response itself needs to be critically analysed: the 
response could be non-specific or it could be targeted towards other antigens and be unrelated 
to maternal periodontal disease or exposure to oral pathogens. In this regard, it is interesting 
that no differences in IgG, IgM, and IgA umbilical blood concentrations were found in a 
study by Mahulja-Stamenkovic et al., (1993) comparing infants with and without signs of 
sepsis.  
Clearly, the role of the foetal immune response to oral and other pathogens is an important 
area for future study.  When present in the amniotic fluid, chronic high levels of cytokines 
and prostaglandins may lead to intra-uterine growth restriction (IUGR), spontaneous pre-term 
labour, premature rupture of membranes, and pre-term birth (Sadowsky et al., 2006).  
 
2.10. Periodontal disease and adverse pregnancy outcomes 
In the early 1990s, Collins and colleagues hypothesized that oral infection, such as 
periodontitis could act as a source of bacteria and inflammatory mediators that could 
disseminate systemically to the foetal-8S placental unit, via the blood circulation inducing 
pregnancy complications (Beck et al., 2005). Determining whether periodontal disease is 
associated with pregnancy complications derives from the fact that despite the advances in 
prenatal care and increased public awareness, adverse pregnancy outcomes still present a 
major public health problem worldwide (Michalowicz et al., 2006; Offenbacher et al., 2006). 
There is increasing evidence to suggest an association between periodontal disease and 
adverse pregnancy outcomes (Katz et al., 2009; Persson et al., 2009) with severe periodontitis 
seen to lower haemoglobin levels which, in turn, had an adverse effect on pregnancy and 
foetal development (Kothiwale et al., 2014). 
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The literature is controversial on the role of periodontitis and its influence on adverse 
pregnancy outcomes (Jared and Boggess, 2008). Recognition and understanding of the 
importance of oral health for systemic health has led to significant research into the role of 
maternal oral health and pregnancy outcomes (Jared and Boggess, 2008).  Studies by authors 
such as Minkoff et al., (1983) Redman et al., (1999) Gibbs (2001) von Dadelszen et al., 
(2002) produce a large body of evidence pointing to infection as a key factor in adverse 
pregnancy outcomes. Oral mechanical manipulation (e.g. tooth brushing, dental procedures, 
and even routine mastication) can cause bacteraemia (Sconyers et al., 1973). Authors such as 
Garcia et al., (2001); Gibbs (2001) and von Dadelszen et al., (2002) highlight that chronic 
periodontal infections can produce local and systemic host responses leading to transient 
bacteraemia. Lipopolysaccharide (LPS) endotoxins and other bacterial substances can gain 
access to gingival tissue, initiate and perpetuate local inflammatory reactions, and 
consequently produce high levels of proinflammatory cytokines. Such activations of maternal 
inflammatory cell responses and cytokine cascades play important roles in the 
pathophysiological processes of preterm labour, low birth weight, and pre-eclampsia 
(Offenbacher et al., 1998; Champagne et al., 2000; Garcia et al., 2001; Gibbs 2001; Paquette, 
2002; von Dadelszen et al., 2002).  
Several studies report associations of adverse pregnancy outcome with higher gingival 
crevicular fluid levels of PGE2 and IL-1b (Offenbacher et al., 1998; Konopka et al., 2003; 
Carta et al., 2004) and elevated amniotic fluid concentrations of PGE2, IL-1b and IL-8 
(Dörtbudak et al., 2005). Despite a tendency of higher mean gingival crevice fluid IL-1b 
levels, Noack et al., (2005) found no periodontitis-associated increased risk for pre-term birth 
and/or low birthweight and the varying results could be due to the effects of specific 
environmental or genetic risk factors, which result in variable maternal reactions. In this 
regard, it has been reported that a higher proportion of women who delivered preterm carried 
the polymorphic TNFa_308 gene (Moore et al., 2004). Importantly, the combination of 
periodontal disease and this allelic variant did not increase the risk of pre-term delivery. 
Moreover, there did not appear to be any interaction between the carriage of allelic variants 
of IL-1b13953 and TNF-a_308 gene and periodontal disease with pre-term delivery as has 
been reported for BV (Moore et al., 2004). It is possible that IL-6 produced in inflamed 
periodontal tissues can affect the foetal membranes and cause preterm uterine contractions 
(Offenbacher et al., 1998, Wang et al., 2001). There is evidence that the gingival crevicular 
fluid levels of IL-6 are higher in gingivitis and periodontitis compared with healthy controls 
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(Giannopoulou et al., 2003). In healthy Caucasians, the G/G homozygote of IL-6 gene 
polymorphism at has been associated with increased plasma levels of IL-6, whereas the C/C 
homozygote has been associated with decreased plasma IL-6 levels (Fishman et al., 1998).  
 
2.10.1. Animal studies  
In 1916, pregnant guinea pigs were inoculated with streptococci harvested from human 
stillborn foetuses and this inoculation resulted in a 100% abortion rate (Galloway et al., 
1931), thus confirming that the focal infection found in teeth, tonsils, sinuses, and kidneys 
pose a risk to the developing foetus (Galloway et al., 1931).  
Various researchers have since explored the possible association of periodontal disease with 
pregnancy complications in several experimental animal models  (Lin et al., 2003; Beck et 
al., 2005; Boggess et al., 2005; Offenbacher et al., 2005; Yeo et al., 2005). In most models, 
periodontal bacteria (P. Gingivalis or C. rectus) are injected in a small chamber that 
previously had been implanted subcutaneously in the pregnant animals (hamsters, mice, 
rabbits) (Boggess et al., 2005; Yeo et al., 2005). A periodontal infection is simulated by 
creating a site of infection distant to the foetal-placental unit and the result of these studies 
reveal that maternal infection with periodontal pathogens has a deleterious effect on foetal 
growth and viability (Boggess et al., 2005; Yeo et al., 2005). Collins and co-workers reported 
a 25% reduction in birth weight in pregnant hamsters challenged subcutaneously in the dorsal 
region with periodontal pathogen P gingivalis, compared with normal healthy pregnant 
hamsters (Collins et al., 1994).  This was also demonstrated in another study using animal 
models, where infection with Gram-negative periodontitis-associated microorganisms 
adversely affected pregnancy outcomes (Offenbacher et al., 1996). 
In a series of animal studies in which pregnant hamsters were injected with the periodontal 
pathogen P gingivalis, Beck et al., (2005) found that infection led to smaller foetuses 
(approximately 20 % reduction in weight) and to an increase of inflammatory mediators 
(TNF-α and PGE2) at the site of infection and in the amniotic fluid. In subsequent 
experiments, in which periodontal disease was induced in pregnant hamsters, the 
investigators found similar results in terms of foetal growth (Lopez et al., 2005).  These were 
the first proof-of-principle experiments to suggest a possible association of periodontal 
disease with adverse pregnancy outcomes (Beck et al., 2005; Lopez et al., 2005).  Since then, 
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many investigators have tried to establish whether this association is also present in humans 
(Beck et al., 2005; Offenbacher et al., 2006).  
 
2.10.2. Human studies  
To show the impact on humans, Galloway et al., (1931) obtained a full mouth radiographic 
series on 242 women presenting for prenatal care. Fifteen % (n=57) had an apical abscess and 
the suggested treatment was extraction of the affected tooth.  Of those who were treated, none 
resulted in a miscarriage or stillbirth (Galloway et al., 1931).  This demonstrated that the 
removal of a known focal infection was more beneficial than allowing the infection to 
manifest throughout the pregnancy.  It was therefore recommended that all foci of infection 
perceived to be a source of danger to any pregnant woman, should be removed early in 
pregnancy3 to the advantage of both the mother and the foetus (Galloway et al., 1931).  
Both gingivitis and bacterial vaginosis (BV) have been linked to adverse pregnancy outcomes 
(Persson et al., 2009) with typical vaginal colonisers such as  Ureaplasma urealyticum, 
Mycoplasma hominis, Bacteroides spp., Gardnerella vaginalis, Neisseria gonorrhoeae, 
Chlamydia trachomatis, Trichomonas vaginalis, and group B haemolytic streptococci being 
commonly isolated from the amniotic cavity following preterm delivery (Pararas et al., 2006).  
Persson et al., (2009) associated bacterial counts in BV with gingivitis, since higher vaginal 
bacterial counts could be found in women with BV and gingivitis in comparison to women 
with BV and no gingivitis, thereby suggesting a systemic infectious susceptibility.  Another 
study (Oittinen et al., 2005) of periodontal disease and BV in 252 women showed a strong 
association between periodontal disease and adverse pregnancy outcome in the first 130 
pregnant women but a borderline association between BV and adverse pregnancy outcome. 
These authors suggested bacterial synergy and that both diseases might have additive effects 
on adverse pregnancy outcome. 
                                                          
3 It is estimated that over 50% of pregnant women suffer from some form of gingival disease, either gingivitis or 
periodontitis (Jeffcoat et al 2001; Line; 2002). Many recent studies (Lopez et al., 2002; Dasanayake et al., 2003; 
Bogies et al., 2006; Offenbacher et al., 2006;  Jared and Boggess, 2008) have reported that maternal periodontal 
disease may be an independent contributor to abnormal pregnancy outcomes including preterm birth, low birth 
weight, risk for preeclampsia, mortality, and growth restriction. However, the causality of how periodontitis 
influences pregnancy outcomes has not been established (Jared, and Boggess, 2008; Dasanayake et al., 2003; 
Offenbacher et al., 2006).  
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Preterm low birth weight is an important cause of morbidity and mortality in newborns 
(Barros et al., 1992).  Low birth weight (LBW) has been associated with maternal oral 
hygiene status, smoking habits, ethnicity, systemic diseases, previous LBW babies, 
complications of pregnancy and type of delivery (López, 2008), while preterm low birth 
weight (PLBW) has been related to the mother's age, onset of prenatal care, systemic 
diseases, previous LBW babies, complications of pregnancy and type of delivery (López 
2008).  Despite intensive research on the aetiology of preterm low birth weight, in over 50% 
of clinical cases, the cause remains unknown (Barros et al., 1992). Epidemiological and 
microbiological studies have lent credence to the concept that periodontal disease may be a 
separate risk factor for cardiovascular disease, cerebrovascular disease, respiratory disease, as 
well as pre-term delivery of low birth weight infants (Barros et al., 1992; DeStefano, 1993; 
Offenbacher et al., 1996; Katz et al., 2009; Persson et al., 2009).   
High oral levels of periodontal pathogens such as P. gingivalis during pregnancy may be 
associated with an increased risk for pre-term delivery (Lin et al., 2007).  The presence of 
P.gingivalis antigens in placental tissues have been identified using immunocytochemistry 
(Katz et al., (2009).  The antigens were detected in the placental sanction trophoblasts, 
chorionic trophoblasts, decidual cells, and amniotic epithelial cells, as well as the vascular 
cells indicating that P.gingivalis may commonly colonize placental tissue, and that the 
presence of the organism may contribute to preterm delivery (Leon et al., 2007; Katz et al., 
2009).  This translocation is accompanied by an increase in inflammatory mediators in the 
placenta inducing a significant alteration in the architecture of the placenta, especially in 
areas that are critical for the exchange of nutrients between the mother and the foetus, thus 
causing a decrease in the size of the foetus and preterm delivery   (Madianos et al., 2001; 
Offenbacher et al., 2006).  A greater mean attachment loss and a higher prevalence of 
periodontitis in pre-term birth mothers (cases n=583) compared with term mothers, with no 
differences in microbial or serum antibody levels detected between the groups (Jarjoura et al., 
2005),  support the concept that maternal periodontal infection in the absence of a protective 
maternal antibody response is associated with systemic dissemination of oral organisms that 
translocate to the foetus and result in preterm deliveries (Madianos et al., 2001; Offenbacher 
et al., 2006).  
Various studies demonstrate that when there is both foetal exposure to maternal oral bacteria 
and an inflammatory response, the relative risk of preterm delivery is huge, with a risk ratio 
of 4:7 (Madianos et al., 2001; Offenbacher et al., 2006).    
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In this context, it should be noted that variations of female sex hormones during pregnancy 
may affect the subgingival microbiota (Kornman and Loesche, 1980) and that elevated 
salivary levels of  estradiol may be associated with  bacteria such as  Campylobacter rectus, 
which may contribute to the progression of periodontal disease in pregnancy (Yokoyama et 
al.,2008). 
 
2.11. Evidence favouring an association of Periodontal Disease with Pre-Term Birth 
Early evidence has shown that women delivering preterm low birth weight babies were 
almost 8 times more likely to have periodontal disease (Offenbacher et al., 1996).  Madianos 
et al., (2001) examined the prevalence of various periodontal bacteria along with the maternal 
and foetal antibody response against these organisms and tried to correlate the results with 
pregnancy outcomes in 400 pregnant women. They concluded that there was a higher rate of 
preterm deliveries among mothers without a protective immunoglobulin (IgG) response 
against the bacteria of the “red” cluster (Madianos et al., 2001). Moreover, the foetal IgM 
response against periodontal pathogens of the “orange” cluster was stronger in preterm 
neonates than in full-term neonates (19.9% versus 6.9%).  Specifically, the prevalence of 
positive foetal IgM to C. rectus was significantly higher for preterm infants, which raises the 
possibility that this maternal oral pathogen may serve as a primary infectious agent causing 
prematurity. Subsequently it has been established that from the foetuses with a robust IgM 
response to periodontal pathogens, the risk of preterm birth is greatest among those that also 
demonstrate an inflammatory response, as indicated by the increase in cord serum levels of 
C-reactive protein, IL-1β, IL-6, TNF-α, PGE2 and 8-isoprostane (Boggess et al., 2005; 
Madianos et al., 2001).   
Lin et al., (2007) examined the association between periodontal diseases and preterm birth 
and explored the underlying microbial and antibody responses associated with oral infection. 
The authors found that antepartum, the levels of periodontal pathogens tended to be higher in 
the preterm (case group) deliveries compared to the term deliveries (control group), with 
maternal anti-P gingivalis IgG significantly lower in the preterm group compared to the term 
group (Lin et al., 2007).  Postpartum, levels of P. gingivalis, T. forsythia, P. intermedia, and 
P. nigrescens were statistically significantly higher in preterm births compared to term 
deliveries when adjusting for baseline levels, demonstrating increased synergy between  the 
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red and orange microbial clusters in the preterm group compared to the term group (Lin et al., 
2007).  This study confirmed that high levels of periodontal pathogens and low maternal IgG 
antibody response to periodontal bacteria during pregnancy are associated with an increased 
risk for preterm delivery (Lin et al., 2007).  Other factors significantly associated with 
preterm birth include a history of previous preterm birth and a low birth weight, frequency of 
prenatal visit, preterm uterine contraction, antepartum haemorrhage, placenta previa and 
preterm premature rupture of membranes (Chan et al; 2010).  After controlling for other risk 
factors, Chan et al. (2010) also associated preterm birth with BANA-positive plaques in the 
3rd trimester.  
In another case-control study, women who delivered a full-term infant weighing <2500 grams 
were matched to women who delivered full term infants weighing >2500 grams. All women 
received a periodontal evaluation after delivery, and poor periodontal health was determined 
to be an independent risk factor for delivering a low-birth-weight infant (Dasanayake 1998; 
Jared and Boggess 2008).  The same conclusion was drawn from a recent case-control study 
on the relationship between maternal periodontal disease and low birth weight babies 
(Haerian-Ardakani et al., 2013) where bleeding on probing, presence of supra-gingival 
calculus and CPITN scores were used for periodontal assessment.    
Two prospective cohort studies (Jeffcoat et al., 2001; Offenbacher et al., 2006) found that 
moderate to severe periodontitis identified early in pregnancy could be associated with an 
increased risk for spontaneous preterm birth, independent of other traditional risk factors. In 
the first study, investigators from the University of Alabama conducted a prospective 
evaluation of over 1300 pregnant women. Complete medical, behavioural, and periodontal 
data were collected between 21 and24 weeks gestation. Generalized periodontal infection was 
defined as 90or more tooth sites with periodontal ligament attachment loss of ≥3 mm.  The 
risk for preterm birth was increased among women with generalized periodontal infection; 
this risk was inversely related to gestational age. After adjusting for maternal age, race, 
tobacco use, and parity, this relationship remained (Jeffcoat et al., 2001).   Offenbacher et al., 
(2006) conducted a prospective study of obstetric outcomes of over 1000 women who 
received an antepartum and postpartum periodontal examination. Moderate to severe 
periodontal infection was defined as 15 or more tooth sites with pockets depth ≥4 mm. The 
incidence of increased periodontal pocketing, defined as clinical disease progression, was 
determined by comparing site-specific probing measurements between the ante partum and 
postpartum examinations (Offenbacher et al., 2006; Jared and Boggess, 2008). Disease 
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progression was considered present if 4 or more tooth sites had an increase in pocket depths 
by ≥2 mm, with the postpartum probing depth being ≥4 mm. Compared to women with 
periodontal health, the relative risk for spontaneous preterm birth < 37 weeks gestation was 
significantly elevated for women with moderate severe periodontal infection, adjusting for 
maternal age, race, parity, previous preterm birth, tobacco use, markers of socioeconomic 
status, and presence of chorioamnionitis.  Here too, periodontal disease progression was 
found to be an independent risk factor for delivery < 32 weeks gestation (Offenbacher et al., 
2006; Jared and Boggess, 2008). 
Santos-Pereira et al., (2007) studied 124 women between the ages of 15-40 to determine if 
chronic periodontitis increased the risk of experiencing preterm labour (PTL). In this cross-
sectional trial, women who were admitted for preterm labour, with intravenous tocolysis, 
were enrolled into the PTL group. The control group consisted of term pregnancies that were 
admitted following the PTL mother. Periodontal examinations were performed within 36-48 
hours after delivery and before discharge. Chronic periodontitis was described as one site 
with clinical attachment loss (CAL) > 1 mm with gingival bleeding. The severity of 
periodontitis was classified as early (CAL <3mm), moderate (CAL > 3 mm and < 5 mm), and 
severe (CAL >5mm). The extent of periodontitis was either localized, CAL < 30%, or 
generalized CAL > 30%. They, and others, confirmed that chronic periodontitis increased the 
risk of having preterm labour and a low-birth-weight infant (Goepfert et al., 2004; Santos-
Pereira et al., 2007; Jared and Boggess, 2008). 
Self-reported periodontitis was considered to be an independent risk factor for poor 
pregnancy outcomes in a cohort of women who completed a self-report questionnaire during 
their second trimester of pregnancy to assess their demographic, medical and reproductive 
history, smoking, pre pregnancy weight, and physical activity at the first prenatal visit 
(Pitiphat et al., 2008). There was no significant increased risk of having a preterm birth or 
small-for-gestational-age infant when adjusting for smoking, race/ethnicity, socioeconomic 
status, BMI, history of preterm delivery, presence of genitourinary infection, weekly weight 
gain, and history of dental check-ups in these mothers but a significant increase in risk for 
those who reported having periodontitis and poor pregnancy outcomes was noted . However, 
caution should be taken when interpreting these results due to the sample size and the indirect 
measurement (self-reported) of periodontitis (Pitiphat et al., 2008). 
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Another prospective cohort, enrolled over 1200 women to evaluate the association between 
periodontitis and preterm birth and/or low birth weight (Agueda et al.2008).  All women were 
between the ages of 18- 40 and were enrolled between 20-24 weeks gestation.  Demographic 
data, socioeconomic status, and medical and obstetric history were collected and full mouth 
periodontal examinations; (PD, CAL, and BOP) were performed by a single calibrated 
examiner and recorded at six sites per tooth. Periodontal disease was defined as four or more 
teeth with one or more sites with PD > 4mm and CAL > 3mm at the same site (Bogies et al., 
2006).  After adjusting for confounding variables, a significant association was found 
between preterm birth and periodontitis. However, no significant association was found 
between low birth weight and periodontitis (Agueda et al., 2008).   
A case-control study of  pregnant or postpartum mothers, in which cases (mothers who 
currently or previously delivered PLBW infants)  had significantly worse periodontal disease 
than controls (mothers who delivered fullterm), the study,  after controlling for other risk 
factors, concluded that periodontal disease is a statistically significant risk factor for PLBW 
(Mokeem et al., 2004). Similarly, in another case-control study, Dasanayake et al., (1998) 
studied 55 pairs of women and using logistic regression, demonstrated that mothers with 
healthy gingiva were at lower risk for LBW infants.    
Based on the analysis of 12 identified studies that met their inclusion and exclusion criteria 
(six case–control, three cross-sectional and longitudinal, and three interventional) 
Scannapieco et al., (2003),  while recognising an association between periodontal disease and 
adverse pregnancy outcomes, reported that they found no clear evidence that periodontal 
disease has a causal role.  Another analysis of 25 studies (13 case–control, nine cohort, and 
three controlled trials) that focused on pre-term low birth weight, low birth weight, pre-term 
birth, birth weight by gestational age, miscarriage or pregnancy loss, and pre-eclampsia, 
found that 18 of the studies suggested an association between periodontal disease and 
increased risk of adverse pregnancy outcome while others found no evidence of such an 
association (Xiong et al., (2006).  These authors agree that  even though it appeared that  
periodontal diseases might be a risk factor for preterm and/or low birth weight, more 
methodologically rigorous studies are needed to confirm this (Scannapieco et al., 2003;  
Xiong et al., 2006).  
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2.12. Evidence against an association of Periodontal Disease with Pre-Term Birth 
While there are data suggesting a relationship between maternal periodontal infection and 
preterm birth, several studies have failed to demonstrate such an association (Holbrook et al., 
2004; Buduneli et al., 2005; Dörtbudak et al., 2005; Rajapakse et al., 2005; Xiong et al., 
2006). In one of the largest studies to date, Moore et al., (2004) examined the relationship 
between multiple periodontal parameters, including mean probing depths, % of tooth sites 
with probing depths ≥4 mm, % of sites with bleeding on probing, and % of sites with clinical 
attachment loss ≥2 or ≥3 mm.  No difference was found in the periodontal parameters 
between women with preterm birth and without preterm birth (Moore et al., 2004).  However, 
a positive association have been demonstrated between maternal periodontal infection and 
spontaneous abortion between 12 and 24 weeks (Moore et al., 2004; Jared and Boggess, 
2008). 
A systematic review by Vettore et al., (2006) identified 36 studies that met their inclusion 
criteria, 26 of which reported associations between periodontal disease and adverse 
pregnancy outcomes. They noted clear differences between studies concerning measurement 
of periodontal disease and adverse pregnancy outcomes. Moreover, they reported that most 
studies did not control for confounders, thus rising serious doubts about conclusions that can 
be drawn from them.   For that reason, it was proposed that the most that can be derived from 
these studies is the conflicting evidence to support a relationship between periodontal disease 
and pre-term birth (Konopka et al. 2003).   
In a case-control study, Budeneli and colleagues found no differences in periodontal infection 
between women who delivered preterm versus those who delivered full term (Buduneli et al., 
2005). However, women were at significantly increased risk for preterm birth if either P. 
Gingivalis or C. rectus were found in their subgingival plaque (Buduneli et al., 2005). In a 
more recent case-control study, Vettore et al., (2008) recruited 542 postpartum women who 
were over 30 years old and sought to explore the relationship between periodontal disease 
and preterm low birth weight. Cases were divided into 3 groups: low birth weight (n = 96), 
preterm (n = 110), and preterm and low birth weight (n = 63). Cases were compared to 
controls who were no preterm and non-low-birth-weight individuals (n = 393). Periodontal 
measurements were collected and later stratified into 15 definitions of periodontal disease for 
analysis. Other covariates were also recorded and used for analysis. The results of this study 
indicated that periodontal disease levels were higher in control individuals than in cases, and 
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that the extent of periodontal disease did not increase the risk of preterm low birth weight. 
They also showed that in the preterm low birth weight group, the mean pocket depth and the 
frequency of sites with CAL > 3 mm were lower than in the control group. It was concluded 
that periodontal disease was less severe in women with preterm low-birth-weight babies 
(Vettore et al., 2008).Xiong et al., 2006 performed a systematic review and meta-analysis of 
44 studies (26 case control, 13 cohort, and 5 controlled trials) to examine the relationship 
between maternal periodontal disease and adverse pregnancy outcome. The meta-analysis 
showed that maternal treatment of periodontal disease reduced the rate of preterm low birth 
weight infants as a group but not preterm or low birth weight individually (Xiong et al., 
2006). 
In a more recent study, Srinivas et al. (2009) compared the risk of adverse pregnancy 
outcomes (preterm birth, preeclampsia, foetal growth restriction, or perinatal death) in 
women with and without periodontal disease in a multicenter prospective cohort study and 
failed to demonstrate an association (Srinivas et al., 2009).  A study of postpartum women in 
Italy yielded similar results (Abati et al., 2013).  
A case-control study on the relationship between oral health status (periodontal disease and 
carious pulpal exposure (CPE)) and preterm low-birth-weight (PTLBW) infant deliveries 
among Tanzanian-African mothers found no evidence to support the claim that periodontal 
disease or carious pulpal exposures are significant risk factors for preterm low-birth-weight 
infant delivery among Tanzanian-African mothers (Mumghamba and Manji, 2007). However 
they found young age, hypertension and being unmarried as significant risk factors and 
suggested a need for research that is not only prospective in nature, but also conducted on a 
larger scale incorporating both periodontal pathogens and mediators of inflammation 
(Mumghamba and Manji, 2007). 
Farrell et al., (2006) found no association between poorer periodontal health and either pre-
term birth or low birth weight in a cohort study of 1793 women who reported no history of 
smoking.   However, they reported an association between higher mean probing depth and 
late miscarriage.  
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2.13. Problems with Studies of periodontal disease and adverse pregnancy  
Many studies have reported a positive association between maternal periodontal disease and 
adverse pregnancy outcomes, especially the increased risk of pre-term birth and low birth 
weight. However, it is impossible to make any clear conclusions from these studies because 
of the many different study designs, sampling methods, definitions of periodontal disease and 
adverse pregnancy outcomes, confounding factors, and possible effect modification by 
known or unknown factors (Borrell and Papapanou, 2005; Hyman, 2006; Vettore et al., 
2008). 
 
2.13.1. Differences in diagnostic criteria  
In previous studies concerning the association of periodontal disease and adverse pregnancy 
outcomes, various periodontal disease definitions have been used with the commonly 
accepted clinical measures of periodontal disease that were established >50 years ago 
(Ramfjord 1959), still being used as diagnostic criteria today  (Xiong et al., 2006).  Although 
various indices have been developed since then (Loë and Silness 1963; Silness and Loë, 
1964; Ainamo et al., 1982), most have limited validity (Carlos et al., 1986; Baelum and 
Papapanou, 1996).Without a universally accepted standard for periodontal disease diagnosis, 
most of the researchers used their own case definitions that combined pocket depth (PD) and 
clinical loss of attachment (CAL), based mostly on disease distribution within the study 
population (Xiong et al., 2006).  Some studies defined periodontal disease in terms of 
Decayed, Missing, and Filled Teeth (DMFT) and Community Periodontal Index of Treatment 
Needs (CPITN), the Russell Periodontal Index (RPI) and similar indices, all of which have 
limited sensitivity for disease detection (Ainamo et al., 1982; Dasanayake 1998; Carta et al., 
2004; Mokeem et al., 2004; Xiong et al., 2006).  However, it is clear that the CPITN is 
unsuitable for measuring the prevalence and severity of periodontal disease (Baelum & 
Papapanou, 1996).  
A consensus on a definition is essential to optimize the interpretation, comparison, and 
validation of clinical data and with no universal consensus  on definition, any prior 
definitions may prove to be obsolete as we gain further information regarding the 
pathophysiology of the associations reported (Borrell and Papapanou, 2005). Clinical markers 
of periodontal disease, such as gingival recession, clinical attachment loss, or bleeding on 
periodontal probing, may be late manifestations of the local infection, such that bacterial 
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exposure may have already occurred with subsequent downstream deleterious effects 
(Kramer 1987; Borrell and Papapanou, 2005; Xiong et al., 2006).  Recognition of the 
variation in clinical criteria used to define periodontal infection is important when reviewing 
the literature. Traditional measurements for diagnosing PD have focused on clinical 
morbidity, and often result in inconsistent diagnosis and the inability to recognize active 
disease thus studying the anaerobic bacterial burden and the inflammatory response may be 
more critical than measuring PD (Manau et al., 2008). 
2.13.2. Consideration of confounding risk factors 
Periodontal disease and adverse pregnancy outcomes are associated with a variety of risk 
factors, many of which, such as smoking and low socioeconomic status, are common to both 
(Hyman 2006).  In addition to the lack of a consistent clinical definition, several of the 
studies (Moore, et al., 2004; Holbrook et al., 2004; Buduneli et al., 2005) with no association 
between maternal periodontal disease and adverse pregnancy outcomes did not control for 
potential confounding variables,  thus  questioning  whether in those studies that reported an 
association, the observed associations represent a causal relationship or are due to the 
confounding effects of other variables such as low socio-economic status and smoking 
(Paquette, 2000; Hujoel et al., 2002; Hyman , 2006 and Xiong et al., 2006). Several important 
confounding variables such as history of adverse pregnancy outcomes, infections (e.g. 
bacterial vaginosis and chorioamnionitis), antibiotic use during pregnancies, excessive body 
mass index, or maternal disorders (hypertension, diabetes) must be considered (Paquette 
2002; Hujoel et al., 2002; Xiong et al., 2006). Moreover, psychosocial and demographic 
factors as well as previous history of adverse pregnancy outcome are almost completely 
neglected, even though they are considered to be among the most prominent risk factors for 
adverse pregnancy outcome (Vettore et al., 2008). 
In a study of poor, rural, non-smoking Sri Lankan women, Rajapakse et al., (2005) found that 
periodontal disease was not significantly associated with an increased risk of preterm low 
birth weight. The authors suggested that previously reported associations might have been 
due to the residual confounding effects of smoking and other variables, while also accepting 
that they were not adequately powered to test the association.   
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2.13.3. Differences in populations studied 
Another potential reason for the disparate findings among studies is the differences in 
populations studied.  Most studies that showed an association between periodontal disease 
and adverse pregnancy outcomes have consistently been found in populations with a high 
incidence of preterm deliveries and within economically challenged families. Quite the 
opposite is true for those studies that did not show an association. They were usually 
conducted in countries with universal health care and a lower incidence of preterm birth or 
low-birth-weight infants. Differential access to health care insurance, dental care, and 
prenatal care, may confound the relationship between maternal periodontal disease and 
adverse pregnancy outcome. Disparities in oral health may also be partially explained by 
racial differences in inflammatory and immune responses (Dasanayake 1998, Carta et al., 
2004, Mokeem et al., 2004).  One of the important differences found in studies conducted in 
the USA or in developing countries tended to include African American women and women 
from economically disadvantaged families, and they consistently reported significant 
associations between periodontal disease and adverse pregnancy outcomes. In contrast, the 
studies conducted in European countries or Canada (all of which offer their citizens universal 
health care) did not find an association between periodontal disease and adverse pregnancy 
outcomes  suggesting that the effects of periodontal disease on adverse pregnancy outcomes 
may be different according to the socio-economic status and access to dental care (Xiong et 
al., 2006). 
 
2.13.4 .Differences in definitions of adverse pregnancy outcomes 
Another issue that complicates that association of adverse pregnancy outcomes with 
periodontal disease is the different ways that studies have defined adverse pregnancy 
outcome (Hyman, 2006; Xiong et al., 2006; Vettore et al., 2008).  A number of studies do not 
use the anticipated delivery date as a fundamental reference baseline.  Each definition of 
adverse pregnancy outcomes may have a very different genesis. For example, many types of 
inflammation and infection may potentially influence IUGR, pre-term labour, premature 
rupture of membranes, pre-term birth, and eclampsia and only one of which may be 
periodontal disease (Hyman, 2006; Vettore et al., 2008).  It is clear that reports that do not 
clearly distinguish between the many types of adverse pregnancy outcomes and simply 
categorize infants as PLBW, apparently excluding preterm infants with normal birth weights 
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and full-term infants with low birth weights (i.e. intrauterine growth restriction) thereby 
adding little to our understanding of the potential relationship between periodontal disease 
and adverse pregnancy outcomes. Of the clinical trials reported to date, only that reported by 
Michalowicz et al., (2006) meets generally accepted standards for clinical trials including 
multicentre design, establishment of adequate sample size based on a priori criteria of a 
clinically meaningful outcome, evidence of appropriate data and safety monitoring by an 
independent review board, intent-to-treat analysis, reporting of secondary periodontal 
outcomes as well as the primary outcome variable, and public registration before trial 
initiation (Hyman, 2006; Vettore et al.,2008). 
 Adverse pregnancy and pre-term birth statistics can have a major impact on health care 
policy because they often form the basis for international comparisons and assessment of 
health care funding needs. Pre-term birth rates are based on gestational age. Because 
gestational age can only be reliably identified in about 15% of cases (Schneider et al., 2006), 
birth weight is often used as a surrogate measure of pre-term birth. As result, incorrect 
conclusions regarding-term births are often made. For example, only two-third of infants born 
in Germany weighing 2500g are preterm; the remaining are term-born underweight due to 
genetic or developmental restriction (Schneider et al., 2006; Wimmer and Pihlstrom, 2008). 
In order to estimate the impact of any disease, it is critical that the disease be well 
characterized and accurately assessed.  While the definitions of preterm birth, very preterm 
birth, low birth weight, small for gestational age, and other obstetric findings are reasonably 
well defined, no consensus has yet been achieved on the definition of periodontitis in 
periodontal research (Kramer 1987; Xiong et al., 2006). Unless this is done, one cannot judge 
whether the periodontal therapy was successful in reducing signs of disease (Carta et al., 
2004; Mokeem et al., 2004).   
 
2.14.   Treatment of Periodontal disease 
Since periodontal disease is considered to be plaque induced, most treatment and prevention 
techniques have used non-specific debridement procedures as the primary means of 
controlling plaque deposits (Loesche, 1976; Loesche, 1999). 
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2.14.1. Mechanical debridement 
Nonsurgical treatment of periodontal disease includes the mechanical removal of 
supragingival and subgingival microbial deposits and calculus by debridement. Debridement 
can be implemented using hand or ultrasonic instruments to remove bacteria and calculus and 
to plane the root surfaces to remove diseased and bacterially contaminated root surfaces 
(Loesche and Grossman 2001).  Preshaw (2004) asserts that the foundation of periodontal 
treatment is root surface instrumentation which is necessary to disrupt the subgingival biofilm 
mechanically and reduce the bacterial bio burden. Although bacteria are necessary for 
periodontal disease to occur, a susceptible host is also required (Preshaw, 2004; Offenbacher 
et al., 2008). The immune-inflammatory response that develops in the gingival and 
periodontal tissues in response to the chronic presence of plaque bacteria results in 
destruction of structural components of the periodontium leading, ultimately, to the clinical 
signs of periodontitis(Preshaw, 2004). 
The "biologic systems model" proposed by Loesche (1999), Harmse and Ehmke (2006) and 
Offenbacher, et al (2008), highlights that the clinical presentation of periodontal disease is 
intimately tied to the underlying biologic phenotype. The model also states that the 
integration of subject-level factors, microbial composition, systemic immune response, and 
gingival tissue inflammatory mediator responses will better reflect the biology of the biofilm-
gingival interface in a specific patient (Loesche, 1999; Harmse and Ehmke, 2006; 
Offenbacher et al., 2008).  
This may provide insights on clinical management and in the treatment of periodontitis. The 
value of microbiological testing is closely linked to the value of a specific, adjunctive 
antimicrobial therapy. However, there is only little evidence that knowledge of a patient’s 
oral microbial colonisation results in improved clinical outcomes (Loesche, 1999; Harmse 
and Ehmke, 2006; Offenbacher et al., 2008). The management of periodontal disease by 
means of a treatment strategy based on the Specific Plaque Hypothesis is easier and less 
expensive to implement than one based on debridement/surgical intervention, as espoused by 
the Non-specific Plaque Hypothesis (Harmse and Ehmke, 2006; Offenbacher et al., 2009). 
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2.14.2. Antimicrobial therapy for periodontitis 
The option of anti-microbial therapy for periodontitis depends upon the type of bacteria that 
are responsible for the periodontal pathology, as clinical symptoms do not indicate which 
antimicrobial agent to use (Loesche, 1999; Offenbacher et al., 2009).   According to Foster 
and Kolenbrander, (2004) microbial communities within the human oral cavity are dynamic 
associations of more than 500 bacterial species that form biofilms on the soft and hard tissues 
of the mouth.  
Highly selective interspecies recognition is evident as initial colonizers pair with early and 
middle colonizers to form multispecies communities that grow on saliva (Foster and 
Kolenbrander, 2004; Kolenbrander, 2011).4 Considering the non-specific plaque hypothesis, 
then it would be best to use antimicrobial agents that kill as many bacterial species as 
possible (Loesche, 1999; Offenbacher et al., 2009).  On the other hand, considering the 
specific plaque hypothesis, which implies that the host response is to a limited number of 
bacterial types, would advocate that an agent that is active against the specific 
periodontopathic species is indicated (Loesche, 1999; Offenbacher et al., 2009). The 
difficulty in eliminating spirochetes or A. actinomycetemcomitans, P. gingivalis, and P. 
intermedia from plaques suggests that the elimination of these species is not a realistic 
treatment outcome (Flemmig et al., 1996; Mombelli et al., 1996; Scannapieco, 2005).  Many, 
if not all, of the periodontopathic bacteria are so prevalent in plaque samples that they could 
be considered as members of the normal microbiota (Flemmig et al., 1996; Mombelli et al., 
1996; Scannapieco, 2005). This persistence of the periodontopathic species probably relates 
to the underlying microbial ecology of the plaque and the relationship of these species to each 
other and to the host4 (Scannapieco, 2005; Loesche, 1999, Africa 2012). 
 
2.14.3. Periodontal treatment and pregnancy  
Prevention and treatment of periodontal infection is aimed at controlling the bacterial biofilm, 
arresting progressive infection, and restoring lost tooth support (Jeffcoat, 1994). Recent 
                                                          
4Human oral bacteria interact with their environment by attaching to surfaces and establishing mixed-species 
communities. As each bacterial cell attaches, it forms a new surface to which other cells can adhere. Adherence 
and community development are spatiotemporal; such order requires communication (Foster and Kolenbrander, 
2004; Kolenbrander, 2011). 
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studies have assessed the value of periodontal therapy in decreasing the incidence of 
pregnancy complications and as an independent risk factor for obstetric complications.  
However, they have been inconclusive on the effects of periodontal therapy during pregnancy 
for preventing adverse pregnancy outcomes (Davenport et al., 2002 ; Lopez et al., 2002b; 
Dasanayake et al., 2003; Lopez et al., 2005; Michalowicz et al., 2006;  Jared and Boggess, 
2008). 
 
2.14.3.1. Studies supporting the effectiveness of therapy in reducing adverse pregnancy 
outcomes.  
In a pilot trial of periodontal treatment, Offenbacher et al., (2006), found a trend towards 
reduced preterm birth among women treated during pregnancy compared with those who 
delayed therapy until postpartum.  In another study, a statistically significant reduction in 
preterm birth was observed when comparing the effect of mechanical, non-surgical therapy 
plus the use of a powered toothbrush with oral hygiene alone and the use of a hand 
toothbrush (Offenbacher et al., 2006b).  The authors concluded that treatment was safe, 
improved periodontal health, prevented periodontal disease progression, and resulted in a 3.8-
fold reduction in pre-term birth (after adjusting for baseline imbalance in periodontal 
disease).  
These studies demonstrated that women who were treated during pregnancy had a significant 
improvement in oral health measures and a reduction in oral pathogen burden.  The women 
treated during pregnancy showed an improvement in clinical markers of periodontal 
infection, with reduction in clinical attachment loss and reduction in bleeding on dental 
probing.  In another randomized, intent to treat study, Tarannum and Faizuddin (2007) found 
that nonsurgical periodontal treatment during pregnancy reduced the risk of preterm births 
(p<0.001) and low birth weight (p<0.002).  An inverse correlation existed between CAL and 
birth weight in the control group, which may suggest that higher CAL were associated with 
lower birth weights. There was also an inverse correlation between gestational age and 
periodontal characteristic in both groups. This may suggest that shorter gestational ages were 
associated with higher values among periodontal parameters (Tarannum and Faizudin, 2007). 
Several earlier  clinical trials have also concluded that periodontal treatment during 
pregnancy may reduce the rates of pre-term birth or the composite outcome of preterm birth 
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and/or low birth weight (Lopez et al., 2002b, Giannopoulou et al.,. 2003, Jeffcoat et al., 2003, 
Lopez et al., 2005, Sadatmansouri et al., 2006, Offenbacher et al., 2006a).  Similar outcomes 
were observed in randomized intervention studies (Mitchell-Lewis et al., 2001; Lopez et al., 
2002; Jeffcoat et al., 2003), consisting  of scaling and root planning of all teeth with or 
without the use of a chlorhexidine mouth rinse or metronidazole.  
Lopez et al., (2005), enrolled 870 pregnant Chilean women with gingivitis in a randomized 
trial of periodontal treatment during pregnancy versus delayed treatment, and found almost a 
2-fold reduction in pre-term birth and/or low birthweight deliveries among women treated 
during pregnancy. The pregnant women were randomly assigned to receive periodontal 
therapy before 28 weeks of gestation (n=580) or after delivery (n=290). Periodontal therapy 
consisted of plaque control instructions, supra and subgingival scaling, once-daily 0.12% 
chlorhexidine mouth rinses and oral hygiene instruction. Lopez et al., (2005) reported that 
women with gingivitis who received periodontal therapy before 28 weeks of gestation had a 
significantly lower incidence of pre-term birth and/or low birthweight deliveries than women 
who did not receive periodontal therapy.  
Periodontal treatment was found to contribute to decreased adverse pregnancy outcomes 
following the effects of non-surgical treatment of periodontal disease during the second 
trimester of gestation (Sant'Ana et al., 2011; Reddy et al., 2014).   
 
2.14.3.2. Studies showing no effect of therapy in reducing adverse pregnancy outcomes 
Randomized clinical trials (RCTs) of antibiotic administration to reduce the rate of pre-term 
birth have yielded conflicting results (Morales et al., 1994; Hauth et al., 1995; McDonald et 
al., 1997; Carey et al., 2000; Paavonen et al., 2000; Rosenstein et al., 2000; Kekki et al., 
2001; Lamont 2003; Ugwumadu et al., 2003) and there is no uniform proof that antibiotic use 
reduces the risk of pre-term birth. 
A   meta-analysis comprising thirteen trials and comparing 3,576 women in intervention 
groups with 3,412 women receiving usual care, demonstrated no significant reduction in 
preterm births and low birth weights.  It was found that primary periodontal care during 
pregnancy could not be considered an efficient way of reducing the incidence of preterm birth 
(Sadatmansouri et al., 2006).    Jeffcoat et al., (2003) reported the results of a single-centre, 
three-arm RCT conducted in the United States although a ‘‘trend’’ was reported, this study 
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found there was no statistically significant benefit of adjunctive metronidazole antibiotic to 
scaling and rootplaning in reducing adverse pregnancy outcomes (Jeffcoat et al., 2003). 
Indeed, consistent with other pre-term birth trials using metronidazole (Klebanoff et al., 
2003); adjunctive use of this antibiotic to scaling and rootplaning actually increased the rate 
of pre-term birth compared with scaling and rootplaning plus placebo.  Although periodontal 
treatment was reported to improve measures of periodontal disease, it did not alter the risk of 
adverse pregnancy outcome (Michalowicz et al., 2006), however, the study indicated that 
treatment of periodontitis in pregnant woman improves periodontal disease and is safe 
(Michalowicz et al., 2006). 
 
2.15. The importance of oral health during pregnancy  
Wilder et al., (2007) surveyed practicing obstetricians in five counties in North Carolina to 
assess their knowledge of periodontal disease and to determine their practice behaviours 
regarding oral disease and adverse pregnancy outcomes.  They found that only 22% looked in 
a patient’s mouth at an initial visit. In addition, while most (84%) considered periodontal 
disease a risk factor for adverse pregnancy outcomes, 49% rarely or never recommended a 
dental visit during pregnancy (Wilder et al., 2007).   
Another North Carolina survey of 504 nurse practitioners, physician assistants and certified 
nurse midwives assessed the knowledge, behaviour, and opinions about periodontal disease 
and its relationship to adverse pregnancy outcomes. Of the 204 who responded, 63% reported 
looking in the patient’s mouth to screen for oral problems at the initial visit, 20% felt that 
their knowledge of periodontal disease was current, and all agreed that their discipline should 
receive instruction regarding periodontal disease. A collaborative effort between the health 
care provider and the oral health care professionals was indicated by 95% in order to reduce 
the patient’s risk of having an adverse pregnancy outcome (Thomas, 2008).  
A later study,  (Morgan et al., 2009) assessed how obstetrician-gynaecologists address oral 
health during pregnancy and found that most obstetrician-gynaecologists agree that routine 
dental care during pregnancy is important (84%), periodontal disease can have adverse 
effects on pregnancy outcome (84%), and treating periodontal disease positively affects 
pregnancy outcome (66%). This study found that the majority seldom ask pregnant patients 
whether they have recently seen a dentist (73%), ask about current oral health (54%), or 
provide information about oral care (69%). Over a third (38%) obstetrician-gynaecologists 
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reported not advising patients to see a dentist for routine prophylaxis, with 80% of these 
saying they had not previously thought about it. Most respondents (77%) reported having 
patients that declined dental services because of pregnancy (Morgan et al., 2009).  It was 
concluded that obstetrician-gynaecologists recognize the importance of good oral health 
during pregnancy but largely do not address it. It was suggested that improved training in the 
importance of oral health including the recognition of oral health problems, and knowledge of 
procedure safety during pregnancy may make doctors more comfortable with assessing oral 
health and more likely to address it with patients (Morgan et al., 2009).  A recent study (Chi 
et al., 2014) found that dentists who were knowledgeable about periodontal disease were 
more likely to counsel pregnant patients and proposed that future interventions should 
improve the oral health knowledge of dentists and other healthcare professionals regarding 
the importance of comprehensive dental care, including periodontal treatment when needed, 
for all pregnant patients. 
The prophylactic programme for the pregnant woman, must entail a thorough interview 
include an informative session on the specific risks during this period, and the motivation of 
the patient towards oral-dental health and for implementing, the needed primary prophylactic 
measures (Iftime 2008). 
Sunita and Kee (2013) and Avula et al. (2013) conducted knowledge, attitudes and practices 
(KAP) assessment of oral health and adverse pregnancy outcomes among pregnant women in 
Hyderabad, India and Brunei, Darussalam respectively. The authors found that most pregnant 
women need more information about oral health and disease prevention and concluded that it 
would be prudent to compile and consider their knowledge, attitudes and practices along with 
sociocultural characteristics, so that health education programmes are customised to different 
sectors of the population  (Sunita and Kee 2013 ; Avula et al. 2013). More intense dental 
health education, including oral health promotion in maternal child health centers, can lead to 
improved oral and dental health and ultimately, favourable pregnancy outcomes (Sunita, 
2013).Information and knowledge of the causes of the main oral-dental diseases during 
pregnancy will assist pregnant women to take corrective action and be able to minimize their 
effects.  A well-defined, realistic and easily applicable programme during early pregnancy 
stages will ensure oral health personnel may achieve this goal (Iftime, 2008; Jeffcoat, 1994, 
Sunita, 2013).  
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Maintaining good oral hygiene before and during pregnancy is crucial for preventing 
gingivitis and periodontitis (Jeffcoat, 1994).  Dental professionals can facilitate this level of 
oral health through assessment, education, and proper treatment planning. Verifying the 
hormonal status and other risk factors for periodontal diseases and poor pregnancy outcomes 
of women during the medical history process will enable the provider to customize the 
treatment plan and oral hygiene instructions. Behavioural interventions such as smoking 
cessation, exercise, healthy diet, and maintenance of optimal weight are also useful 
preventive measures against periodontal disease (Iftime, 2008; Jeffcoat, 1994). While the 
mechanisms of these interventions is unknown, they likely operate by reducing conditions 
that promote growth of pathologic bacteria, improving immune function, reducing 
inflammatory responses, and improving glucose control (Jeffcoat, 1994).  
 
2.16. Dental procedure safety guidelines 
Current guidelines and data suggest that dental care during pregnancy is safe. However, 
scaling and root planning is best accomplished between 14-20 weeks gestational age. 
Providing dental care for pregnant women will help remove potentially harmful bacteria from 
dissemination and possibly leading to other complications (Offenbacher et al., 2006).  
In 2004, the American Academy of Periodontology (AAP) issued a position statement 
regarding dental care for pregnant women. The AAP recommended that all women who were 
pregnant or planning a pregnancy should receive preventive dental care, including a 
periodontal examination, a prophylaxis, and restorative treatment (American Academy of 
Periodontology, 2004). The American Academy of Periodontology (2004) also proposed that 
scaling and root planning should be complete early in the second trimester and that any 
presence of acute infection or abscess should be treated immediately, irrespective of 
gestational age. Treating infection as early as possible will remove a potential source of 
infection that could be harmful to the mother and the baby (American Academy of 
Periodontology, 2004). AAP confirmed that treatment of periodontitis in pregnant women is 
safe and should be performed to improve the oral health of the woman. This has been 
supported by The Academy of General Dentistry (AGD) whose recommendations are similar 
to the AAP but they suggest that pregnant women have a tiered treatment plan to include an 
examination in the first trimester, a dental cleaning in the second trimester, and then, 
depending on the patient, another appointment early in the third trimester (National Institute 
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of Dental and Craniofacial Research. 2006). They also recommend communication between 
the dental provider and the obstetrician for any dental emergency that would require 
anaesthesia or other medication to be prescribed.  
The American Dental Association (ADA) suggestions are similar to the AAP and the AGD; 
however, they also address the safety issues surrounding taking a dental radiograph during 
pregnancy. If a radiograph is needed for diagnosis or treatment, as they often are, then 
pregnant women should have the radiographs taken. Matteson et al., (1991) estimated that a 
full mouth series of radiographs, with 20 radiographs, exposes the mother to <1 m rem of 
radiation. The foetus is usually exposed to approximately 75 m rems of naturally occurring 
radiation during a pregnancy. Therefore, dental radiographs contribute to a negligible amount 
of radiation exposure (Matteson et al., 1991). Care and caution should be taken to prevent 
further exposure by using a leaded apron with a thyroid collar (Matteson et al., 1991). 
In 2004, Bright Futures Practice in Oral Health published an oral health pocket guide 
designed to provide health care providers with an overview of preventative oral health 
supervision for 5 developmental periods, including pregnancy and postpartum. Bright Futures 
began in 1990 and was initiated by the Health Resources and Services Administration 
(HSRA) Maternal and Child Health Bureau (MCHB). The guidelines suggest that health care 
providers assess the risk of oral disease and provide general suggestion to prevent carious 
lesions in pregnant women (Bright Futures Practice in Oral Health 2004). Other suggestions 
or recommendations for the prevention of carious lesions included to expectorate and not 
rinse the mouth after brushing with fluoridated toothpaste to allow the fluoride additional 
time to protect the teeth (Bright Futures Practice in Oral Health 2004). They recommended 
that pregnant women use an alcohol free, over the counter-fluoridated mouth rinse at night. 
While carious lesions do not lead to periodontal diseases, the accumulation of bacterial 
plaque biofilm is a culprit in these diseases.  Like many other initiatives, Bright Futures 
recommends that pregnant women visit an oral health care provider for an examination and 
restoration of all active carious lesions as soon as possible (Bright Futures Practice in Oral 
Health 2004). 
According to the National Institute of Dental and Craniofacial Research (2006), early in the 
second trimester (14-20 weeks gestation) is the most favourable time to perform dental 
procedures. During this gestational age there is no threat of teratogenicity, nausea and 
vomiting have usually subsided, and the uterus is below the umbilicus, providing more 
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comfort to the mother (American Academy of Periodontology, 2004; National Institute of 
Dental and Craniofacial Research, 2006). Unrestored carious lesions should be restored as 
soon as possible as some pregnant women require general anaesthesia with intubations at 
delivery. Some physicians are hesitant to intubate due to the increased risk of airway 
obstruction due to the decreased integrity of decayed teeth that could break off (American 
Academy of Periodontology, 2004; National Institute of Dental and Craniofacial Research. 
2006).  
If treatment is provided in the last trimester, care should be taken to prevent suppression of 
the inferior vena cava by keeping the woman in an upright position (American Academy of 
Periodontology, 2004; National Institute of Dental and Craniofacial Research. 2006). All 
health care providers should advise women that maintaining good oral health during 
pregnancy is not only safe but necessary to reduce the risk of infection to the mother and 
possibly the foetus.  While it remains inconclusive whether maternal periodontal treatment 
improves pregnancy outcome, it is clear that treatment of varying degrees of clinical 
periodontal disease during pregnancy is safe and improves maternal oral health (Offenbacher 
et al., 2006; Jeffcoat et al., 2003; Michalowicz et al., 2006).  
All dental services should be available to pregnant women; however, despite the benefit of 
treatment, periodontal infection in women of childbearing age remains highly prevalent, 
particularly among low-income women and members of racial and ethnic minority groups 
(Jared and Boggess, 2008).  
 
2.17. Summary and objectives  
 
This chapter reviewed the literature investigating periodontal disease as a possible risk factor 
for adverse pregnancy outcomes. The rate of pre-term birth appears to be increasing 
worldwide and efforts to prevent or reduce its prevalence have been largely unsuccessful. 
Thus, while there are indications of an association between periodontal disease and increased 
risk of adverse pregnancy outcome in some populations, there is no conclusive evidence that 
treating periodontal disease improves birth outcome.  
Available evidence from clinical trials indicates that, although non-surgical mechanical 
periodontal treatment in the second trimester of pregnancy is safe and effective in reducing 
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signs of maternal periodontal disease, its ability to reduce the rate of pre-term birth has not 
been conclusively established.  
Results of the studies of the association between periodontal disease and deliveries of 
preterm, low-birth weight infants vary with some of the studies showing a correlation. The 
variability among studies in definitions of periodontal disease and adverse pregnancy 
outcomes as well as widespread inadequate control for confounding factors have resulted in 
widespread results which makes it difficult to validate conclusions . 
 
Null hypothesis 
Positive BANA tests during pregnancy have no bearing on pregnancy outcomes.   
 
Objectives 
• To determine the presence or absence of periodontal disease in pregnant women. 
• To conduct a BANA test in pregnant women to establish the presence of selected 
BANA positive species. 
• To ascertain the pregnancy outcomes of women who do not have periodontal disease 
and a negative BANA test result. 
• To ascertain the pregnancy outcomes of women who have periodontal disease and a 
positive BANA test result. 
• To compare the pregnancy outcomes of women who do not have periodontal disease 
and a negative BANA test result and women who have periodontal disease and a 
positive BANA test result. 
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   CHAPTER 3: RESEARCH DESIGN AND METHDOLOGY 
 
This chapter discusses the research design and methodology used in the study. It describes 
the development of the research instrument and data collection method. While keeping a 
focus on the objectives, consideration was given to the methodology employed by other 
researchers who carried out similar studies. 
 
3.1. Study sample 
3.1.1. Subject selection 
The study population consisted of pregnant women attending maternal obstetric units (MOU) 
in KwaZulu- Natal. Nonprobability sampling was employed to select the sites where 
participants were enrolled using convenience sampling.  However, when logistical problems 
were encountered (lack of room space or staff support) and in the event that these problems 
could not be circumvented, the target was foregone and more patients were recruited from 
another site.  The provincial Department of Health and the Municipal health district managers 
respectively granted permission for the research to be conducted at various hospitals and 
clinics selected (Appendix 2). Individuals attending MOU clinics located at Community 
Health Centres (CHC's) were approached and offered the opportunity to anonymously 
participate in the study. The nature of the study was explained to them verbally and in writing 
and they were requested to sign or indicate with an X that they had understood the nature of 
the study and voluntarily consented to participate. 
3.1.2. Sample Size 
The sampling of the participants from the MOU`s was by means of convenience sampling 
and a sample size of 400 participants was targeted. Regarding the question of the sample size 
required, it was necessary to have a knowledge of estimates of the variance (σ2 = ± 5) which 
was available from similar studies. According to the calculation, it was discovered that 400 
participants would be adequate given a 95% confidence interval and a standard deviation of 
10 (derived from similar studies).  However, more participants were enrolled based on 
availability during the first phase of the study and to cover for attrition. 
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3.1.3. Inclusion Criteria 
The participant was pregnant. 
The participant was 18 years or older. 
The participant gave written informed consent to be part of this study. 
 
3.1.4. Exclusion Criteria 
The exclusion criteria was a history of medications or medical problems that may affect the 
study outcome such as, current use of systemic corticosteroids, antibiotics, congenital heart 
disease, and existing hypertension or diabetes before pregnancy, asthma, and chronic renal 
disease. Participants with urinary tract infections, vaginal infections, history of cervical 
intraepithelial lesions or neoplasia were excluded. Further exclusion criteria were the 
mothers, whose labour was induced or delivered by C- section, multiple pregnancies and 
those who used tobacco, thus avoiding the bias of confounding. 
 
3.2. Data Collection 
A cross sectional study structure was used with data collection in a standardized format using 
a structured questionnaire and data capture sheets (Appendix 3). 
 
3.2.1. Questionnaire data 
The questionnaire had several sections that contained closed-ended questions and was 
interviewer-administered (Williams, 1996; Marshall and Rossman, 1995); all participants, 
however, had access to the researcher to clarify any uncertainties they had about answering 
the questions. The questionnaire elicited demographic information about the participants and 
contained items designed to obtain information regarding medical history, factors 
predisposing for periodontal disease and oral hygiene habits (Appendix 3). 
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3.2.2. Clinical examination 
The clinical data was collected by recording the results of a clinical examination of the 
participants to determine the presence or absence of periodontitis. The clinical data was 
recorded on a data capture sheet (Appendix 3). The examination was conducted with the 
subject supine in a dental chair or hospital bed or doctor’s examination couch and where 
necessary an external headlamp was used to facilitate the calibrated periodontal examination. 
The clinical assessment included obtaining the patient history which included administration 
of a questionnaire containing items designed to obtain information regarding medical history, 
factors predisposing for periodontal disease and oral hygiene habits (Appendix 3). 
The calibrated periodontal examination entailed recording of clinical indices and recording 
the presence of any oral lesions. Measurements of the clinical indices and periodontal 
recordings were taken at the mesial or distal locations of the Ramfjord teeth (Table 1).  
 
Table 1 Description of Ramfjord teeth 
Maxillary right 
first molar    
16 
Maxillary left 
central incisor   
21 
Maxillary left first 
bicuspid   
24 
Mandibular right 
first bicuspid 
44 
Mandibular right 
central incisor 
41 
Mandibular left 
first molar 
36 
   (Ramfjord, 1959) 
If the teeth selected were missing, teeth substitution was as follows (Ramfjord, 1959; 
Gettinger et al., 1982):  
16: by the mesial of 15, if not by the distal of 17 
21: by the distal of 22 
24: by the distal of 25 
36: by the mesial of 35, if not by the distal of 37 
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41: by the distal of 42 
44: by the distal of 45  
The following clinical indices were recorded:  
• Decayed, missing, and filled (DMF) teeth. 
• Plaque Index (P1, Table 2) was scored from 0-3 using the plaque index criteria of Silness 
and Loë, (1964). 
• Gingival Index (GI) was scored (Table 3) from 0-3 using the gingival index criteria of 
Silness and Loë, (1964).  
• Periodontal pocket depth (PD) and clinical attachment level (CAL) measures were 
recorded to the nearest higher millimetre by means of the North Carolina periodontal 
probe (Hu-Friedy®, Chicago, IL, USA), 15 mm in length and 0.35 mm in diameter. 
Pocket depth was measured from the base of the pocket to the gingival margin. 
• Clinical loss of attachment was measured from the cemento-enamel junction to the base 
of the pocket. 
• Oral plain mirrors (Hu-Friedy®, Chicago, IL, USA) and an external headlamp was used 
to facilitate periodontal examinations. The presence or absence of calculus and oral 
lesions was also recorded. 
The above data was used to classify the patient as either periodontally healthy or 
periodontally unhealthy (Loesche 1979; Watson et al. 1994). The clinical severity of the 
disease was determined in participants who have periodontitis by means of the following 
grading system adapted from Offenbacher et al. (2001).  
• Mild Periodontitis  ≥ PD 3mm or Clinical Attachment Level (CAL>2mm) 
• Moderate (≥2 sites with PD ≥5 mm and ≥2 sites with CAL ≥2 mm) 
• Severe Periodontitis(≥4 sites with PD ≥5 mm and ≥4 sites with CAL ≥2 mm) 
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                   Table 2 Measurement of Plaque Index (PI) scores: 
 
0 
 
No plaque in the gingival area.  
 
1 
A film of plaque adhering to the free gingival margin and 
the adjacent area of the tooth. Plaque may only be 
recognized, by running a probe across the tooth surface.  
 
2 
Moderate accumulation of soft deposits within the 
gingival pocket, on the gingival margin and /or adjacent 
tooth surface, which can be seen by naked eye.  
 
3 
Abundance of soft matter within the gingival pocket and 
/or on the gingival margin and adjacent tooth surface. 
  (Silness & Loë, 1964) 
 
        Table 3 Measurement of Gingival Index (GI) scores: 
 
0  
 
Normal gingival. 
 
1 
 
Mild inflammation – slight change in colour, slight oedema. 
No bleeding on probing. 
 
2 
 
Moderate inflammation – redness, oedema and glazing. 
Bleeding on probing. 
 
3 
 
Severe inflammation – marked redness, oedema and 
ulceration. Tendency to spontaneous bleeding. 
 (Silness & Loë, 1964) 
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3.3. Intra-examiner reliability 
A single investigator was calibrated prior to the study and carried out all periodontal 
examinations. Intra-examiner reliability in using the dental examination criteria was tested 
(pilot test) by performing duplicate examination on 10 randomly selected mothers on two 
consecutive days. Intra examiner reliability was determined using Kappa statistic. Ninety-five 
percent agreement on criteria for pocket depth was obtained. 
 
3.4. Plaque sample collection 
The plaque sample collection similar to the method employed by Watson et al., (1994) was 
used which entailed using the tip of a sterile periodontal probe to obtain the subgingival 
plaque samples as follows.  Supragingival plaque was removed from the site by means of a 
curette and discarded. The periodontal probe was then introduced subgingivally between the 
first molar and second premolar of each quadrant, or, if one of these teeth was missing, then 
between either the first and second molars, or between the premolars (Watson et al., 1994).  
 
3.5. BANA assay 
The BANA reagent card (Perioscan®, Oral-B Laboratories Inc., Redwood City, CA) was 
used according to the manufacturer's instructions (Perioscan, Oral B). Briefly, the principle of 
the test is as follows. The BANA hydrolysis test is a plastic card with two separate reagent 
matrices (strips). The lower strip is impregnated with BANA reagent and the upper strip 
contains a chromogenic diazo reagent, Fast Black K.B-naphthylamide. One of the hydrolytic 
products of the BANA reaction reacts with the Fast Black K, producing a permanent blue 
colour (Loesche et al., 1990b; Watson et al., 1994).  
Following plaque collection, the tip of the periodontal probe containing the plaque was wiped 
onto the BANA impregnated lower strip, located on the bottom of the BANA reagent card.  
The reaction was immediately activated by water applied to the upper strip containing the fast 
black dye. The lower strip was folded onto the upper, and both strips were held in place with 
a metallic clip. The card was placed in an incubator at 55ᵒC for 15 min. Site information was 
recorded on the BANA Test card in the marked space (Loesche et al., 1990b; Watson et al., 
1994). 
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Positive results appeared as blue spots that reflect weak or strong BANA reactions, whereas 
negative results did not show any colour change (Loesche et al., 1992) (Watson et al., 1994). 
The result of the BANA analysis was recorded on the data capture sheet (Appendix1). 
 
3.6. Recording of Pregnancy Outcomes 
The pregnancy outcomes data (whether the pregnancy was successful, stillborn or 
miscarriage) was obtained from the maternal notes of the participants along with and 
maternal age, weight, sex of infants, and method of delivery. In the event of a successful 
pregnancy the gestation period and the infant birth weights were recorded.  
In the case of successful pregnancies, a live infant whose birth weight was less than 2.500 kg 
was considered to have low birth weight (LBW) and those delivered before 37 weeks 
gestation were considered as preterm births (PLBW). In the case of successful pregnancies, a 
live infant who weighed 2.500 kg or more and delivered at 37 weeks gestation or later was 
considered as normal birth (NB). The pregnancy outcomes information was recorded on a 
data capture sheet (Appendix 2). 
Data was collected through structured interviews and medical records. Anthropometric and 
socio demographic characteristics' including height, Body Mass Index (BMI), ethnicity, 
education level, marital status, and information on work and income were ascertained. The 
women were questioned about smoking and alcohol intake, illicit drug use, physical violence, 
contraceptive methods, and parental desire for and satisfaction with pregnancy.  
Pregnancy information - including gestational age, method of delivery, baby weight at birth, 
type of birth, sex of neonate, baby length, and proportion weight/gestational age were 
transcribed from medical records. Occurrences of hypertension, pre-eclampsia, hepatitis B, 
anaemia, gestational diabetes, urinary infection, and infections during pregnancy were also 
recorded (Leal et al., 2004; Vettore et al., 2008). 
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3.7. Ethical Considerations 
 
• This research proposal was submitted to the University of the Western Cape research 
committee for ethical clearance and was registered accordingly.  
• Permission in principle to conduct the study at the various hospitals and clinics was 
obtained from the KwaZulu-Natal Health Department.  
• Specific permission was obtained from the participating hospitals and clinics to 
conduct the study at their facilities. 
• The nature of the study was explained and informed consent was obtained in writing 
from the participants. 
• Participation in this study was entirely voluntarily and the participants were allowed 
to withdraw from the study at any time if they wished to do so. 
• Anonymity and confidentiality were achieved by not using the participant’s names on 
the questionnaire, the participant was given a serial number and the hospital or clinic 
was recorded as a serial number. 
• A letter of thanks and a small token of appreciation were sent to the participating 
hospitals and clinics staff who assisted in making the research possible. 
• The study complied with the declaration of Helsinki (2013). 
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3.8. Pilot Survey 
A pilot study was conducted on 20 participants to determine the validity and reliability of the 
data collection process. Conducting a pilot study gave the researcher the opportunity to 
ensure that the questions in the questionnaire were clear and unambiguous, and determined 
the length of time for executing the clinical examination the BANA test Conducting a pilot 
study created an opportunity to check if the data collection methods were viable, clear and 
unambiguous, and to make the necessary adjustments where necessary. 
 
3.9. Data Analysis  
 
Questionnaire data were categorized, coded and then captured in Excel for basic descriptive 
analysis. The database was imported into SPSS to perform complex statistical analyses. 
Statistical significance was defined as p<0.05. 
Sensitivity (Sens), specificity (Spec), positive predictive value (PPV) and negative predictive 
value (NPV) for BANA and PD (periodontal disease) to predict adverse pregnancy outcomes 
were calculated as follows: 
Sens = TP/ TP+ FN X 100 
Spec = TN/FN+ FP X 100 
PPV = TP/TP+FP X 100 
NPV = TN/TN+FN X 100 
 
Where: TP= True Positive, TN = True Negative, FP = False Positive  
and FN = False Negative. 
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CHAPTER 4: MATERNAL PRENATAL ANALYSES 
 
4.1. Study population and sample 
There were 488 individuals who participated in the study and completed the questionnaires.  
However, 45 questionnaires were excluded from the analysis due to the exclusion criteria, 
incomplete data and/or loss to follow up. The final sample consisted of 443 pregnant female 
adults.  
 
4.1.1. Racial distribution 
Figure 4.1 demonstrates the racial distribution of the entire study population.  Using the racial 
classification system commonly used to address national and regional inequities in South 
Africa, 360 (81.26%) of the group were Black, 56 (12.64 %) Coloured, 23 (5.19%) Indian 
and 4 (<1%) were White.   
 
 
 
                        Figure 4.1: Racial distribution of the study population 
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4.1.2 Age distribution 
The mean (SD) age of the study population was 24.13 (±5.30) years. The median age of 
participants was 23 years (range 18-42). The first quartile was 20 years and the third quartile 
was 27 years.   The age distribution is reflected in Figure 4.2. 
 
 
 
                         Figure 4.2 Age distribution of the study population 
 
4.1.3. Regional distribution  
It should be borne in mind that individuals often travel from their home towns to obtain care. 
Even though convenience sampling was utilised to select recruitment, it is erroneous to 
assume that participants live in the town where the MOU is situated (where the participant 
was recruited) and therefore participants were asked to disclose where they lived. These areas 
were classified as urban versus rural areas according to municipal regional classification. The 
majority of the participants lived in urban areas (Table 4.1). 
 
4.1.4. Educational level 
All the participants had some formal education. The majority had attained at least secondary 
level education (70.88%).  Tertiary education was attained by 22.35 % and primary level 
education was attained by 6.77% (Table 4.1).  
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Table 4.1 Frequency distribution of the regional distribution and educational level of 
mothers who participated in the study 
Variable Frequency (%) 
Regional distribution 
Urban 
   Rural 
 
403 (90.97) 
  40 ( 9.03) 
 
Education 
   Primary 
   Secondary  
   Tertiary  
 
 
  30 (6.77) 
314 (70.88) 
  99 (22.35) 
 
4.1.5. Stage of pregnancy at time of sampling 
The majority of the participants were in their second trimester of pregnancy (4-7 months) 
with 71 (16.03%) in their 4th month, 108 (24.4%) in their 5th month, 97 (21.9%) in their 6th 
month and 86 (19.4%) in their 7th month of pregnancy. Fifty-four (12.19%) and 8 (1.8%) 
were in the third trimester (8-9 months) and a few, 1(<0.5%) and 18 (4.06%) were in the first 
trimester (2nd and 3rd month respectively).  Figure 4.3 demonstrates the pregnancy stage 
distribution of the study population.  
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         Figure 4.3 Pregnancy stage distribution of the study population 
 
4.2. Maternal oral health status  
 
4.2.1. Decayed Missing Filled Teeth (DMFT) scores 
Figure 4.4 illustrates the DMFT scores of the participants. The mean (SD) DMFT was 7.187 
(± 4.223).  
 
Figure 4.4 Distribution of DMFT scores  
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4.2.2. Plaque index (PI) 
The mean of the plaque index was 2.172 (±0.647).  Frequency distribution of the plaque 
index scores shows that most of the mothers had a plaque index of 2 or 3 (Figure 4.5).  
 
                             
                                     Figure 4.5 Distribution of plaque index scores 
 
4.2.3. Gingival Index (GI) 
The gingival index frequency is illustrated in Figure 4.10 and the mean (SD) of the gingival 
index was 2.439 (±0.581).  The gingival index scores are indicative of severe gingivitis in 
more than half of the mothers examined (Figure 4.6).   
                      
                              Figure 4.6 Distribution of Gingival Index scores  
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4.2.4. Maternal periodontal disease status (PD) 
Maternal periodontal disease status was classified according to Offenbacher et al. (2001), 
using PPD and CAL measurements (Table 4.2).  Of the 443 mothers who participated in the 
study, 72% had periodontal disease classified as either mild (44%), moderate (19%) or severe 
(10%).  The remaining 27% showed no signs of periodontal disease (Table 4.2).   
 
                  Table 4.2 Periodontal disease status in sampled population 
 Frequency (%)  
    Periodontal disease classification  
    None 
    Mild (PPD>3mm or CAL >2mm) 
    Moderate (≥ 2 sites with PPD ≥5mm and 2 sites with CAL ≥2mm) 
    Severe (≥ 4 sites with PPD ≥5mm and ≥4 sites with CAL ≥2mm)  
 
123 (27) 
193 (44) 
82 (19) 
45 (10) 
   BANA test 
   Positive  
   Negative  
 
282 (64) 
161 (36) 
 
 
4.2.5. BANA 
BANA results were recorded as positive (indicating periodontal pathogens associated with 
periodontal disease) if a blue colour was produced or negative if there was no colour 
production.   In line with the periodontal disease diagnosis above, 282 of the mothers tested 
produced a positive BANA test result while BANA-negative mothers constituted 161 of the 
443 mothers recruited to this study, (Table 4.2). 
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4.3. Association of maternal demographics with clinical indices   
An association was sought between maternal oral health status and the demographic variables 
of age, race, location, level of education and pregnancy stage at time of sampling. 
4.3.1. Decayed Missing Filled Teeth (DMFT) 
4.3.1.1. DMFT and age 
Although no linear correlation was observed (Figure 4.7), the mean DMFT scores were found 
to differ significantly with age (Table 4.3). 
 
 
                   
Figure 4.7 DMFT and age 
 
The individual components of DMFT i.e. decayed, missing and filled teeth were also 
individually analysed and for ease of reading, will hereafter be referred to as D, M, or F, 
respectively.  When looking at the DMFT components individually, significant correlations 
were observed between D and age and M and age, but no significant correlation was observed 
between F and age (Table 4.3). 
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     Table 4.3 Correlation of DMFT scores with age 
Score r p 
DMFT 0.220 < 0.001 
D 0.107    0.025 
M 0.200 <0.001 
F 0.091    0.058 
 
 
4.3.1.2. DMFT and race 
The frequencies and means of DMFT for the four race groups are summarised in Table 4.4.   
Using one way ANOVA, significant differences were observed between races for mean 
DMFT scores (p= 0.012) as well as for F scores (p=0.0001).  
 
Table 4.4 Comparison of mean DMFT, PI, GI scores with race 
 African Coloured Indian             White F df p 
Frequency 360 56 23 4    
DMFT 6.889 8.661 7.783 10.000 3.681 3,399 0.012 
D 2.938 3.125 2.956 2.000 0.263 3,438 0.852 
M 2.825 3.482 2.695 3.000 1.186 3,439 0.314 
F 1.155 2.160 2.043 5.000 11.59 3.439 0.0001 
PI 2.167 2.100 2.404 2.225 1.235 3,439 0.297 
GI 2.440 2.359 2.596 2.600 1.016 3,439 0.05 
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4.3.1.3. DMFT and education  
The mean DMFT scores associated with different educational levels are listed in Table 4.5. 
Using one way ANOVA, a significant difference in DMFT was observed between those with 
secondary and tertiary education (F 2,440 = 5.591, p = 0.004) but not between those with 
primary and tertiary education (p =0.088).  According to a one way ANOVA the D and M 
means did not differ significantly according to educational levels,  while the F mean of the 
participants who had tertiary education was significantly greater (p = 0.0002) than the means 
of the participants who had primary and secondary education (Table 4.5).  
 
                      Table 4.5 Education levels and mean DMFT, PI and GI scores  
 Primary Secondary Tertiary F df p 
DMFT 6.933            6.822          8.424 5.591 2,440 0.004 
D 3.200 2.907 3.030 0.226 2,439 0.797 
M 2.733               2.780 3.343 2.012 2,440 0.135 
F 1.033 1.178                                   2.050 8.901 2,440 0.0002 
PI 2.350             2.146          2.198 1.460 2,440 0.233 
GI 2.353             2.460         2.400 0.752 2,440 0.472 
 
 
4.3.1.4. DMFT and urban/rural distribution  
Figure 4.8 shows the frequency distribution of DMFT in urban/rural settings.  Since this 
variable has exactly two levels, the ANOVA and Welch t-tests were used to compare the 
DMFT means of the urban and rural participants. No significant differences in DMFT, D and 
M scores were found between the two groups (Table 4.6).  However, a significant difference 
was noted for F scores (Table 4.6).   
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          Figure 4.8 Frequency distribution of Urban (1) and Rural (2) DMFT scores  
 
 
   Table 4.6 Comparison Urban/Rural Distribution and DMFT 
 Urban Rural F t df p 
Frequency 403 40     
DMFT 7.156 7.500 5.591  2,440 0.633 
D 2.920 3.300  0.898 47.52 0.373 
M 2.851 3.425 1.94  1,441 0.164 
F 1.419               0.800 3.975  1.441 0.046 
 
 
4.3.1.5. DMFT and pregnancy stage  
No significant correlation was observed between DMFT and pregnancy stage (Table 4.7).  
The same applies to correlations between pregnancy stage and D or M.  Significant 
differences were observed for F in the different stages of pregnancy at the time of sampling 
(Table 4.7).  
 
 
 
 
66 
 
 
                      Table 4.7 Correlation of pregnancy stage with DMFT scores 
Score Pregnancy stage 
 r p 
DMFT 0.057 0.232 
D -0.039 0.410 
M 0.012 0.800 
F 0   0.0005 
 
4.3.2. Plaque index (PI)   
 
4.3.2.1. PI and age 
Age and PI were not significantly associated (r = 0.079, p = 0.05).  The distribution is 
demonstrated in Figure 4.9.   
 
 
      Figure 4.9 PI and age 
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4.3.2.2. PI and race 
One way ANOVA confirms that plaque index scores did not differ significantly between the 
different race groups (F 3,439 =1.235, p = 0.297) as illustrated in Table 4.4. 
 
4.3.2.3. PI and education  
According to a one way ANOVA (F2, 440 = 1.460, p = 0.233) the plaque index means of the 
participants who received primary, secondary and tertiary education did not differ 
significantly (Table 4.5).   
 
4.3.2.4. PI and urban/rural distribution  
The Welch Two Sample t-test showed that the difference between the plaque index means of 
urban and rural participants (data not shown) was not significant (p = 0.082).  
 
4.3.2.5. PI and pregnancy stage at time of sampling 
Table 4.8 lists the mean PI for each pregnancy stage.  The correlation between plaque index 
and pregnancy stage at the time of sampling is illustrated in Figure 4.10. The red dots are the 
means and the line is a least squares regression line whose slope is -0.07155, demonstrating a 
significant correlation (p = 0.001). 
 
Table 4.8 Mean PI and GI at pregnancy stage  
Pregnancy stage 
(months)  
2 3 4 5 6 7 8 9 p-value 
N 1 18 71 108 97 86 54 8  
Mean PI  2.100 2.528 2.225 2.291 2.125 2.051 2.030 2.125 0.001 
Mean GI 2.000   2.478   2.530    2.528   2.436   2.331   2.341 2.275 0.008 
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          Figure 4.10 Correlation between PI and pregnancy stage at the time of sampling  
 
4.3.3. Gingival Index (GI ) 
4.3.3.1. GI and age   
No significant correlation was found between age and gingival index (r-0.015, p = 0.05).  The 
distribution of gingival index scores according to age is demonstrated in Figure 4.11.  
 
                 
Figure 4.11 GI scores according to age.  
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4.3.3.2. GI and race  
Although the mean gingival index scores differed between the race groups (Table 4.4), these 
differences were not found to be significant (F 3,439 =1.016, p = 0.05). 
 
4.3.3.3. GI and education  
One way ANOVA (Table 4.5) also revealed no significant difference between educational 
levels and mean gingival index scores (F2, 440 = 0.752, p = 0.472).  
 
4.3.3.4. GI and Urban/Rural distribution  
The distribution of GI scores across the urban and rural populations is shown in Figure 4.12. 
According to the Welch Two Sample t-test the difference between the gingival index means 
of the urban and rural participants was not significant (p=0.729). 
 
 
Figure 4.12 Urban/rural distribution of GI scores 
 
 
 
 
 
70 
 
4.3.3.5. GI and pregnancy stage at time of sampling  
The frequency and means of the gingival index and pregnancy stage are illustrated in Table 
4.9, while Figure 4.13 is a plot of gingival index and pregnancy stage.  The red dots are the 
means; the line is a least squares regression line whose slope is -0.05030. It is significantly 
different from zero (p = 0.008). 
 
 
 
Figure 4.13 Correlation between Gingival index and pregnancy stage at the time of 
sampling 
 
4.3.4. Probing Pocket Depth (PPD) and Clinical Attachment Loss (CAL) 
The probing pocket depth and clinical attachment loss distribution is illustrated in Table 4.9. 
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        Table 4.9 Frequency distribution of PPD and CAL 
Variable Frequency (%) 
PPD  
1(< 3mm)   
2(≥  3-5 mm)  
3  (>5 -7 mm) 
4  (>7 mm) 
106(24) 
285(64) 
 51(12) 
  0(0) 
CAL 
None 
Mild (1-3 mm) 
Moderate (3-6 mm) 
Severe ( ≥ 6 mm) 
 
175 (39.5) 
232 (52) 
34 ( 8) 
2 (0.5) 
 
 
 
 
4.3.5. Periodontal Pocket Depth (PPD) 
 
4.3.5.1. Age and PPD 
Table 4.10 illustrates that the one way ANOVA showed no significant association between 
age and probing pocket depths in this study (F 3,439 = 0.835, p = 0.570). 
       Table 4.10 Probing Pocket depth and mean age distribution 
                                     Pocket Probing Depth 
 1(< 3mm) 2(≥  3-5 mm) 3(>5 -7 mm) 4(>7 mm) 
Mean Age (yrs) 24.09 23.96 25.15 24.41 
F3,438 0.671 
p-value 0.570 
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4.3.5.2.   PPD and race  
Chi-squared analysis demonstrated no significant association between race and probing 
pocket depth measurements (Table 4.11).   
 
   Table 4.11 Pocket Probing Depth and race 
Race                                      Pocket Probing Depth  
 1(< 3mm)    2 (≥  3-5 mm) 3(>5 -7 mm) 4(>7 mm) 
African 84 221 42 13 
Coloured 16 36 0 3 
Indian 3   16 3 1 
White 0 4 0 0 
X 2 11.551 
Df 9 
p-value 0.2398   
 
 
4.3.5.3.  PPD and education  
Table 4.12 shows the distribution of probing pocket depths according to education levels of 
the participants.  The observed chi-squared shows no significant difference (X2 = 5.6556, df = 
6, p = 0.4629).  
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Table 4.12   Frequency distribution of PPD, CAL and education 
 Primary Secondary Tertiary X2 df p 
PPD (mm) 
1 
2 
3 
4 
 
23 
58 
11   
7 
 
73 
202 
29 
9 
 
7 
17 
5 
1 
5.6556 6 0.4629     
CAL  
None 
Mild 
Moderate 
Severe 
 
11 
15 
4 
0 
 
119 
167 
26 
2 
 
45 
50 
4 
0 
5.218 6 0.516 
 
4.3.5.4. PPD and Urban/Rural distribution  
This Chi-squared test showed a significant difference in the distribution of probing pocket 
depth between urban and rural participants (Table 4.13)  
                          Table 4.13 PPD and Urban/Rural distribution  
                                Probing Pocket Depth 
 1 2   3    4 
Urban 99 (24.6) 255 (63.4) 33 (8.2) 15 (3.7) 
Rural 4 (10) 22 (55) 12 (30)   2 (5) 
 X 2   20.873 
Df 3 
p-value <0.0001 
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4.3.5.5. PPD and pregnancy stage 
All the PPD and pregnancy stage data are summarised in Table 4.14.  A chi-squared test 
applied to the reduced table shows no significant association (X2 = 25.892, df = 21, p = 
0.2106).   
                     Table 4.14 Probing Pocket Depth and Pregnancy Stage 
                              Probing Pocket Depth 
Pregnancy 
Stage 
1   
 
2 
 
3 
 
4 
 
2   1   0   0   0 
3     5   8 2 2 
4 16 41 9 5 
5 27 65 10   6 
6 28 60 9 0 
7 17 61  5   3 
8   9 36 8 1 
9 0   6 2  0 
X2 25.892 
Df 21 
p-value 0.2106 
 
 
4.3.5.6. PPD and PD status 
According to a chi-squared test (Chi-squared = 378.6152, df =9, p-value < 2.2e-16) there is a 
highly significant association between periodontal disease status and probing pocket depth 
(Table 4.15).Inspection of the table indicates that at Periodontal disease =1 the Probing depth 
is predominantly 1 or 2. At Periodontal disease =4 the Probing depth is predominantly 3 or 4. 
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     Table 4.15   Probing Pocket Depth and Periodontal Disease Status  
                                      PPD 
PD 1    2    3   4 
1 76 46 0 0 
2   20 163 10  0 
3 7 60 15  0 
4    0    8 20 17 
Chi-squared 378.6152 
Df 9 
p-value < 0.0001 
 
4.3.6. Clinical  Attachment Loss (CAL) 
4.3.6.1. CAL and age 
One way ANOVA revealed no significant association between age and clinical attachment 
loss (F 3,439 = 0.835, p=0.475).  The distribution of clinical attachment loss according to age 
is captured in Figure 4.14.  
 
                                                         Figure 4.14 CAL and age  
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4.3.6.2. CAL and race  
The following is a frequency table of clinical attachment loss and race.  Chi-squared 
observation revealed a significant difference in clinical attachment loss according to race 
(Table 4.16)   
 
Table 4.16 Frequency Table of CAL and race  
Race  CAL mm 
 1 2 3 4 
African  119 206 33 2 
Coloured 36 19 1 0 
Indian 16 7 0 0 
White 4 0 0 0 
X2 37.03 
Df 9 
p-value <0.0001 
 
4.3.6.3. CAL and education  
The chi-squared observation of clinical attachment loss distribution and the education level of 
the participants (Table 4.12) did not reveal a significant difference either (X2 = 5.218, df = 6, 
p =0.516). 
 
4.3.6.4. CAL and Urban/rural distribution 
The clinical attachment loss distribution and the location of the participants are summarised 
in Table 4.17.  According to the Fisher exact test there is no significant association (p 
=0.111). 
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                  Table 4.17   Urban/rural distribution of clinical attachment loss 
CAL Urban  Rural 
None     162 13 
Mild 212 20 
Moderate 27 7 
Severe 2 0 
Frequency 403 40 
Mean 2.442 2.408 
p- value 0.111 
 
 
4.3.6.5.  CAL and pregnancy stage 
 
All the clinical attachment loss and pregnancy stage data are summarised in Table 4.18.  A 
chi-squared test applied to the table shows no significant association between pregnancy 
stage and clinical loss of attachment (X2=11.015, df=12, p = 0.528). 
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                    Table 4.18 Clinical attachment loss and pregnancy stage 
Pregnancy  stage               Clinical attachment loss 
Months 1 2 3 4 
2 1 0 0 0 
3 5 10 3 0 
4 25 40 6 0 
5 43 56 9 0 
6 45 46 6 0 
7 34 46 6 0 
8 21 29 2 2 
9 1 5 2 0 
X2 11.015 
Df 12 
p-value 0.528 
       
4.3.6.6. CAL and PPD 
According to a chi-squared test (Chi-squared =209.1284, df =9, p-value < 2.2e-16) there is a 
highly significant association between clinical attachment level and probing pocket depth 
(Table 4.19). Inspection of the Table indicates that as clinical attachment loss increases, so 
does probing pocket depth e.g. at CAL=1 the PPD is predominantly 1 or 2, while at CAL=3 
the PPD is predominantly 3. 
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    Table 4.19 Clinical attachment loss and Probing Pocket Depth 
                                Probing Pocket depth 
Clinical 
attachment loss    
1 2 3 4 
1   72 90 6 6 
2 29 182 15 6 
3 2 5 23 4 
4 0 0 1 1 
X2 209.1284 
Df 9 
p-value < 0.0001 
 
 
4.3.6.7. Clinical attachment loss and periodontal disease status 
Comparison of clinical attachment loss with periodontal disease status (Chi-squared 
=156.7557, df = 9, p-value < 2.2e-16) revealed that there is a highly significant association 
between the two (Table 4.20). Increased severity of periodontal disease occurs at increased 
values of clinical attachment loss (Table 4.20).  
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             Table 4.20 Clinical attachment loss and Periodontal Disease Status 
                                  Periodontal disease 
Clinical 
attachment loss       
1 2 3 4 
1   89 58 19 9 
2 33 130 51 18 
3    1 5 12 16 
4 0    0 0    2 
X 2 156.7557 
Df 9 
p-value <0.0001 
 
 
4.3.7. BANA 
 
4.3.7.1. BANA and DMFT  
Table 4.20 shows that the DMFT means of the BANA- negative and BANA-positive groups 
were not significantly different.   
 
4.3.7.2. BANA and PI 
Table 4.20 also shows that the PI means of the BANA-negative and BANA-positive groups 
were significantly different (F-statistic: 66.17 on 1 and 439 DF, p-value: 4.279e-15). 
4.3.7.3. BANA and GI 
A significant difference was also observed (Table 4.21) between BANA- negative and 
BANA-positive groups for GI (F-statistic: 57.21 on 1 and 439 DF, p-value: 2.312e-13). 
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Table 4.21 Association of BANA with DMFT, PI and GI  
 BANA F df p 
 Negative Positive    
DMFT 7.503106 7.021429  
 
1.327  1,439 0.25 
PI 1.860248 2.349286  
 
66.17 1, 439 <0.0001 
GI 2.177019 2.586071  
 
57.21  1,439 <0.0001 
 
4.3.7.4. BANA and PPD  
Table 4.22 shows that the distributions of probing pocket depths at BANA-negative and 
BANA-positive are significantly different (Chi-squared = 102.3855, df = 3, p-value < 2.2e-
16).  
 
Table 4.22 Association of BANA with PPD 
 Probing Pocket Depth 
 1   2 3    4 
BANA negative  78 78    3         1 
BANA positive 24 199       41   16 
X2 102.3855 
Df 3 
p-value <0.0001 
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4.3.7.5.  BANA and CAL 
The distributions of clinical attachment loss at BANA negative and BANA positive are 
considerably different. According to a chi-squared test (Chi-squared = 73.5438, df = 2, p-
value < 2.2e-16) there is a highly significant association between BANA and clinical 
attachment loss (Table 4.23).  The frequency of BANA-negative samples decreased with 
increased clinical attachment loss. 
 
 
  Table 4.23 Association of BANA with CAL 
 Clinical  Attachment Loss 
BANA 1 2 3 4 
Negative 105 55 3 0 
Positive 70 176 32 2 
Chi-squared 73.5438 
Df 2 
p-value < 0.0001 
 
 
4.3.7.6. BANA and PD 
The distributions of BANA-negative and BANA-positive samples are considerably different 
according to periodontal disease status. Using chi-squared analysis, the difference was found 
to be highly significant (Table 4.24). 
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                 Table 4.24 Association of BANA with Periodontal Disease Status 
                           Periodontal Disease 
BANA.    Absent Mild Moderate Severe 
Negative 117 38 5 1 
Positive 6 155 76 45 
Chi-squared 260.3 
Df 3 
p-value < 0.0001 
 
Figure 4.15 illustrates this association of periodontal disease with BANA. As the severity of 
periodontal disease increased, the number of BANA-negative plaques decreased.  On the 
other hand, the number of BANA-positive plaques was very low for subjects with no 
periodontal disease, reaching a high in subjects with mild periodontal disease, then 
decreasing for moderate and severe periodontal disease respectively. 
Figure 4.15 Decrease of BANA-negative samples with increased severity of 
Periodontal Disease  
1= No PD, 2= Mild PD, 3=Moderate PD, 4=Severe PD 
BANA=1 (black): BANA-negative; BANA=2 (red): BANA-positive 
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CHAPTER 5: PREGNANCY OUTCOMES 
 
The preceding chapter focused on the assessment of the mothers when visiting the antenatal 
clinic in order to establish risk factors which may threaten their pregnancies.  This chapter 
examines the outcomes of those pregnancies and through association, identifies risk factors 
for adverse pregnancy outcomes.  The pregnancy outcomes of 442/443 mothers follow.  
 
5.1. Gestational age at delivery (GA)  
The mean (SD) for gestational age at delivery are indicated in Table 5.1.One hundred and 
forty-two infants were born preterm (PTB, <37 weeks gestation) and 300 were born full term 
(FTB, ≥ 37 weeks gestation).  
 
    Table 5.1 Gestational age at delivery  
Gestational age Total Mean    SD Min Max 
 
PTB (< 37 weeks) FTB (≥ 37 weeks)      
n=142 n=300 442 37.317 2.502 22 40 
 
 
5.1.1. GA and maternal demography  
ANOVA showed that there was no correlation between gestational age and race, location or 
level of education (Table 5.2).   
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               Table 5.2   Association between GA and race, location and education 
Variable N Mean GA (weeks) F df p 
Race 
  African  
  Coloured 
  Indian 
  White 
 
360 
56 
23 
 4 
 
37.21 
37.83 
37.43 
38.50 
1.332 
 
3.438 0.263 
Location 
   Urban 
   Rural 
 
403 
 40 
 
37.35 
36.97 
0.820 
 
1,440 0.366 
Education 
Primary    
Secondary 
Tertiary 
 
30 
314 
 99 
 
37.43 
37.20 
37.64 
1.226 
 
2,439 0.294 
 
 
5.1.2. GA and maternal oral health  
Likewise, correlation coefficients showed no significant correlation between GA and 
maternal age, DMFT, PI or GI when statistically evaluating the entire study group (Table 
5.3).  These results did not change significantly when the group was divided into preterm 
(PTB) and full term (FTB) as shown in Table 5.4.   
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            Table 5.3   Correlation coefficients for maternal age, DMFT, PI and GI 
Variable R p 
Maternal age 0.0016 0.739 
DMFT 0.037 0.434 
PI -0.003 0.958 
GI -0.079 0.097 
 
 
                    Table 5.4 Comparison of PTB and FTB for DMFT, PI and GI 
Variable              Gestational term t df p 
 
PT FT    
DMFT Mean (SE) 6.782 (0.310) 7.397 (0.256) 
 
 
-1529 
 
 
328 
 
 
0.127 
PI Mean (SE) 2.207 (0.053) 2.159 (0.038) 
 
 
0.736 
 
 
291 
 
 
0.462 
GI Mean (SE) 2.496 (0.044) 2.411 (0.035) 
 
 
 
1.509 
 
 
 
312 
 
 
 
0.132 
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5.1.3. Gestational Age (GA)  
 
5.1.3.1. GA and PPD 
The mean gestational age at delivery showed a significant trend of decreasing with an 
increase in probing pocket depth severity (Table 5.5).  By ANOVA, the differences between 
the means are highly significant (p =2.547e-05).  
 
               Table 5.5 Gestational age at delivery and Probing Pocket Depth 
 Probing  Pocket Depth F df p 
 1 2 3 4    
N 103 276 45 17    
Mean GA 37.534 37.493 36.689 34.706 8.2 3,437 <0.0001 
 
This significant difference remained with Chi-squared comparison of preterm birth and full 
term birth (Table 5.6).   FTB was more likely to occur when PPD was ≤ 2 and decreased with 
increased PPD (Table 5.6).  
 
              Table 5.6 Comparison of PTD and FTD with Probing Pocket Depth 
 Gestational term X2 df p 
Probing Pocket Depth PTB FTB 16.5362 3 0.0008 
1   28 75    
2   82 194    
3   20 25    
4   12 5    
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5.1.3.2  GA and CAL  
As observed with PPD, the mean gestational age at delivery showed a trend of decreasing 
with an increase in CAL (Table 5.7). Using ANOVA, this difference between means was 
found to be significant (p = 0.0139).   
 
   Table 5.7 Gestational age at delivery and Clinical attachment loss 
                                              CAL F df p 
 1 2 3 4    
n    175 231 34 2    
Mean 
GA  
37.611 37.272 36.235 35.000 3.583 3,438 0.0139 
 
However, when gestational age was classified as PTB and FTB, Chi-squared analysis 
revealed no significant differences between the two for CAL (Table 5.8).  
 
             Table 5.8 Comparison of PTB and FTB for Clinical Attachment Loss 
                       GA 
CAL < 37weeks (PTB) ≥ 37weeks (FTB) 
1   51 124 
2   74 157 
3   15 19 
X 2 2.9532 
Df 2 
p-value 0.2284 
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5.1.2.3. GA and PD severity 
Most of the mothers were found to have mild or no periodontal disease (Table 5.9).  Further 
analysis of data compared the periodontal disease classification (none, mild, moderate and 
severe) with mean gestational age.  One way ANOVA (F3, 438 =11.54, p<0.0001) showed that 
mean gestational age decreased significantly with an increase in periodontal disease severity 
(Table 5.9).  This trend continued when divided into PTB and FTB (Table 5.10).  
 
         Table 5.9 Correlation with gestational age and periodontal disease severity 
Variable n Mean gestational age 
(weeks) 
p 
Periodontal disease (PD) 
None 
Mild 
Moderate 
Severe 
 
123 
193 
82 
45 
 
38.09 
37.39 
36.79 
35.80 
<0.0001 
BANA 
Positive 
Negative 
 
282 
161 
 
37.97 
36.92 
<0.0001 
 
 
Of the 45 mothers with severe periodontal disease, 26 (58%) delivered preterm, while of the 
123 with no periodontal disease, 99 (80.5%) delivered full term (Table 5.10).  
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   Table 5.10 Comparison of PTB and FTB for periodontal disease status 
GA           Periodontal Disease Status  Total  
 
Absent Mild Moderate Severe  
PTB 24 56 36 26 142 (32.1) 
% 5.4 12.7 8.1 5.9  
Row % 16.9 39.4 25.4 18.3  
Column % 19.5 29.2 43.9 57.8  
FTB 99 136 46 19 300 (67.9) 
% 22.4 30.8 10.4 4.3  
Row % 33 45.3 15.3 6.3  
Column % 80.5 70.8 56.1 42.2  
Total  
123 
(27.8) 192 (43.4) 82 (18.6) 45 (10.2) 
442 (100) 
Missing     1 
X 2 28.540 
Df 3 
p-value < 0.0001 
 
5.1.3.4. GA and BANA 
The mean gestational age of the BANA-negative and BANA-positive deliveries differed 
significantly (p< 0.0001) with a lower gestational age associated with a BANA-positive test.  
When categorised into preterm and full-term, BANA was significantly associated with 
gestational term as evidenced by 107 of 142 (75%) PTD having a BANA-positive test (Table 
5.11). In the light of the very large observed X 2 one can take every difference in percentage 
between PTB and FTB as statistically significant.  
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Table 5.11 Contingency Table for PTB/ FTB and BANA 
Gestational term                                  BANA    Total  
 
Negative   Positive   
< 37weeks (PTB)    
Frequency      35   107  142 
% 7.9 24.3  
Row % 24.6 75.4  
Column % 21.7 38.4  
  ≥ 37weeks (FTB)    
Frequency 126 172 298 
% 28.8 39.0  
Row % 42.3 57.7  
Column % 78.3 61.6  
Total (effective sample 
size) 161(36.6) 279 (63.4) 
440 (100) 
Frequency missing   3 
X2 12.1405 
Df 1 
p-value 0.0005 
 
 
 
 
 
 
 
 
 
92 
 
5.2. Infant Birth Weight (BW)  
The mean infant birth weight of the 442 mothers was 2.986 kg (Table 5.12).   
Table 5.12 Descriptive statistics of infant birth weight 
N     Mean    SD     Min Max 
442   2.986   0.531      1.5    4.2 
 
5.2.1. BW and maternal demography 
As with GA, no significant correlation was observed between infant birth weight and race, 
location, and education levels (Table 5.13), nor was a correlation found with age (Table 
5.13).    
      Table 5.13 Association of infant birth weight with race, location and education 
Variable N mean F df p 
Race 
  African  
  Coloured 
  Indian 
  White 
 
360 
56 
23 
 4 
 
2.98 
3.02 
2.99 
2.87 
0.146 3,439 0.932 
Location 
   Urban 
   Rural 
 
403 
 40 
 
2.98 
2.95 
0.122 1,441 0.727 
Education 
   Primary 
   Secondary 
   Tertiary 
 
 30 
314 
 99 
 
2.93 
2.98 
3.04 
0.697 2,440 0.499 
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5.2.2. BW association with oral health  
 
5.2.2.1. BW association with PI and GI 
A significant correlation was observed between infant birth weight and maternal PI and GI 
(Table 5.14).  As the PI and GI increased, the birth weight of the infant dropped (Figures 5.1 
and 5.2).  
 
         Table 5.14 Correlation of infant birth weight with maternal PI and GI 
Variable R p 
Age  0. 008  0.872 
Plaque index 0.217 <0.001 
Gingival index 0.257 <0.001 
 
         Figure 5.1 Infant Birth Weight and Maternal PI 
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        Figure 5.2 Infant Birth Weight and Maternal GI 
Low birth weight (LBW, < 2500 grams) was compared with normal birth weight (NBW, ≥ 
2500 grams) for DMFT, PI and GI.  No significant difference was observed between DMFT 
scores in mothers who delivered LBW infants compared to mothers who delivered NBW 
infants (Table 5.15).  However, when comparing birth weight with PI and GI, highly 
significant differences were observed (Table 5.15).    
 
Table 5.15   LBW compared to NBW for Maternal DMFT, PI and GI 
Variable LBW Mean 
(SE)  
NBW Mean (SE) Welch t df p value 
Maternal DMFT  6.818 (0.406) 7.309(0.231) -1.052 18
5 
0.259 
Plaque Index 2.422 (0.055) 2.092(0.036) 4.997 20
7 
< 
0.0001 
Gingival Index 2.647 (0.043) 2.371(0.033)  5.100 24
7 
< 
0.0001 
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5.2.2.2. Birth weight and PPD  
Even though BW was found to decrease with increasing PPD, the difference between the 
means was not significant as evident with ANOVA (Table 5.16).   
 
Table 5.16 Mean birth weight and PPD 
                               Pocket Probing Depth 
        1         2   3         4 
Mean BW 3.413592 3.228881 2.622222 2.376471 
F 3,438 2.534  
p-value 0.05637 
 
However, when birth weight was divided into low birth weight (LBW, <2500g) and normal 
birth weight (NBW, ≥ 2500g), Chi-squared showed the distributions of PPD at LBW and 
NBW (Table 5.17) to differ significantly (X2= 70.8876, df = 3, p = 2.755e-15).   
  Table 5.17   Birth Weight and Probing Pocket Depth 
                                         Birth Weight 
Probing Pocket Depth   LBW<2500gm NBW>=2500gm 
1 9   94 
2 59 218 
3 23 22 
4   15 2 
X 2 70.8876 
df 3 
p-value <0.0001 
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5.2.2.3. Birth weight and CAL 
One way ANOVA (Table 5.18) shows a significant trend in decreasing mean BW with 
increasing CAL.  This is clearly demonstrated in Figure 5.3 where the red circles indicate the 
mean clinical attachment loss for birth weight. 
 
  Table 5.18 Birth Weight and Clinical Attachment Loss 
Clinical 
Attachment 
Loss 
1 (None) 2 (Mild)  3 (Moderate) 4 (Severe) 
N    175 232 34     2 
Mean BW 3.091 2.964 2.638 2.200 
F3,439 9.216    
P 0.001 
 
 
 
            Figure 5.3   Birth Weight and Clinical Attachment Loss (1, 2, 3 and 4) 
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When divided into categories of LWB and NBW, the distributions of clinical attachment loss 
at LBW and NBW are notably different.  According to a chi-squared test (X2= 23.7121, df = 
2, p = 7.096e-06), this difference is highly significant (Table 5.19).   
 
         Table 5.19 Birth Weight and CAL 
                                                Birth Weight 
Clinical attachment loss    LBW <2500gm NBW ≥2500gm 
1 30 145 
2   55 177 
3 19   15 
4 2 0 
X 2 23.7121  
Df 2  
p-value <0.0001  
 
 5.2.3. Infant birth weight and maternal periodontal disease status 
The mean BW of infants born of mothers with no, mild, moderate or severe periodontal 
disease is shown in Table 5.20.  The association between BW and PD is reflected in Figure 
5.4.  A significant decrease in infant birth weight was observed with increased severity of 
periodontal disease (Table 5.20). 
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Table 5.20 Frequency distribution of Infant birth weight, maternal periodontal disease 
and BANA  
Variable n Mean 
BW/g 
F Df p 
Periodontal disease 
    None 
    Mild 
    Moderate 
    Severe 
 
 
123 
193 
82 
45 
 
3.28 
3.04 
2.70 
2.41 
2.940 3,439 <0.0001 
BANA 
    Positive 
    Negative 
 
282 
161     
 
 
2.849 
3.224 
     36.43 
 
1.438 <0.0001 
 
      Figure 5.4 Infant birth weight and maternal periodontal disease 
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Categorising the above into LBW and NBW revealed a similar significant association 
(p<0.000001). The majority of mothers who delivered NBW infants had some form of 
periodontal disease. Although not all LBW may be attributed to periodontal disease severity, 
maternal periodontal disease severity showed a definite decrease in the delivery of infants 
with NBW (Table 5.21).  
 
    Table 5.21   Comparison of LBW and NBW for maternal periodontal disease 
Birth weight                                   Periodontal Disease Status  Total  
 Absent  Mild  Moderate  Severe   
< 2500g LBW      
Frequency 4 33 39 34 110 
% 0.9 7.5 8.8 7.7 24.8 
Row % 3.6 30 35.5 30.9  
Column % 2.7 17.0 47.5 75.5  
      
 ≥ 2500g NBW      
Frequency  119 160 43 11 333 
% 26.9 36.11 9.7 2.5 75.2 
Row % 35.7 48 12.9 3.3  
Column % 96.7 82.9 52.4 24.4  
Total  123 (27.8) 193 (43.6) 82 (18.5) 45 (10.2) 443 (100) 
X2 121.598     
Df 3     
p-value <0.000001     
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5.2.4 Infant birth weight and BANA 
BANA positive plaques are an indication of periodontal disease activity.  Table 5.20 shows a 
highly significant correlation between infant birth weight and BANA (F1, 438 = 36.43, p 
<0.0001).  This significance remained after categorising the infants into LBW and NBW.  
The number of LBW infants increased significantly when BANA was positive (Table 5.22) 
i.e. 95/109 (87.1%).  
  Table 5.22 Frequency of LBW and NBW for BANA 
Birth weight                                  BANA    Total  
 
Negative   Positive   
< 2500g (LBW)    
Frequency        14    95  109  
% 3.2 21.5 24.7 
Row % 12.8 87.2  
Column % 8.7 33.9  
    
  ≥ 2500g (NBW)    
Frequency 147  185  332  
% 33.3 42.0 75.3 
Row % 44.3 55.7  
Column % 91.3 66.1  
Total (effective sample size)  161 (36.5) 280 (63.5) 441 (100) 
Frequency missing   2 
X2 33.63   
Df 1   
p-value 0.000001   
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Mean GA and BW were compared in mothers who were BANA-, PD- and BANA+, PD+ 
(Table 5.23).  Both GA and BW decreased significantly when PD and BANA were positive, 
providing evidence of an association between PD/BANA and both GA and BW.  
 
Table 5.23 Birth Weight, Gestational Age association with BANA and Periodontal 
disease status  
Variable BANA-   
PD- 
(n = 167) 
BANA+ 
 PD+ 
 (n=274) 
p -value Frequency 
missing 
Mean birth 
weight (grams) 
3222      2842 
 
< 0.0001 2 
Mean 
gestational age 
(weeks) 
38.018      36.875 
 
< 0.0001 2 
 
 
5.3. Birth weight for gestational age (BWGA) 
The mean BWGA for all the infants is indicated in Table 5.24. 
 
Table 5.24 Mean Birth Weight for Gestational Age 
N Mean BW/g SD Min Max 
443 0.080      0.013    0.044    0.150 
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5.3.1. Birth Weight for Gestational Age and maternal demography  
Regression analysis revealed that there was no significant correlation between BWGA and 
maternal age (r = 0.005, p = 0.912), race, location nor education (Table 5.25).   
 
Table 5.25 Comparison of Birth Weight for Gestational Age and maternal demography 
Variable 
 
N Mean BW for  
gestational age/g  
F Df p 
Race 
 
  African  
  Coloured 
  Indian 
  White 
 
 
360 
56 
23 
 4 
 
 
0.08 
 0.08 
 0.08  
            0.07 
 
 0.240    
 
3,438 0.869 
Location 
 
   Urban 
   Rural 
 
 
403 
 40 
 
 
0.08 
0.08 
 0.005 
 
1,440 0.943 
Education 
 
   Primary 
   Secondary 
   Tertiary 
 
 
 30 
314 
 99 
 
 
0.08 
0.08 
0.08 
 0.473    
 
2,439 0.623 
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5.3.2. Birth Weight for Gestational Age and maternal oral hygiene status 
5.3.2.1. Plaque Index  
 
 
Figure 5.5 Birth Weight for Gestational Age and Plaque Index 
 
Figure 5.5 demonstrates a significant correlation between birth weight for gestational age and 
plaque index (r = 0.220, p <0.001).  As the PI increased, the BWGA decreased.   
 
5.3.2.2. Birth Weight for Gestational Age and Gingival Index  
A significant correlation between BWGA and GI was also demonstrated (r =0.230, p <0.001) 
(Figure 5.6).  Increased GI resulted in lower BWGA. 
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              Figure 5.6 Birth Weight for Gestational Age at delivery and Gingival Index 
 
5.3.2.3. Birth Weight for Gestational Age and Probing Pocket Depth   
One way ANOVA (F3,438 = 1.454, p = 0.2265) showed that although the mean BWGA 
decreased with increased PPD, this association was not significant (Table 5.26).  
 
Table 5.26 Birth Weight for Gestational Age and pocket Probing Depth 
                               Probing Pocket Depth 
 1    2           3           4 
Mean BW for GA 0.091 0.088 0.072 0.070 
F3,438 1.454  
p-value 0.2265 
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5.3.2.4. Birth Weight for Gestational Age and Clinical attachment loss 
 
The BWGA means of the different clinical attachment loss groups differ significantly  
(F 3,438 =5.023, p = 0.002).  The trend is decreasing mean with increasing clinical attachment 
loss as indicated in Table 5.27. 
 
        Table 5.27 Birth Weight for Gestational Age and Clinical attachment loss 
                                          CAL 
BWGA   None    Mild (1-3mm) Moderate(3-
6mm) 
Severe(6mm or 
more) 
N    175   232    34   2 
Mean 0.0821 0.0795 0.0740 0.0629 
F3,438 5.023 
p-value 0.002 
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Figure 5.7 illustrates the relation between BWGA and CAL. The red circles indicate the mean 
BWGA. 
 
 
                Figure 5.7 Birth Weight for Gestational Age and Clinical attachment loss 
 
5.3.2.5. Birth Weight for Gestational Age and Periodontal disease  
Regression analysis revealed that when controlling for PD, BWGA decreased significantly 
from 0.086g to 0.068g (F3, 438 = 5.023, p = 0.002).  Results for ANOVA are clearly 
demonstrated in Figure 5.8.  The red circles indicate the mean BWGA.  
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      Figure 5.8 Birth Weight for Gestational Age at delivery and periodontal disease 
 
 
5.3.2.6. Birth Weight for Gestational Age and BANA 
The mean BWGA differed significantly between BANA- negative and BANA- positive 
subjects (Table 5.28). According to the Welch t-test these two means are significantly 
different at level p<0.0001. 
 
      Table 5.28 Birth Weight for Gestational Age and BANA 
BANA Negative Positive 
N   161     282 
Mean BWGA/g 0.084 0.077 
p-value <0.0001 
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5.4. PTLB and FTNB  
Further analysis of BWGA grouped the pregnancy outcomes as preterm low birth weight 
(PTLB) and full term normal birth weight (FTNB).  For this comparison, PTLB was defined 
as preterm birth (gestation that lasts less than <37 weeks) and Low Birth Weight (birth 
weight < 2500 grams). FTNB was defined as full term birth (gestation that lasts for ≥37 
weeks) and normal birth weight (birth weight ≥2500 grams).  No significant differences were 
observed between PTLB and FTNB for DMFT and GI, while a marginal significance was 
observed for PI (Table 5.29).  
 
     Table 5.29 Comparison of PTLB and FTNB for Maternal DMFT, PI and GI 
Variable Gestational term/Birth Weight t Df p 
 
PTLB FTNB    
DMFT Mean (SE) 6.676 (0.456) 7.299 (0.223) -1.2271 106 0.2225 
PI Mean (SE) 2.311 (0.073)  2.148 (0.034) 2.0341 104 0.0445 
GI Mean (SE) 2.531 (0.057) 2.420 (0.031) 1.7002 115 0.0918 
 
 
5.4.1. Comparison of PTLB and FTNB for PPD 
The PTLB frequency for the different levels of PPD differed significantly from the FTNB 
(Table 5.30). The trend is decreasing FTNB frequency with increasing PPD.   
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Table 5.30 PTLB compared to FTNB for probing pocket depths 
Gestational term 
Probing pocket depths   
n (%) 
Total  
 
1 2 3 4  
PTLB 10 44 17  
 
71 
FTNB 75 171 14 
 
260 
Total  85 215 31 331 
X 2 25.367 
df 2 
p-value <0.0001 
 
5.4.2. Comparison of PTLB and FTNB for CAL 
The PTLB frequency for the different levels of CAL differed significantly from the FTNB 
(Table 5.31). The trend is decreasing FTNB frequency with increasing CAL.  Note the small 
frequency at CAL >3mm.  
Table 5.31 Comparison of PTLB and FTNB for CAL 
 Clinical attachment loss 
   None    Mild (1-3mm) Moderate (3-6mm) Severe ( ≥6mm) 
PTLB 19 41 9 2 
FTNB  156 190 25   0 
Total 112 140 9 0 
Chi-square 17.1867 
df 3 
p-value 0.0006 
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In the analysis of the preterm low birth weight and clinical attachment loss, where the 
standardized residual exceeds 2 in absolute value, a significant difference between row 
percentages, at level p = <0.05, is indicated. 
 
5.4.3. Comparison of PTLB and FTNB for Periodontal Disease 
However, when PTLB and FTNB were compared while controlling for the periodontal status 
of the mothers, Chi-squared revealed that the difference was highly significant (Table5.32)   
 
     Table 5.32 PTLB compared to FTNB for periodontal disease status 
Gestational term 
Periodontal Disease Status   
n (%) 
Total  
 
Absent Mild Moderate Severe  
PTLB 4 (5.6) 25 (35.2)  20 (28.2) 22 (31.0) 71 (16.1) 
FTNB 119(32.1) 167 (45) 62 (16.7) 23 (6.2) 371 (83.9) 
Total  123(27.8) 192 (43.4) 82 (18.6) 45 (10.2) 442 (100) 
X 2 56.4703 
df 3 
p-value <0.00001 
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5.4.4. Comparison of PTLB and FTNB for BANA 
The BANA means of PTLB and FTNB means differ significantly (Table 5.33). In the light of 
the very large observed chi-squared one can take every difference in percentage between PTB 
and FTB as statistically significant.  
 
 Table 5.33 Contingency Table for PTB/ FTB and BANA 
Gestational term                                  BANA    Total  
 
Negative   Positive   
< 37weeks/<2500g (PTLB)    
Frequency      9 62 71 
% 12.7 87.3  
Row % 12.7 87.3  
Column % 5.6 22.2  
    
  ≥ 37weeks/ ≥ 2500g (FTNB)    
Frequency 152 217 369 
% 41.2 58.8  
Row % 41.2 58.8  
Column % 94.4 77.8  
Total (effective sample size)  161(36.6) 279 (63.4) 440 (100) 
Frequency missing   3 
X 2 19.6577 
df 1 
p-value 9.263e-06 i.e. <0.0001 
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The sensitivity (Sens), specificity (Spec), positive predictive value (PPV) and negative 
predictive value (NPV) for periodontal disease and BANA to predict PTD confirmed this 
association regardless of which variable was used as the gold standard (Table 5.34).  
Periodontal disease (PD) could predict PTD with a sensitivity of 83% and a negative 
predictive value of 80.5% (Table 5.34).  BANA showed a specificity of 78% and a positive 
predictive value of 75.3% for PTD.   PTD was likely to occur in 75.3% of mothers with a 
positive BANA test and did not occur in 78.3% of mothers with a negative BANA test.  
 
 
Table 5.34 Usefulness of BANA and PD diagnosis to predict preterm delivery (PTD) 
Gold Standard Sens Spec PPV NPV 
PD 83 33 36.9 80.5 
BANA 38 78 75.3 42.3 
PTD 75.3 42.3 38.35 78.3 
 
In evaluating the likelihood of BANA and PD to detect LBW, BANA showed a sensitivity of 87% 
and a NPV of 91%, while PD showed a sensitivity of 96% and NPV of 97% (Table 5.35).  LBW was 
showed a specificity of 91% for BANA.  
 
Table 5.35 Usefulness of BANA and PD diagnosis to predict low birth weight (LBW) 
Gold Standard Sens Spec PPV NPV 
PD 96 36 33 97 
BANA 87 74 34 91 
LBW 34 91 29 44 
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CHAPTER 6: DISCUSSION 
 
6.1 Introduction 
This study investigated the effect of the presence of periodontal disease and a positive BANA 
test result during pregnancy on pregnancy outcomes. The objectives of this research were to 
compare the pregnancy outcomes of women who do not have periodontal disease and a 
negative BANA test result with pregnancy outcomes of women who have periodontal disease 
and a positive BANA test result. In this chapter, the findings of this study are discussed. It 
commences by highlighting the socio-demography of the study population. The discussion 
expands on the oral health status and the birth outcomes of the participants. Where 
appropriate, reference is made to the literature in order to consider this investigation in the 
context of its similarities and differences with similar studies locally and abroad.  
 
6.2. Socio-demographic data 
There were 488 women that participated in the study and completed the questionnaires.  
However, 45 questionnaires were excluded from the analysis due to medical exclusion and 
incomplete data. The final sample size was 443. The average age of the study population was 
24.13 years (± 5.30) which is in the age group (20-29 years) that represents a substantial 
portion of the most economically active individuals (Swartz and Roux, 2004; Dorrington et 
al, 2004; Bachnann and Booysen, 2003).The median age of participants was 23 years (range 
18-42). The first quartile was 20 years and the third quartile was 27 years.  
In South Africa the black racial group constitutes the majority of the public health facility 
users (Swartz and Roux, 2004; Dorrington et al, 2004) and as was expected, the sample 
consisted predominantly of individuals of black ethnic origin, (81.26%) followed by 
Coloured (12.64 %) then Asian (5.19%) and White (>1%). reflecting the racial constitution of 
SA population (Dorrington et al, 2004). It should be borne in mind that individuals often 
travel from their dwelling areas to the MOU to obtain care. Even though convenience 
sampling was utilised to select recruitment, it is erroneous to assume that participants live in 
the town where the MOU is situated (where the participant was recruited) and therefore 
participants were asked to disclose where they lived. These areas were classified as urban 
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versus rural areas according to municipal regional classification. The majority of the 
participants lived in urban areas (90.97%).  
All the participants had some formal education with more than half of the participants had 
attained at least a secondary education (70.88%) and Tertiary education was attained by 
22.35 % and primary level education was attained (6.77%). The educational level determines 
the level of empowerment and employability of the individual though there are no guarantees 
as other market factors also contribute to determining employment status and income 
(Bachnann and Booysen, 2003; Swartz and Roux, 2004; Dorrington et al, 2004). 
Participants in the survey were at different stages of pregnancy, the majority of the 
participants were 5 months pregnant (24 38%), followed by 6 months (21.90%), 7 months 
(19.41%) and 8 months (12.19%). A few of the participants were 2 months (0.22%) and 9 
months (1.81%). 
 
6.3. Oral health Status 
6.3.1. Decayed Missing Filled Teeth (DMFT) 
The mean DMFT of the participants recorded was 7.187 (± 4.223). The correlation 
coefficient between DMFT and age was 0.220, which was low but statistically significant 
(p<0.001). The means of the DMFT for the four race groups were Black (6.889), Coloured 
(7.783), Asian (8.661) and White (10.000), and statistically significant (p = 0.012). 
According to the Welch t-test the DMFT means of the urban (7.156) and rural participants 
(7.500) were not significantly different (p = 0.633). The DMFT means of primary (6.933) 
secondary (6.822)   and tertiary (8.424) education were significantly different (p = 0.004). 
The correlation coefficient of DMFT and pregnancy stage was small (0.057) and not 
statistically significant (p-value =0.232). 
There was a significant correlation between decayed teeth and age (p = 0.025). However no 
significant association was found between decayed teeth and location of the participants, 
race, education nor pregnancy stage at time of examination. The correlation coefficient of 
missing teeth and age was small (0.200) but statistically significant (p <0.001). No significant 
correlation was found between missing teeth and race, location, nor education.  
A significant correlation was found between filled teeth and race (p <0.0001), with the mean 
F score of the White race group being significantly greater than the Black, Coloured and 
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Asian groups.  Significant correlations were also found between filled teeth and location (p = 
0.046), education (p = 0.0002), and pregnancy stage (p=0.0005).  No correlation was found 
between filled teeth and age (p = 0.058).   Race could probably dictate the socio-economic 
status of the participants.  Whether the participants lived in urban or rural areas would 
influence their access to medical and dental care as well as access to educational schooling, 
which in turn would influence their affordability for dental fillings thus explaining these 
findings.   
 
6.3.2 Plaque Index 
This study investigated the association between the clinical parameters used to diagnose 
periodontal disease and maternal demography. The mean plaque index of this study was 
2.172 (± 0.647) which differed from the mean plaque index of 0.69 reported by Tilakaratne et 
al. (2000) and that of 0.85 reported by Silness and Löe (1964).  No significant association 
was observed between plaque index and age (p = 0.05), race (p = 0.297), location (p = 0.082) 
nor education (p = 0.233).  These results agree with previous reports (Silness and Löe, 1964; 
Yalcin et al., 2002; Taani et al., 2003) but disagree with the one reported by Tilakaratne et al., 
(2000).  
 
6.3.3 Gingival Index 
The mean of the gingival index of this study was 2.439 (± 0.581)) which was slightly higher 
compared with the results found by Löe and Silness (1963) in their study of pregnant women 
(1.03 ± 0.03). However studies by (Yalcin et al., 2002; Family Gentle Dental Care, 2003; 
Lieff et al., 2004) showed the prevalence of pregnancy gingivitis ranging from 35% to 
100%).In this study the correlation coefficient between age and gingival index was very low 
(-0.015) and it was not statistically significant (p= 0.05) similar to that of Yalcin et al., (2002) 
who reported no association between the increase of age and clinical parameters. These 
findings disagree with Taani et al., (2003) who reported that the increase of age was 
associated with significantly higher gingival scores. 
The Gingival index for the Black (2.440), Coloured (2.359), Asian (2.596) and White (2.600) 
race groups did not differ significantly (p = 0.05).  Nor could the gingival index be 
significantly associated with location (p = 0.729) or education (p =0.472).  Gingival index 
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and pregnancy stage of this study was significantly different from zero at level 0.008.  
Gingival index scores were reported to increase 10 to 30 times more during the third trimester 
of pregnancy than during the menstrual cycle (Agbelusi et al., 2000; Tilakaratne et al., 2000; 
Yalci et al., 2002; Taani et al., 2003). This study yielded similar results. Progesterone and 
oestrogen levels are said to increase causing dilatation of gingival capillaries, gingival 
exudates and permeability which causes the redness and bleeding tendency during pregnancy 
(Zachariasen et al., 1993; Sooriyamoorthy, 1989).  
 
6.3.4 Clinical Attachment Loss (CAL) and Probing Pocket Depth (PPD) 
Clinical Attachment Loss (CAL) and/or Probing Pocket Depth (PPD) may well be the best 
indicators to use in epidemiology of periodontal diseases (Albandar et al., 1999; Kingman 
and Albandar, 2002), CAL gives an indication of past periodontal disease and PD may give 
better indication of current disease status. This study demonstrated a highly significant 
association between CAL and PPD (p < 0.0001) such that as CAL increases so does PPD.  
The high prevalence of score 3 may also reflect elevations in gingival inflammation leading 
to enlarged gingiva and, hence, an increase in PPD and CAL, though this may not always be 
true for CAL as enlarged gingiva may give rise to pseudo-pocketing as well. 
This study found no significant association between  clinical parameters of  PPD  (p = 0.570), 
and CAL (p = 0.475)  with age, similar to  results of Bayangani (2005) and Yalcin et al., 
(2002) who reported no association between the increase of age and clinical parameters of  
PPD or CAL . These findings disagree with Taani et al., (2003) who reported that the 
increase of age was associated with significantly higher CAL and PPD scores. There was no 
significant association between PPD measurements and race (p-value-0.2398), education 
levels (p = 0.4629) and pregnancy stage (p = 0.2106).  However there was a significant 
difference in the distribution of PPD between urban and rural participants (p-value <0.0001). 
A significant difference in CAL between the different race groups (p-value <0.0001) which is 
in agreement with  the generalisation that periodontal disease profiles differ from one 
population group to another (Miyazaki  et al., 1991; Williams et al ., 2000). However there 
was no significant association found in the CAL distribution and the location of the 
participants (p =0.111), pregnancy stage (p = 0.528) and the education level of the 
participants (p =0.516).   
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Periodontal disease progresses and CAL occurs through the destruction of the periodontal 
ligament and its adjacent alveolar bone subsequently leading to gingival recession and 
pathological probing depth (Kinane, 2001) therefore the degree of CAL reflects the severity 
of CAL and can be used as an indicator of the severity of periodontal disease (Baelum et al., 
1995).This study found a highly significant association between CAL and PD status (p-value 
< 0.0001). Similarly there is a highly significant association between PD status and PPD (p-
value < 0.0001). Increased severity of PD occurred at increased values of CAL and PPD. 
The distributions of periodontal disease for BANA-negative and BANA-positive mothers 
differed significantly (p<0, 0001). Though one case of severe periodontal disease in this 
study tested negative for BANA, these findings confirm a correlation between BANA and the 
clinical indices used to indicate periodontal infection with the red complex (T. denticola, T. 
forsythia, P.gingivalis) (Loesche et al., 1990; Grisi et al., 1999; Grisi et al., 2001; Figueiredo 
et al., 2000; Africa, 2011). 
 
6.4. The influence of maternal demography and oral health on pregnancy outcomes 
6.4.1. Gestational Age (GA) 
Various factors such as age, height, weight, socioeconomic status, ethnicity, smoking, 
nutritional status and stress have been associated with the delivery of PTLBW infants 
(Nordstrom et al., 1996; MacDorman et al., 2007).  The mean gestational age in this study 
was 37.317 (± 2.502) with the minimum gestational age 22 and the maximum gestational age 
40 weeks.  
Gestational age and race were not significantly associated in the present study contrary to the 
findings of Nordstrom et al., (1996), who found an association between delivery of PLBW 
infants and ethnicity. Nor was a significant association found between gestational age and 
location (p=0.366), pregnancy stage (p=0.662), education (p=0.294), and maternal age (p = 
0.739).When pregnancy outcomes were compared (i.e. PTB and FTB), DMFT, plaque index, 
and gingival index did not differ significantly either in the present study.  
Periodontitis can induce a primary host response in the chorioamnion, leading to PTB 
(Dortbudak et al., 2005). This has been confirmed in other cases of adverse pregnancy 
outcomes as well  (Lopez et al., 2002; Dasanayake et al., 2003; Bogies et al., 2006; 
Offenbacher et al., 2006;  Jared and Boggess, 2008) with PPD and CAL  scores found to be 
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significant risk indicators for PTB (Offenbacher et al. 2001; Radnai et al. 2004; Jarjoura et al. 
2005). In this study, the mean gestational age at delivery showed a significant trend of 
decreasing with an increase in probing pocket depth severity (p <0, 0001) and this significant 
difference remained with comparison of PTB and FTB.  FTB was more likely to occur when 
PPD was ≤ 2 and decreased with increased PPD. As observed with PPD, the mean gestational 
age at delivery showed a trend of decreasing with an increase in CAL and the difference 
between means was found to be significant (p = 0.013).  Other studies found no difference in 
the periodontal parameters between women with PTB and FTB (Holbrook et al., 2004; 
Moore et al. 2005; Rajapakse et al. 2005; Abati et al. 2013).  
Gestational age could be significantly associated with periodontal disease severity in this 
study (p<0.0001).  The mean gestational age for no periodontal disease was 38.09 weeks, for 
mild periodontal disease it was 37.39 weeks, for moderate periodontal disease it was 36.79 
weeks and for severe periodontal disease it was 35.80 weeks.  
BANA could also be significantly associated with gestational age with the mean gestational 
age for the BANA-positive and periodontal disease group being significantly smaller than the 
gestational age mean of the BANA-negative and no periodontal disease group (p<0.0001).  
Since BANA is an indicator of the presence of three of the most commonly detected 
periodontopathogens, this study concurs with that of Lin et al., (2007) who examined the 
association between periodontal diseases and preterm birth and explored the underlying 
microbial and antibody responses associated with oral infection.  The authors found that ante 
partum, the levels of periodontal pathogens tended to be higher in the preterm (case group) 
deliveries compared to the term deliveries (control group). 
Using periodontal disease (PD) as the gold standard in this study, PTD could be predicted 
with a sensitivity of 83% and a negative predictive value of 80.5%.   With BANA as the gold 
standard, a specificity of 78% and a positive predictive value of 75.3% for PTD was 
achieved. PTD as the gold standard revealed that it was likely to occur in 75.3% of mothers 
with a positive BANA test and did not occur in 78.3% of mothers with a negative BANA test. 
The results of the present study indicate that BANA could be a useful screening method for 
PTD.  
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6.4.2. Birth Weight  
The mean birth weight in this study was 2.986 (± 0.531) with the lowest weight being 1.5 kg 
and the highest weight 4.2 kg.  
Young maternal age was previously reported to be one of the most significant risk factors in 
PTLBW infant delivery,  with mothers <20 years and >35years of age being more likely to 
give birth to LBW babies (Nadar et al ,1995; Nordstrom et al., 1996; Mumghaba and Manji, 
2006; López ,2008).  However in this study there was no significant association between birth 
weight and age of the mother (p=0.872).  Race did not significantly influence birth weight 
either in this study, nor did location, education levels and pregnancy stage.     
Moderate to severe periodontitis identified early in pregnancy has been associated with an 
increased risk for spontaneous preterm birth, independent of other traditional risk factors 
(Offenbacher et al., 1996; Jeffcoat et al., 2001; Offenbacher et al., 2006 Haerian-Ardakani et 
al., 2013; Kothiwale et al., 2014; Reddy et al., 2014).  Other studies have failed to 
demonstrate such an association (Davenport et al., 2002; Moore et al., 2004; Holbrook et al., 
2004; Buduneli et al., 2005; Rajapakse et al., 2005 Mumghaba and Manji 2006; Agueda et 
al., 2008 ;Abati et al.,2013).    
This study showed that the correlation coefficient of birth weight and plaque index and that 
of birth weight and gingival index were both statistically significant (p<0.001) which is in 
accordance with the findings of Persson et al., (2009) who linked gingivitis to  adverse 
pregnancy outcome (APO).  A significant association between birth weight and periodontal 
disease severity was established in the present study (p<0.0001) with a trend of decreasing 
birth weight with increasing periodontal disease severity.  
When comparing the means of the plaque index and gingival index of  LBW and NBW the 
Plaque Index mean for the  LBW group was 2.422 (±0.055) and the gingival index was 2.647 
(±0.043) while for the NBW group the plaque index and gingival index were 2.092 (± 0.036) 
and 2.371(± 0.231) respectively . The means for both PI and GI differ significantly at level 
p<0.0001 unlike the DMFT means which showed no significant difference. 
Birth Weight was found to decrease with increasing PPD, and when birth weight was divided 
into LBW (<2500g) and NBW (≥ 2500g), the distributions of PPD at LBW and NBW 
differed significantly (p<0.0001).  Similarly this study showed a significant trend in 
decreasing mean BW with increasing CAL (p = 0.001) and when divided into categories of 
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LWB and NBW, the distributions of clinical attachment loss at LBW and NBW were 
significantly different (p<0.0001). This is agreement with earlier studies which associated 
PPD and CAL with LBW (Dortbudak et al. 2005; Jarjoura et al. 2005).  However, Moore et 
al. (2004) also looked at PPD and CAL and concluded that there is no association between 
LBW and periodontal disease nor was an interruption of periodontal therapy seen to increase 
the risk for LBW (Hujoel, 2006; Michalowicz, 2006).  
The distributions of periodontal disease severity for LBW were 4 (3.6%) for no periodontal 
disease, 33 (30.0%) for mild periodontal disease, 39 (35.5%) for moderate periodontal 
disease, and 34 (30.9%) for severe periodontal disease in the present study.  For NBW, the 
distributions were 119 (35.7%) for no periodontal disease, 160 (48.0%) for mild periodontal 
disease, 43 (12.9%) for moderate periodontal disease and 11(3.3%) for severe periodontal 
disease. The result of applying a chi-squared test of association yielded a highly significant 
result p-value < 2.2e-16 (i.e.<0.000001) lending support to other studies which  identified 
periodontal disease severity as a risk for LBW (Sembene et al. 2000; Louro et al. 2001; 
Romero et al. 2002;  Kothiwale et al. 2014).   
This study showed a significant correlation (p <0.0001) between periodontal disease and 
LBW as demonstrated in previous studies (Jeffcoat et al. 2001; Romero et al. 2002; 
Goepfert et al. 2004; Manau et al. 2008). However the findings of the present study were 
contrary to reports from the UK which found no evidence of an association between the 
severity of periodontal disease and pregnancy outcome (Davenport et al. 2002; Moore et al. 
2005). 
In this study, the birth weight means of infants born of BANA-negative (3.224) and BANA-
positive (2.849) mothers were significantly different (p<0.0001) as were their gestational 
ages (p<0.0001) and birth weight for gestational age (p<0.0001). Chan et al (2010) in their 
prospective study in Changhua, Taiwan reported similar findings and concluded that BANA-
positive plaques in the 3rd trimester were associated with preterm births, after controlling for 
other risk factors. BANA-positive mothers with periodontal disease delivered infants with a 
mean birth weight of 2.842 Kg which was significantly smaller (p<0.0001) than the birth 
weight mean of BANA-negative mothers with no periodontal disease (3.222 kg) supporting 
the study of Mokeem et al., (2004) which found that periodontal disease may influence 
pregnancy outcome by the direct and/or indirect effect of periodontal pathogens on the 
developing foetus.  
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Chi-squared test of association showed a highly statistically significant association between 
pregnancy outcomes (i.e. LBW vs NBW) for BANA-positive and BANA-negative tests (p-
value <0.000001).  BANA showed a sensitivity of 87% and a NPV of 91% in detecting 
LBW, while PD showed a sensitivity of 96% and NPV of 97%.  Using LBW as the golden 
standard, a specificity of 91% was found for BANA.  
 
6.4.3. Birth Weight for Gestational Age (BWGA)      
No significant associations were observed between BWGA and age, location, education and 
pregnancy stage.  However, BWGA was significantly associated with plaque index and 
gingival index (p<0.001).  
Although the mean BWGA decreased with increased PPD in the present study, the 
association was not significant (p= 0.2265).  CAL showed a similar but significant 
association with decreasing BWGA (p = 0.002). 
Santos-Pereira et al., (2007) studied 124 women between the ages of 15-40 to determine if 
chronic periodontitis increased the risk of experiencing preterm labour (PTL) using the same 
parameters as the present study where chronic periodontitis was described as one site with 
clinical attachment loss (CAL) > 1 mm with gingival bleeding and the severity of 
periodontitis was classified as early (CAL <3mm), moderate (CAL > 3 mm and < 5 mm), and 
severe (CAL >5mm). The extent of periodontitis was either localized, CAL < 30%, or 
generalized CAL > 30%. They, too, concluded that chronic periodontitis increased the risk of 
having PTLBW infants as was demonstrated in the present study when a significant 
association (p=0.002) between PTLBW and periodontal disease was established.  No 
significant risk of PTB or small-for-gestational-age infant was found when adjusting for 
smoking, race/ethnicity, socioeconomic status, BMI, history of preterm delivery, presence of 
genitourinary infection, weekly weight gain, and history of dental check-ups by Pitiphat et 
al., (2008), nor was an association found between poorer periodontal health and either PTB or 
LBW in a cohort study of 1793 women with no history of smoking (Farrell et al., 2006).   
However, the latter reported an association between higher mean probing depth and late 
miscarriage. 
Mumghaba and Manji (2006) examined the relationship between carious pulpal exposure and 
preterm low-birth-weight (PTLBW) and found no evidence for carious pulpal exposure being 
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significant risk factors in PTLBW infant delivery. DMFT for PTLBW and FTLBW did not 
differ significantly in the present study either.  
Plaque Index for the PTLBW and FTLBW differed significantly (p =0.0445) in the study by 
Mumghaba and Manji (2006), but this was not the case in our study.  
Buduneli et al. (2005) evaluated the number of sites with bleeding on probing and found no 
significant differences between PTLBW and FTLBW. However, PTLBW was significantly 
associated with periodontal disease and BANA when compared with FTLBW (p<0.00001) in 
our study. In this study the distributions of PTLBW and BANA-negative were 9 (12.7%), and 
62 (87.3%) for PTLBW and BANA-positive.  Significant differences were also observed 
between PTLBW and FTNBW for PPD (p <0.0001) and CAL (p =0.0006) in our study, as 
has previously been reported in other studies (Williams et al. 2000; Offenbacher et al. 2001; 
Jarjoura et al. 2005). 
 
6.5. Conclusions and recommendations 
BANA is a rapid and effective diagnostic aid and has shown to correlate well with the clinical 
indices used to diagnose periodontal disease (Loeshe et al., 1997a, b; Grisi et al., 2001). 
There was no significant difference in the socio-demographic attributes of the participants 
observed in this research. Exclusion criteria for participants were relevant confounders, such 
as tobacco use, multiple pregnancies chronic diseases like hypertension, diabetes mellitus and 
previous periodontal treatment, thus avoided bias of confounding.The findings of this study 
indicate a significant correlation that a positive BANA test result and the presence of 
periodontal disease during pregnancy have a significant association with negative pregnancy 
outcomes such as preterm birth and low birth weight. 
 
Calculation of sensitivity, specificity, PPV and NPV for PD and BANA in predicting PTD 
showed that a diagnosis of PD and BANA hydrolysis could both predict PTD and that PTD 
was not likely to occur in mothers without PD or a negative BANA test.  It can be concluded 
that the present study showed a significant association between PD and PTD and that PD is 
independently associated with PTD and LBW. Limitations of the study include the difficulty 
in making comparisons with other studies due to differences in (amongst others) sampling 
techniques, diagnostic criteria, pregnancy stage at recruitment, ethnicity and geographical 
location.   
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Within the limitations of the study  the findings of this study proves the null hypothesis 
wrong and confirms that periodontal disease and a BANA positive test was associated with 
low birth weight and  preterm birth. The findings  support the hypothesis that a positive 
BANA test result and the presence of periodontal disease during pregnancy have a significant 
association with negative pregnancy outcomes such as miscarriage, preterm birth (gestation 
that lasts less than 37 weeks) and low birth weight (LBW) - a weight less than2.5 kilograms. 
The findings of this study suggests that the risk for LBW or PTB infants may be potentially 
reduced by microbial monitoring of potential colonization of periodontal pathogens and 
establishing oral hygiene and dental preventive measures in pregnant women. It can be 
suggested that the role of the microbial load and maternal immune response as related to 
pregnancy outcomes needs to be explored in other studies.  This study also demonstrated the 
usefulness of the BANA test as a screening test for PTD. Its implementation as a chairside 
screening test for preterm delivery during antenatal visits should be considered.     
 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
124 
 
REFERENCES 
 
Abati S, Villa A, Cetin I, Dessole S, Lugliè PF, Strohmenger L, Ottolenghi L, Campus GG. 
(2013). “Lack of association between maternal periodontal status and adverse pregnancy 
outcomes: a multicentric epidemiologic study”. J Matern Fetal Neonatal Med.Mar; 
26(4):369-72.  
 
ACOG Practice Bulletin. (2001). Assessment of risk factors for preterm birth. Clinical 
management guidelines for obstetrician-gynaecologists. Number 31, Obstet Gynecol. Oct; 
98(4):709-16. 
 
ACOG practice bulletin (2003). Management of preterm labour. Number 43, Int J Gynaecol 
Obstet.Jul; 82(1):127. 
 
Africa CW (2011).Oral colonization of Gram-negative anaerobes as a risk factor for preterm 
delivery.Virulence. Nov-Dec; 2(6):498-508.  
 
Africa CWJ (2012). Chapter 1: The microbial aetiology of periodontal diseases. 
In: Periodontal Diseases: A Clinician’s Guide; ISBN 978-953-307-818-2, Publishers 
INTECH, Rijeka, Croatia (Commissioned). 
 
Africa CW, Bayingana C, Yasin-Harnekar S (2009). The use of Perioscan as a potential 
screening test for mothers at risk for delivery of pre-term and low birth-weight infants.J Int 
Acad Periodontol. Apr; 11(2):193-9. 
 
 
 
 
 
 
125 
 
Agueda A, Ramon JM, Manau C, Guerrero A, Echeverria JJ (2008).Periodontal disease as a 
risk factor for adverse pregnancy outcomes: a prospective cohort study. J Clin Periodontol.; 
35(1):16-22. 
 
Ainamo J, Barmes D, Beagrie G, Cutress T, Martin J, Sardo-Infirri J (1982). Development of 
the World Health Organization (WHO) community periodontal index of treatment needs 
(CPITN). Int Dent J.; 32: 281–91. 
 
Albandar JM, Brunelle JA, Kingman A (1999).  Destructive Periodontal Disease in Adults 30 
Years of Age and Older in the United States, 1988-1994. J Periodontal; 70(1):13-9. 
 
Albandar J and Rams T (2002) .Global epidemiology of periodontal diseases: an overview. 
Periodontol 2000; 29: 7–10. 
 
Al-Shammari KF, Al-Ansari JM,  Moussa NM, Ben-Nakhi A,  Al-Arouj M, Wang HL 
(2006). Association of periodontal disease Severity with diabetes duration and diabetic 
complications in patients with type 1 diabetes mellitus. J Int Acad Periodontol.; 8(4):109-14. 
 
Al-Zahrani MS, Bissada NF, Borawskit EA (2003). Obesity and periodontal disease in 
young, middle-aged, and older adults. J Periodontol; 74:610-615. 
 
American Academy of Periodontology (2004). Statement regarding periodontal management 
of the pregnant patient. J Periodontol.75 (3):495. 
 
Andrade JA, Feres M, Figueiredo LC, Salvador SL, Cortelli SC ( 2010) . The ability of the 
BANA Test to detect different levels of P. gingivalis, T. denticola and T. forsythia.Braz Oral 
Res.; Apr-Jun; 24(2):224-30. 
 
 
 
 
 
126 
 
Andrews WW,Goldenberg RL,Mercer B , Iams J, Meis P, Moawad  A, et al (2000). The 
Preterm Prediction Study: Association of second-trimester genitourinary chlamydia infection 
with subsequent spontaneous preterm birth Am J Obstet Gynecol.; 183:662-8. 
 
Annells MF, Hart PH, Mullighan CG, Heatley SL, Robinson JS, Bardy P, McDonald HM 
(2004). Interleukins-1, -4, -6, -10, tumor necrosis factor, transforming growth factor-beta, 
FAS, and mannose binding protein C gene polymorphisms in Australian women: risk of 
preterm birth. American Journal of Obstetrics and Gynaecology; 191, 2056–2067. 
 
Armitage GC (2004). Periodontal diagnoses and classification of periodontal diseases. 
Periodontol 2000; 34:9-21. 
 
Avula H, Mishra A, Arora N, Avula J (2013). KAP assessment of oral health and adverse 
pregnancy outcomes among pregnant women in Hyderabad, India.OralHealth Prev Dent.; 
11(3):261-70. 
 
Azarpazhooh A and Leake JL (2006).  Systematic review of the association between 
respiratory diseases and oral health. J Periodontol; 77(9):1465-82. 
 
Baelum V and Lopez R (2003). Defining and classifying periodontitis: Need for a paradigm 
shift? Eur J Oral Sci.; 111:2-6. 
 
Baelum V and Papapanou PN (1996). CPITN and the epidemiology of periodontal disease. 
Community Dent Oral Epidemiol; 24: 367–8.  
 
Baelum V, Manji F,Wanzala P, Federskof O, (1995). Relationship between CPITN and 
periodontal attachment loss in an adult population. J Clinical Periodontol. Feb 22 (2): 146 -
52. 
 
 
 
 
127 
 
 
Bassani DG, Olinto MTA, Kreiger N (2007). Periodontal disease and perinatal outcomes: a 
case-control study.J Clin Periodontol, 34:31–39. 
 
Barak S, Oettinger-Barak O, Oettinger M, Machtei EE, Peled M, Ohel G. (2003). Common 
oral manifestations during pregnancy: a review. Obstet Gynecol Surv.; 58(9):624-8. 
 
Barak S, Oettinger-Barak O Machtei E.  E, Sprecher H, Ohel G (2007). Evidence of 
Periopathogenic Microorganisms in Placentas of Women with Preeclampsia. Journal of 
Periodontology; April, Vol. 78, No. 4, Pages 670-676. 
 
Barros F C, Victoria C G, Vaughan J P, Tomasi E, Horta B L, Cesar JA, Menezes MB, 
Halpern R, Post C L,  del Mar Garcia M (2001).The epidemiological transition in maternal 
and child health in a Brazilian city, 1982–93: a comparison of two population-based cohorts. 
Paediatr.Perinat. Epidemiol.; 15: 4–11. 
 
Bayingana C (2005). The prevalence of members of the "red complex" in pregnant women as 
revealed by PCR and BANA hydrolysis. Thesis. 
 
Bearfield C, Davenport ES, Sivapathasundaram V, Allaker R P (2002). Possible association 
between amniotic fluid microorganism infection and microflora in the mouth. British Journal 
of Obstetrics and Gynaecology;109:527–33. 
 
Beck JD, Eke PI, Heiss G, et al (2005). Periodontal disease and coronary heart disease: a 
reappraisal of the exposure. Circulation. (1); 112:19-24. 
 
Behrman R, Stith-Butler A (2006). Preterm Birth: Causes, Consequences, and Prevention. 
Washington, D.C., The National Academies Press; 329. 
 
 
 
 
128 
 
Billings F (1912). Chronic focal infections and their etiologic relations to arthritis and 
nephritis. Arch Intern Med.;9:484-498. 
 
Blondel B, Macfarlane A, Gissler M, Breart G, Zeitlin J (2006). Preterm birth and multiple 
pregnancy in European countries participating in the PERISTAT project. British Journal of 
Obstetrics and Gynaecology;113, 528–535. 
 
Bobetsis A, Barros S, Offenbacher S (2006). Exploring the relationship between periodontal 
disease and pregnancy complications J Am Dent Assoc.; Vol. 137, No suppl_2, 7S-13S. 
 
Boggess KA, Beck JD, Murtha AP, Moss K, Offenbacher S (2006).  Maternal periodontal 
disease in early pregnancy and risk for a small-for-gestational-age infant. Am J Obstet 
Gynecol.; 194:1316–22. 
 
Boggess KA, Madianos PN, Preisser JS, Moise KJ Jr, Offenbacher S (2005). Chronic 
maternal and fetal Porphyromonas gingivalis exposure during pregnancy in rabbits. Am J 
Obstet Gynecol; 192(2):554-7. 
 
Boggess KA, Lieff S, Murtha AP, Moss K, Beck J, Offenbacher S (2003).Maternal 
periodontal disease is associated with an increased risk for preeclampsia. Obstet Gynecol.; 
101(2):227-31. 
 
Boggess KA, Moss K, Madianos P, Murtha AP, Beck J, Offenbacher S (2005). Fetal immune 
response to oral pathogens and risk of preterm birth. Am J Obstet Gynecol.; 193(3 part 
2):1121-6. 
 
Bogies KA, Beck JD, Murtha AP, et al (2006). Maternal periodontal age infant. Am J Onsted 
Gynecol.; 194(5): 1316–22. 
 
 
 
 
129 
 
 
Borrell L and Papapanou PN (2005). Analytical epidemiology of periodontitis. J Clinic 
Periodontol: 32(6 suppl) 132-158. 
 
Bright Futures in Practice (2004). Oral Health Pocket Guide: National Maternal and Child 
Oral Health Resource Center; Georgetown University. 
 
Buduneli N, Baylas H, Buduneli E, Turkoglu O, Kose T, DahlenG (2005). Periodontal 
infections and pre-term low birth weight: a case-control study. J Clin Periodontol; 32 (2):174-
81. 
 
Carey J C, Klebanoff  MA, Hauth JC, Hillier S L, Thom EA, Ernest JM,Heine R P, Nugent R 
P, Fischer  ML,Leveno KJ, Wapner R, Varner M (2000). Metronidazole to prevent preterm 
delivery in pregnant women with asymptomatic bacterial vaginosis. National institute of child 
health and human development network of maternal-fetal medicine units.  New England 
Journal of Medicine; 342, 534–540. 
 
Carlos JP, Wolfe MD, Kingman A (1986). The extent and severity index: a simple method 
for use in epidemiologic studies of periodontal disease. J Clin Periodontol.; 13: 500–5. 
 
Carta G, Persia G, Falciglia K, Iovenitti P (2004).Periodontal disease and poor obstetrical 
outcome. Clinical and Experimental Obstetrics and Gynecology; 31, 47–49.  
 
Champagne CM, Madianos PN, Lieff S, Murtha AP, Beck JD, Offenbacher S (2000). 
Periodontal medicine: emerging concepts in pregnancy outcomes. J Int Acad Periodontol.; 2: 
9–13. 
 
 
 
 
 
130 
 
Chan H,Wu C, Welch KB, Loesche WJ (2010). Periodontal Disease Activity Measured by 
the Benzoyl-DL-Arginine-Naphthylamide Test Is Associated With Preterm Births . Journal of 
Periodontology.; July, Vol. 81, No. 7, 982-991. 
 
Chi DL, Milgrom P, Carle AC, Huebner CE. Mancl LA (2014). Multilevel factors associated 
with dentists’ counseling of pregnant women about periodontal health. Special Care in 
Dentistry, 34: 2–6.  
 
Collins JG, Windley HW 3rd, Arnold RR, Offenbacher S (1994). Effects of a Porphyromonas 
gingivalis infection on inflammatory mediator response and pregnancy outcome in hamsters. 
Infect Immun.; 62(10):4356-61. 
 
Collins JG, Smith MA, Arnold RR, Offenbacher S (1994). Effects of Escherichia coli and 
Porphyromonas gingivalis lipopolysaccharide on pregnancy outcome in the golden hamster. 
Infect Immun.; 62(10):4652-5. 
 
Costerton W, Veeh R, Shirtliff  M, Pasmore M, Post C, Ehrlich G (2003). The application of 
biofilm science to the study and control of chronic bacterial infections. Journal of Clinical 
Investigation. ; 112, 1466–1477. 
 
Cowling P, McCoy DR, Marshall RJ, Padfield CJ and Reeves DS (1992). Bacterial 
colonization of the non-pregnant uterus: a study of pre-menopausal abdominal hysterectomy 
specimens. European Journal of Clinical Microbiology and Infectious Diseases; 11, 204–205. 
 
Cronin CM, Shapiro CR, Casiro OG and Cheang MS (1995).  The impact of very low-birth-
weight infants on the family is long lasting. A matched control study.  Archives of Pediatrics 
and Adolescent Medicine. ; 149,151–158. 
 
 
 
 
131 
 
Cuttress TW (1986). Periodontal health and periodontal disease in young people: Global 
epidemiology. Int Dent J.; 36:146–152. 
 
D’Aiuto F, Parkar M, Nibali L, Suvan J, Lessem J, Tonetti MS (2006) . Periodontal 
infections cause changes in traditional and novel cardiovascular risk factors: results from a 
randomized controlled clinical trial. Am Heart J.; 15 :( 5):977-84. 
 
Dasanayake AP (1998). Poor periodontal health of the pregnant woman as a risk factor for 
low birth weight. Ann Periodontol.; 3(1):206-12. 
 
Dasanayake AP (2010).  Periodontal disease is related to local and systemic mediators of 
inflammation. J Evid Based Dent Pract; 10:246-7. 
 
Dasanayake AP, Boyd D, Madianos PN, Offenbacher S, Hills E (2001).The association 
between Porphyromonas gingivalis-specific maternal serum IgG and low birth weight. J 
Periodontol; 72:1491–7.  
 
Dasanayake AP, Russell S, Boyd D, et al (2003). Preterm low birth weight and periodontal 
disease among African Americans.Dent Clin North Am.; 47(1):115-25. 
 
Davenport ES, Williams CE, Sterne JA, Murad S, Sivapathasundram V, Curtis MA (2002) 
.Maternal periodontal disease and preterm low birth weight: case-control study. J Dent Res.; 
81: 313–18.  
 
DeStefano F, Anda RF, Kahn HS, et al (1993). Dental disease and risk of coronary heart 
disease and mortality. BMJ; Mar 13; 306 (6879): 688-91. 
 
 
 
 
 
132 
 
Dorrington R, Bradshaw D, Johnson L, Budlender D (2004). The demographic impact of 
HIV/AIDS in South Africa. National indicators for 2004. Cape Town: Centre for Actuarial 
Research, South African Medical Research Council and Actuarial Society of South Africa. 
 
Dortbudak O, Eberhardt R, Ulm M, Persson GR (2005). Periodontitis: a marker of risk in 
pregnancy for preterm birth. J Clin Periodontol.; 32(1):45-52. 
 
Duff P, Gibbs RS, Blanco JD, St Clair PJ (1983). Endometrial culture techniques in puerperal 
patients. Obstetrics and Gynecology; 61, 217–222. 
 
Ellenberg JH (1996). Intent to treat versus as treated analysis. Drug Information Journal; 30, 
535–544. 
 
Eskenazi B, Marks AR, Catalano R, Bruckner T, Toniolo PG (2007).  Low birth weight in 
New York City and upstate New York following the events of September 11th. Human 
Reproduction; 22, 3013–3020.  
 
Espinoza J, Erez O, Romero R (2006).Preconceptional antibiotic treatment to prevent preterm 
birth in women with a previous preterm delivery. American Journal of Obstetrics and 
Gynecology; 194, 630–637. 
 
Faria-Almeida R, Navarro A, Bascones A (2006). Clinical and metabolic changes after 
conventional treatment of type 2 diabetic patients with chronic periodontitis. J Periodontol; 
77(4): 591-8. 
 
Farrell S, Ide M, Wilson RF (2006).The relationship between maternal periodontitis, adverse 
pregnancy outcome and miscarriage in never smokers. J Clin Periodontol.; 33:115-120. 
 
 
 
 
 
133 
 
Feinberg AP (2007). Phenotypic plasticity and the epigenetics of human disease. Nature; 
447:433-440.   
 
Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S Woo P (1998). 
The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and 
plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. Journal 
of Clinical Investigation. ; 102, 1369–1376. 
 
Flynn CA, Helwig AL, Meurer LN (1999). Bacterial vaginosis in pregnancy and the risk of 
prematurity: a meta-analysis. Journal of Family Practice; 48, 885–892. 
 
Foster JS and Kolenbrander PE (2004). Development of a multispecies oral bacterial 
community in a saliva-conditioned flow cell.Appl Environ Microbiol, Jul; 70(7):4340-8. 
 
Galloway CE (1931). Focal Infection. Am J Surg.; 14(3):643-645. 
 
Garcia RI, Henshaw MM, Krall EA (2001). Relationship between periodontal disease and 
systemic health. Periodontology 2000, 25: 21–36.  
 
Garcia R, Henshaw M, Krall E (2001). Relationship between periodontal disease and 
systemic health. Periodontol 2000; 25: 21–36. 
 
Gardosi JO (2005). Prematurity and fetal growth restriction. Early Human Development; 81, 
43–49.  
 
 
 
 
 
134 
 
Gettinger G, Patters MR, Testa MA, Loe H, Anerud A, Boysen H, Robertson PB (1982). The 
use of six selected teeth in population measures of periodontal status. Journal of 
Periodontology. 54: 155-159. 
 
Giannopoulou C, Cappuyns I, Mombelli A (2003). Effect of gingival crevicular fluid 
cytokine profile during experimental gingivitis. J Clin Periodontal; 30:996-1002. 
 
Giannopoulou C, Kamma JJ, Mombelli A (2003). Effect of inflammation, smoking and stress 
on gingival crevicular fluid cytokine level. J Clin Periodontol; 30:145-153. 
 
Gibbs RS, Romero R, Hillier SL, Eschenbach DA, Sweet RL (1992). A review of premature 
birth and subclinical infections. Am J Obstet Gynecol. 166(5): 1515-1528. 
 
Genc MR, Onderdonk AB, Vardhana S,Delaney ML, Norwitz ER, Tuomala RE, Paraskevas 
LR,Witkin SS (2004). Polymorphism in 2 of the interleukin-1 receptor antagonist gene, local 
mid-trimester cytokine response to vaginal flora, and subsequent preterm birth. 
AmericanJournal of Obstetrics and Gynecology; 191, 1324–1330. 
 
Genuit T, Bochicchio G, Napolitano LM, McCarter RJ, Roghman MC (2001).  Prophylactic 
chlorhexidine oral rinse decreases Ventilator-associated pneumonia in surgical ICU patients. 
Surg Infect (Larchmt); 2(1):5-18. 
 
Giannopoulou C, Kamma JJ, Mombelli A (2003). Effect of inflammation, smoking and stress 
on gingival crevicular fluid cytokine level. Journal of Clinical Periodontology; 30, 145–153. 
 
Gibbs RS, Romero R, Hillier SL, Eschenbach DA, Sweet R L (1992). A review of premature 
birth and subclinical infection. American Journal of Obstetrics and Gynecology; 166, 1515–
1528. 
 
 
 
 
135 
 
Gibbs R S (2001). The relationship between infections and adverse pregnancy outcomes:an 
overview. Annals of Periodontology; 6, 153–163. 
 
Goepfert AR, Jeffcoat MK, Andrews WW, et al (2004).  Periodontal disease and upper 
genital tract inflammation in early spontaneous preterm birth. Obstet Gynecol; 104(4):777-
83. 
 
Goldenberg RL, Culhane JF, Iams JD, Romero R (2008). Epidemiology and causes of 
preterm birth. Lancet; 371, 75–84. 
 
Goldenberg RL, Hauth JC, Andrews WW (2000). Intrauterine infection and preterm delivery. 
N Engl J Med.; 342:1500-1507. 
 
Grisi MFM, Correa Filho TA, Fanganiello CLS, Martins W, Silva-Neto CR, Salvador SL 
(2001). Relationship Between the Presence or Absence of Gingival Bleeding and the 
Enzymatic BANA Test. Braz Dent J.; 12(1): 23-26. 
 
Hack M, Taylor HG, Klein N, Eiben R, Schatschneider C, Mercuri-Minich N (1994). School-
age outcomes in children with birth weights under 750 g. New England Journal of Medicine; 
331, 753–759. 
 
Haerian-Ardakani A, Eslami Z, Rashidi-Meibodi F, Haerian A, Dallalnejad P, Shekari M, 
Moein Taghavi A, Akbari S (2013). Relationship between maternal periodontal disease and 
low birth weight babies.Iran J Reprod Med.; Aug; 11(8):625-30. 
 
Han YW, Houcken W, Loos BG, Schenkein HA, Tezal M (2014). Periodontal Disease, 
Atherosclerosis, Adverse Pregnancy Outcomes, and Head-and-Neck Cancer.Adv Dent Res.; 
May; 26(1):47-55. 
 
 
 
 
136 
 
 
Han YW, Ikegami A, Bissada NF, Herbst M, Redline RW (2006).Transmission of an 
uncultivated Bergeyella strain from the oral cavity to amniotic fluid in a case of preterm birth. 
Journal of Clinical Microbiology; 44, 1475–1483. 
 
Harmsen D and Ehmke B (2006). Current Microbiological Diagnostic Strategies in 
Periodontitis and Future Trends. Perio - Periodontal Practices Today; Volume 3, Issue 
1.Pages: 63 
 
Hasegawa K, Furuichi Y, Shimotsu A, Nakamura M, Yoshinaga M, Kamitomo M, et al 
(2003). Associations between systemic status, periodontal status, serum cytokine levels, and 
delivery outcomes in pregnant women with a diagnosis of threatened premature labor. 
Journal of Periodontology; 74:1764-1770. 
 
Hauth JC, Goldenberg RL, Andrews WW, DuBard MB, Copper RL (1995). Reduced 
incidence of preterm delivery with metronidazole and erythromycin in women with bacterial 
vaginosis. New England Journal of Medicine; 333, 1732–1736. 
 
Hillier SL, Nugent RP, Eschenbach DA, Krohn MA, Gibbs RS, Martin DH, Cotch MF, 
Edelman R, Pastorek JG. II, Rao AV, McNellis D, Regan J A, Carey JC, Klebanoff MA 
(1995).  Association between bacterial vaginosis and preterm delivery of a low-birth-weight 
infant. The vaginal infections and prematurity stud group. New England Journal of Medicine; 
333, 1737–1742. 
 
Holbrook WP, Oskarsdottir A, Fridjonsson T, Einarsson H, Hauksson A, Geirsson RT 
(2004). No link between low-grade periodontal disease and preterm birth: a pilot study in a 
healthy Caucasian population. Acta Odontol Scand.; 62(3):177-9. 
 
 
 
 
 
137 
 
Holmlund A, Holm G, Lind L (2006). Severity of periodontal disease and numbers of 
remaining teeth are related to the prevalence of myocardial infarction and hypertension in a 
study based on 4,254 subjects. J Periodontol; 77(7):1173-8. 
 
Horowitz S, Mazor M, Romero R, Horowitz J, Glezerman M (1995). Infection of the 
amniotic cavity with Ureaplasma urealyticum in the mid-trimester of pregnancy. Journal of 
Reproductive Medicine. ; 40, 375–379. 
 
Hujoel PP, Drangsholt M, Spiekerman C, DeRouen TA (2002). Periodontitis-systemic 
disease associations in the presence of smoking—causal or coincidental? Periodontol 2000; 
30: 51–60.  
 
Hujoel PP, Lydon-Rochelle M, Robertson PB, del Aguila MA (2006). Cessation of 
periodontal care during pregnancy: effect on infant birthweight. Eur J Oral Sci, 114:2-7. 
 
Hyman J (2006). The importance of assessing confounding and effect modification in 
research involving periodontal disease and systemic diseases. J Clin Periodontol.; 33(2):102–
103.  
 
Iftime C, Galuscan A, Jumanca D, Podariu A, Oancea R, Popovici R , Sava-Rosianu R 
(2008).  Health education and prophylactic measures needed during pregnancy. Medicine in 
evolution; Nr. 4117. 
 
Ishira K, Naitoy, Kato T, et al (1991). A sensitive enzymatic method (SK-013) for detection 
and quantification of specific periodontopathogens. J Periodont Res.; 27: 81-91. 
 
 
 
 
 
 
138 
 
Jared H and Boggess KA (2008). Periodontal Diseases and Adverse Pregnancy Outcomes: A 
Review of the Evidence and Implications for Clinical Practice. Journal of Dental Hygiene; 
Vol. 82, No. 3, July 2008. 
 
Jarjoura K, Devine PC, Perez-Delboy A, Herrera-Abreu M, D’Alton M, Papapanou PN 
(2005).  Markers of periodontal infection and preterm birth. Am J Obstet Gynecol; 
192(2):513-9. 
 
Jason H, Lind Holm E, Lindh C, Groop L, Bratthall G (2006). Type2 diabetes and risk for 
periodontal disease: a role for dental Health awareness. J Clin Periodontol.; 33(6):408-14. 
 
Jeffcoat MK (1994). Prevention of periodontal diseases in adults: strategies for the future. 
Prev Med.; 23(5):704-8. 
 
Jeffcoat MK, Hauth JC, Geurs NC, Reddy MS, Cliver SP, Hodgkins PM, Goldenberg RL 
(2003). Periodontal disease and preterm birth: results of a pilot intervention study. Journal of 
Periodontology; 74, 1214–1218. 
 
Jeffcoat MK, Geurs NC, Reddy MS, Cliver SP, Goldenberg R, Hauth JC (2001). Periodontal 
infection and preterm birth: results of a prospective study. JADA; 132(7):875-80 
 
Jensen J, Liljemark W, Bloomquist C (1981). The effect of female sex hormones on 
subgingival plaque. J Periodontol; 52(10):599-601. 
 
Kanaparthy R, Kanaparthy A, Dev K (2012).  BANA Hydrolysis as a Comparative Tool in 
the Evaluation of Amoxicillin and Azithromycin in the Treatment of Chronic Periodontitis, J 
Periodontol Implant Dent; 4(2):43-47. 
 
 
 
 
139 
 
Katz J, Chegini N, Shiverick K, Lamont RJ (2009). Localization of P. gingivalis in preterm 
delivery placenta. J Dent Res.; Jun; 88(6):575-8. 
 
Katzenellenbogen J and Joubert G (1997). Data Collection and Measurement. In: 
Epidemiology A manual for South Africa. Oxford University Press Southern Africa. 82-92. 
 
Kekki M, Kurki T, Pelkonen J, Kurkinen-Raty M, Cacciatore B, Paavonen J (2001). Vaginal 
clindamycin in preventing preterm birth and peripartal infections in asymptomatic women 
with bacterial vaginosis: a randomized, controlled trial. Obstetrics and Gynecology; 97, 643–
648. 
 
Kenagy G, Linsk N, Bruce D, Warnecke R, Gordon A, Wagaw F , Densham A (2003). 
Service Utilization, Service Barriers, and Gender among HIV-Positive Consumer in Primary 
Care. AIDS Patient Care and STD’s.; 17 (5): 235 -244. 
 
Kinane D and Bouchard P (2008). Group E of European Workshop on Periodontology. J Clin 
Periodontol.; Sep; 35(8 Suppl):333-7. 
 
Kinane DF (2001). Causation and pathogenesis of periodontal disease Periodontol 2000, 
25:8-20. 
 
Kingman A, Albandar JM (2002). Methodological aspects of epidemiological studies of 
periodontal diseases. Periodontol 2000, 29:11-30. 
 
Kolenbrander PE (2011). Multispecies communities: interspecies interactions influence 
growth on saliva as sole nutritional source.Int J Oral Sci.; 2011 Apr; 3(2):49-54. 
 
 
 
 
 
140 
 
Kolenbrander PE (2011). Multispecies communities: interspecies interactions influence 
growth on saliva as sole nutritional source.Int J Oral Sci.; Apr; 3(2):49-54. 
 
Komiya Ito A, Ishihara K, Tomita S, Kato T, Yamada S (2010). Investigation of subgingival 
profile of periodontopathic bacteria using polymerase chain reaction.Bull Tokyo Dent Coll.; 
51(3):139-44. 
 
Konopka T, Rutkowska M, Hirnle L, Kopec W, Karolewska E (2003). The secretion of 
prostaglandin E2 and interleukin 1-beta in women with periodontal diseases and preterm low-
birth-weight. Bulletin du Groupement International Pour la Recherche Scientifiqueen 
Stomatologie et al Odontologie; 45, 18–28. 
 
Kornman KS and Loesche WJ (1980).  The subgingival microbial flora during pregnancy. 
Journal of Periodontal Research; 15, 111– 122.  
 
Kornman K, Page R, Tonetti M (1997).The host response to the microbial challenge in 
periodontitis: assembling the players. Periodontol 2000; 14: 33–53. 
 
Kothiwale SV, Desai BR, Kothiwale VA, Gandhid M, Konin S (2014). Periodontal disease as 
a potential risk factor for low birth weight and reduced maternal haemoglobin levels.Oral 
Health Prev Dent.; 12(1):83-90. 
 
Kramer MS (1987). Determinants of low birth weight, Methodological assessment and meta- 
analysis. Bulletin of the World Health Organization. ; 65(5):663-737. 
 
Kramer MS, Séguin L, Lydon J, Goulet L (2000). Socio-economic disparities in pregnancy 
outcome: why do the poor fare so poorly? Paediatr Perinat Epidemiol.; 14:194–210.  
 
 
 
 
141 
 
Lamon DF (2003). Changes in vaginal flora after 2% clindamycin vaginal cream in women at 
high risk of preterm birth. British Journal of Obstetrics and Gynaecology; 110,788–789. 
 
Lamont RF (1998). New approaches in the management of preterm labour of infective 
aetiology. Br J Obstet Gynaecol. Feb.; 105(2):134-7.  
 
Langhoff-Roos J, Kesmodel U, Jacobsson B, Rasmussen S, Vogel I (2006). Spontaneous 
preterm delivery in primiparous women at low risk in Denmark: population based study. 
BMJ. ; 332, 937–939. 
 
Lawn JE, Cousens S, Zupan J (2005). 4 Million neonatal deaths: when? Where? Why? 
Lancet;365, 891–900. 
 
Leal MC, da Gama SG, Ratto KMN, Cunha CB (2004). Use of the modified Kotelchuck 
index in the evaluation of prenatal care and its relationship to maternal characteristics and 
birth weight in Rio de Janeiro, Brazil. Cad Saúde Pública.;20 (Suppl 1):63S-72S. 
 
Lieff S, Boggess, AK, Murtha PA, Jared H, Madianos NP, Moss K, Beck J ,Offenbacher S ( 
2004). The Oral Conditions and Pregnancy Study: Periodontal Status of a Cohort of Pregnant 
Women. J Periodontol;75(1): 116-126. 
 
Leitich H, Bodner-Adler B, Brunbauer M, Kaider A, Egarter C, Husslein P (2003a). Bacterial 
vaginosis as a risk factor for preterm delivery: a meta-analysis. American Journal of 
Obstetrics and Gynecology.; 189, 139–147. 
 
Leitich H, Brunbaue M, Bodner-Adler B, Kaider A, Egarter C, Husslein P (2003b). 
Antibiotic treatment of bacterial vaginosis in pregnancy: a meta-analysis. American Journal 
of Obstetrics and Gynecology.; 188, 752–758. 
 
 
 
 
142 
 
Leon R, Silva N, Ovalle A, Chaparro A, Ahumada A, Gajardo M, Martinez M, Gamonal J 
(2007). Detection of Porphyromonas gingivalis in the amniotic fluid in pregnant women with 
a diagnosis of threatened premature labor. Journal of Periodontology; 78, 1249–1255. 
 
Lin D, Moss K, Beck J D, Hefti A, Offenbacher S (2007). Persistently high levels of 
periodontal pathogens associated with preterm pregnancy outcome. Journal of 
Periodontology; 78, 833–841.  
 
Lin D, Smith MA, Champagne C, Elter J, Beck J, Offenbacher S (2003). Porphyromonas 
gingivalis infection during pregnancy increases maternal tumor necrosis factor alpha, 
suppresses maternal interleukin-10, and enhances fetal growth restriction and resorption in 
mice. InfectImmun; 71(9):5156-62. 
 
Loe H and Silness J (1963). Periodontal Disease in pregnancy. I. Prevalence and severity. 
Acta Odontol Scand; 21: 533–51. 
 
Loe H and Silness J (1966). Periodontal disease in pregnancy. 2. Prevalence and Severity. 
Acta Odontol Scand; 21:533-549. 
 
LoescheWJ (1997). Association of the oral flora with important medical diseases.Current 
Opinion in Periodontology; 4:21-8. 
 
Loesche WJ (1993). Bacterial mediators in periodontal disease.Clin Infect Dis. Jun; 16 Suppl 
4:S203-10. 
 
Loesche WJ (1979).  Clinical and microbiological aspects of chemotherapeutic agents used 
according to the specific plaque hypothesis. J Dent Res.; 58:2404-2412. 
 
 
 
 
143 
 
 LoescheWJ (1999).The antimicrobial treatment of periodontal disease: changing the 
treatment paradigm.Critical reviews in oral biology and medicine: an official publication of 
the American Association of Oral Biologists.; 10(3):245-75. 
 
Loesche WJ (1987). The bacterial etiology of periodontal disease: The specific plaque 
hypothesis. In: Clinical dentistry. Clark JW, editor. Ch. 12. Hagerstown, MD: Harper & Row 
Publishers, pp. 1-11. 
 
Loesche WJ (1986). The identification of bacteria associated with periodontal disease and 
dental caries by enzymatic methods. Oral Microbiol Immunol; 1:65-72. 
 
Loesche WJ, Bretz WA, Kerschensteiner D, Stoll J, Socransky SS, Hujoel PP, et al (1990a). 
Development of a diagnostic test for anaerobic periodontal infections based on plaque 
hydrolysis of Benzoyl-DL-Arginine-Naphthylamide. J Clin Microbiol; 28:1551-1559. 
 
Loesche WJ, Bretz WA, Lopatin DE, Stoll J, Rau CF, Hillenburg KC, et al (1990b). Multi-
center clinical evaluation of a chairside method for detecting certain periodontopathic 
bacteria in periodontal disease.J Periodontol; 61:189-196. 
 
LoescheW J and  GiordanoJ R (1997). Disease. Compendium of continuing education in 
dentistry (Jamesburg, N.J.: 1995); 18(3):221-6, 228-30. 
 
Loesche WJ, Giordano J, Hujoel PP (1990c). The utility of the BANA test for monitoring 
anaerobic infections due to spirochetes (Treponema denticola) in periodontal disease. J Dent 
Res.; 69:1696-702. 
 
Loesche WJ and Grossman NS (2001). Periodontal disease as a specific, albeit chronic 
infection: Diagnosis and Treatment. Clinical Microbiology Reviews; 14: 727-752. 
 
 
 
 
144 
 
 
Loesche W J,  Kazor C E,  Taylor G W (1997).The optimization of the BANA test as a 
screening instrument for gingivitis among subjects seeking dental treatment.Journal of 
clinical periodontology. ; 24(10):718-26. 
 
Loesche WI and Lopatin DE (1998). Interactions between periodontal disease, medical 
diseases and immunity in the older individual. Periodontol 2000. ; 16:80-105. 
 
Loesche WJ, Lopatin DE, Giordano J, Alcoforado G, Hujoel PP (1992). Comparison of the 
Benzoyl-DL-Arginine-Naphthylamide (BANA) test, DNA probes, and immunological 
reagents for ability to detect anaerobic periodontal infections due to Porphyromonas 
gingivalis, Treponema denticola, and Bacteroides forsythus.J Clin Microbiol. ; 30:427-433. 
 
Loesche WJ, Syed SA, Stoll J (1987). Trypsin-like activity in subgingival plaque. A 
diagnostic marker for spirochetes and periodontal disease? J Periodontol; 58:266-273. 
 
Loesche W J,  Taylor G,  Giordano J R,  Hutchinson R, Rau C F,  Chen YM,  Schork M A 
(1997).  A logistic regression model for decision to perform access surgery. Journal of 
clinical periodontology; 24(3):171-9. 
 
Lopez, NJ, Da Silva I, Ipinza J, Gutierrez J (2005). Periodontal therapy reduces the rate of 
preterm low birth weight in women with pregnancy-associated gingivitis. Journal of 
Periodontology; 76, 2144–2153. 
 
Lopez NJ, Smith PC, Gutierrez J (2002) .Higher risk of preterm birth and low birth weight in 
women with periodontal disease. J Dent Res.; 81(1):58-63. 
 
 
 
 
145 
 
Lopez N J, Smith P C, Gutierrez J (2002b). Periodontal therapy may reduce the risk of 
preterm low birth weight in women with periodontal disease: a randomized controlled trial. 
Journal of Periodontology.; 73,911–924. 
 
Louro PM, Fiori HH, Filho PL, Steibel J, Fiori RM. (2001). Periodontal disease in pregnancy 
and low birth weight. J Pediatr (Rio J); 77(1):23-8. 
 
Lovegrove J (2004). Dental plaque revisited: bacteria associated with periodontal disease. J N 
Z Soc Periodontol. ; (87):7-21. 
 
MacDorman MF, Callaghan WM, Mathews T J, Hoyert D L, Kochanek KD (2007) .Trends 
in preterm-related infant mortality by race and ethnicity, United States,1999–2004. 
International Journal of Health Services; 37, 635–641.  
 
Madianos PN, Lieff S, Murtha AP, et al. (2001). Maternal periodontitis and prematurity, II: 
maternal infection and fetal exposure. Ann Periodontol.; 6(1):175-82. 
 
Mahulja-Stamenkovic V, Beleznay O, Stamenkovic M, Samardzija R, Makis J (1993). IgG, 
IgM and IgA umbilical blood concentrations in normal singleton vaginal deliveries with 
stinking amniotic fluid or intrapartal maternal febrility 4or 5 38 degrees C or duration of 
delivery 412 h. Zentralblatt fu¨r Gynakologie; 115, 33–35. 
 
Manau C, Echeverria A, Agueda A, Guerrero A, Echeverria JJ (2008). Periodontal disease 
definition may determine the association between periodontitis and pregnancy outcomes. 
Journal of Clinical Periodontology; 35: 385–397.  
 
 
 
 
 
146 
 
Marsh P and Martin M. (1992). Oral Microbiology. London, New York, Tokyo, Melbourne, 
Madras: Chapman & Hall: pp167-196. 
 
Marshall C and Rossman G (1995). Designing Qualitative Research. 2nd Edition. London: 
SAGE Publications. 
 
Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F,Kirmeyer S, et al (2007). 
Births: final data for 2005. Natl Vital Stat Rep.; 56:1–103.  
 
Matteson SR, Joseph LP, Bottomley W, et al (1991).The report of the panel to develop 
radiographic selection criteria for dental patients. Gen Dent.; 39(4):264-70. 
 
Mattila KJ, Valtonen WV, Nieminen MS, Huttunen IK (1995). Dental infection and the risk 
of new coronary events: prospective study of patients with documented coronary artery 
disease. Clin Infect Dis; 20:588-592. 
 
Mattsby-Baltzer I, Platz-Christensen J J,Hosseini N, Rosen P (1998) . IL-1beta,IL-6, TNF 
alpha, fetal fibronectin, and endotoxin in the lower genital tract of pregnant women with 
bacterial vaginosis. Acta Obstetricia et Gynecologica Scandinavica; 77, 701–706. 
 
McCormick M (2003). The contribution of low birth weight to infant mortality and childhood 
morbidity. N Engl J Med.; 1985; 312: 82–90.  
 
McDonald H, Brocklehurst P, Parsons J (2005). Antibiotics for treating bacterial vaginosis in 
pregnancy. The Cochrane Database of Systemic Reviews; Issue 1. Art. No.: CD000262. 
 
 
 
 
 
147 
 
McDonald HM, O’Loughlin, JA, Vigneswaran R, Jolley PT, Harvey JA, Bof A, McDonald 
PJ (1997). Impact of metronidazole therapy on preterm birth in women with bacterial 
vaginosis flora (Gardnerella vaginalis): a randomised, placebo controlled trial. British Journal 
of Obsteterics and Gynaecology; 104, 1391–1397. 
 
Menon R and Fortunato SJ (2007). Infection and the role of inflammation in preterm 
premature rupture of the membranes. Best Practice and Research Clinical Obsteterics and 
Gynaecology. ; 21, 467–478. 
 
Michalowicz BS, Hodges JS, DiAngelis AJ, Lupo VR, Novak MJ, Ferguson JE, Buchanan 
W, Bofill J, Papapanou PN, Mitchell DA, Matseoane S, Tschida PA (2006) . OPT Study: 
Treatment of periodontal disease and the risk of preterm birth.N Engl J Med, 355:1885-1894. 
 
Miller WD (1891). The human mouth as a focus of infection. Dent Cosmos; 33: 689-713. 
 
Minkoff H. (1983) Prematurity: infection as an etiologic factor. Obstet Gynecol.; 62: 137–44.  
 
Mitchell-Lewis D, Engebretson SP, Chen J, et al (2001). Periodontal infections and pre-term 
birth: early findings from a cohort of young minority women in New York. Eur J Oral Sci.; 
Feb; 109(1):34-9. 
 
Miyazaki H, Pilot T, Leclercq MH, Barmes DE (1991). Profiles of periodontal conditions in 
adults measured by CPITN.Int Dent J, 41:74–80. 
 
Miyazaki H, Yamashita Y, Goto-Kimura K, et al (1991). Periodontal condition of pregnant 
women assessed by CPITN. J Clin Periodontol.; Nov; 18(10):751-4 
 
 
 
 
 
148 
 
Mokeem SA, Molla GN, Al-Jewair TS (2004) .The prevalence and relationship between 
periodontal disease and pre-term low birth weight infants at King Khalid University Hospital 
in Riyadh, Saudi Arabia. J Contemp Dent Pract; 5(2):40-56. 
 
Moller BR, Kristiansen FV, Thorsen P, Frost L, Mogensen SC (1995). Sterility of the uterine 
cavity. Acta Obstetricia et Gynecologica Scandinavica.; 74, 216–219. 
 
Moore S, Ide M, Coward PY, et al (2004). A prospective study to investigate the relationship 
between periodontal disease and adverse pregnancy outcome. Br Dent J.; 197:251-8; 
discussion 247. 
 
Moore S, Randhawa M, Ide M (2005) .A case-control study to investigate an association 
between adverse pregnancy outcome and periodontal disease. J Clin Periodontol.; 32(1):1-5. 
 
Morales WJ, Schorr S, Albritton J (1994). Effect of metronidazole in patients with preterm 
birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind 
study. American Journal of Obstetrics and Gynecology; 171, 345-349. 
 
Morgan M, Crall J, Goldenberg R, and Schulkin J (2009). Oral health during pregnancy. J 
Matern Fetal Neonatal Med.; Sep; 22 (9):733-9. 
 
Moutquin JM (2003). Classification and heterogeneity of preterm birth. British Journal of 
Obstetrics and Gynaecology.; 110 (Suppl. 20), 30–33. 
 
Mukhopadhaya N and Arulkumaran S (2007). Reproductive outcomes after in-vitro 
fertilization. Current Opinion in Obstetrics and Gynecology.; 19, 113–119. 
 
 
 
 
 
149 
 
Mumghamba EGS and  Manji KP (2007). Maternal oral health status and preterm low birth 
weight at Muhimbili National Hospital, Tanzania: a case-control study. BMC Oral Health; 
7:8.  
 
Nishihara T and Koneke T (2004). Microbial aetiology of periodontitis. Periodontology 2000; 
36:14-26. 
 
Noack B, Klingenberg J, Weigelt J, Hoffmann T (2005). Periodontal status and preterm low 
birth weight: a case control study. Journal of Periodontal Research; 40, 339–345. 
 
Nordstrom ML, Cnattingius S (1996). Effects on birthweights of maternal education, socio-
economic status, and work-related characteristics. Scand J Soc Med.; Mar; 24(1):55-61. 
 
Offenbacher S, Barros S, Beck J (2008). Rethinking Periodontal Inflammation. Journal of 
Periodontology.; Vol. 79, No. 8s, Pages 1577-1584,  
 
Offenbacher S and Beck J (2007). Has Periodontal Treatment Failed to Reduce Adverse 
Pregnancy Outcomes? The Answer May Be Premature. Journal of Periodontology; 78:2, 195-
197. 
 
Offenbacher S, Beck JD, Jared HL, Mauriello S M, Mendoza L C, Couper D J, Stewart DD, 
Murtha AP et al (2009). Effects of Periodontal Therapy on Rate of Preterm Delivery. 
Obstetrics & Gynecology.; 114:3, 551-559. 
 
Offenbacher S, Boggess KA, Murtha AP, et al (2006).Progressive periodontal disease and 
risk of very preterm delivery.Obstet Gynecol.; 107(1): 29-36. 
 
 
 
 
 
150 
 
Offenbacher S, Jared HL, O'Reilly PG, Wells SR, Salvi GE, Lawrence HP et al 
(1998).Potential pathogenic mechanisms of periodontitis associated pregnancy complications. 
Annals of Periodontology; 3:233-250. 
 
Offenbacher S, Katz V, Fertik G, et al (1996). Periodontal infection as a possible risk factor 
for preterm low birth weight. J Periodontol; 67(supplement 10):1103-13. 
 
Offenbacher S, Lieff S, Boggess KA, Murtha AP, Madianos PN, Champagne CME, Mckaig 
RG, Jared HL, Mauriello SM, Auten RL Jr, Herbert WNP, Beck JD (2001). Maternal 
periodontitis and prematurity. Part I: Obstetric outcome of prematurity and growth restriction. 
Ann Periodontol, 6:164–174. 
 
Offenbacher S, Lin D, Strauss R, McKaig R, Irving J, Barros SP, Moss K, Barrow DA, Hefti 
A, Beck JD (2006). Effects of periodontal therapy during pregnancy on periodontal status, 
biologic parameters, and pregnancy outcomes: a pilot study.J Periodontol; 77(12):2011-24. 
 
Offenbacher S, Madianos PN, Suttle M (1999). Elevated human IgM suggests in utero 
exposure to periodontal pathogens. J Dent Res.; 78:2191. 
 
Offenbacher S, Riche EL, Rabbors SP, Bobetsis YA, Lin D, BeckJD (2005). Effects of 
maternal Campylobacter rectus infection on murine placenta, fetal and neonatal survival, and 
brain development. J Periodontol; 76(supplement 11):2133-43. 
 
Oittinen J, Kurki T, Kekki M, Kuusisto M, Pussinen P, Vilkuna-Rautiainen T, Nieminen A, 
Asikainen S, Paavonen J (2005). Periodontal disease and bacterial vaginosis increase the risk 
for adverse pregnancy outcome. Infect Dis Obstet Gynecol.; 13(4):213-216.  
 
 
 
 
 
151 
 
Organization for Economic Co-operation and Development (OECD) (2001). OECD Health 
Data 99: A Comparative Analysis of 29 Countries. OECD; Paris, France:  
 
Paige DM, Augustyn M, Adih WK, et al (1998). Bacterial vaginosis and preterm birth: a 
comprehensive review of the literature. J Nurse Midwifery.; Mar-Apr; 43(2):83-9. Review. 
 
Page RC and Kornman KS (1997). The pathogenesis of human periodontitis: An 
introduction. Periodontol 2000; 14:9-11. 
 
Paquette DW (2002) .The periodontal infection-systemic disease link: a review of the truth or 
myth. J Int Acad Periodontol.; 4: 101–19. 
 
Pararas M, Skevaki C, Kafetzis D (2006). Preterm birth due to maternal infection: Causative 
pathogens and modes of prevention. Eur J Clin Microbiol Infect Dis. Sep; 25 (9):562-9. 
 
Perioscan, Oral-B Laboratories Inc., Redwood City, CA. 
 
Persson R, Hitti J, Verhelst R, Vaneechoutte M, Persson R, Hirschi R, Weibel M, Rothen M, 
Temmerman M, Paul K, Eschenbach D (2009).The vaginal microflora in relation to 
gingivitis. BMC Infect Dis. Jan 22; 9:6. 
 
Philstrom BL, Lowenguth RA, et al (1995). Evaluation of periodontal treatments using 
controlled-release tetracycline fibers: clinical response. Periodontol; 66:692-699. 
 
Philstrom BL, Michalowixz BS, Johnson NW (2005) .Periodontal Diseases. Lancet; 
366(9499):1809-20. 
 
 
 
 
 
152 
 
Pitiphat  W, Joshipura K J, Gillman M W, Williams P L, Douglass C W, Rich-Edwards J W 
(2008). Maternal periodontitis and adverse pregnancy outcomes. Community Dentistry and 
Oral Epidemiology, 36: 3–11.  
 
Platz-Christensen JJ, Mattsby-Baltzer I, Thomsen P, Wiqvist N (1993). Endotoxin and 
interleukin-1 alpha in the cervical mucus and vaginal fluid of pregnant women with bacterial 
vaginosis. ; 169, 1161–1166. 
 
Precht DH, Andersen PK, Olsen J (2007). Severe life events and impaired fetal growth: a 
nation-wide study with complete follow-up. Acta Obstetricia et Gynecologica Scandinavica.; 
86, 266–275. 
 
Preshaw PM (2009). Definitions of periodontal disease in research.J Clin Periodontol.; Jan; 
36 (1):1-9  
 
Preshaw PM, Hefti AF, Jepsen S, Etienne D, Walker C, Bradshaw MH. (2004). 
Subantimicrobial dose doxycycline as adjunctive treatment for periodontitis: a review. J Clin 
Periodontol.; 31:697-707. 
 
Radnai M, Gorzo I, Nagy E, Urban E, Novak T, Pal A (2004). A possible association 
between preterm birth and early periodontitis: a pilot study. J Clin Periodontol; 31(9):736-41. 
 
Rajapakse PS, Nagarathne M, Chandrasekra KB, Dasanayake AP (2005). Periodontal disease 
and prematurity among non-smoking Sri Lankan women. J Dent Res.; 84(3):274-7. 
 
 
Raju TN (2008). Late-preterm births: challenges and opportunities. Pediatrics; 121(2); 402-3. 
 
 
 
 
 
153 
 
Ramfjord SP (1959). Indices for prevalence and incidence of periodontal disease.  
J Periodontol; 30: 51–59.  
 
Ramfjord SP, Emslie RD, Greene JC, Held AJ, Waerhaug J (1968). Epidemiological studies 
of periodontal diseases. Amer. J. Pub. Health.; 58:1713-22. 
 
Reddy BV, Tanneeru S, Chava VK (2014). The effect of phase-I periodontal therapy on 
pregnancy outcome in chronic periodontitis patients.J Obstet Gynaecol.; Jan; 34(1):29-32.  
 
Reddy UM, Wapner RJ, Rebar RW, Tasca RJ (2007). Infertility assisted reproductive 
technology, and adverse pregnancy outcomes: executive summary of a National Institute of 
Child Health and Human Development workshop. Obstetrics and Gynecology. ;  
109, 967–977. 
 
Redman CW, Sacks GP, Sargent IL (1999). Preeclampsia: an excessive maternal 
inflammatory response to pregnancy. Am J Obstet Gynecol.; 180: 499–506.  
 
Romero BC, Chiquito CS, Elejalde LE, Bernardoni CB (2002). Relationship between 
periodontal disease in pregnant women and the nutritional condition of their newborns. J 
Periodontol; 73(10):1177-83. 
 
Romero R, Chaiworapongsa T, Kuivaniemi H, Tromp G (2004). Bacterial vaginosis, the 
inflammatory response and the risk of preterm birth: a role for genetic epidemiology in the 
prevention of preterm birth. American Journal of Obstetrics and Gynecology; 190, 1509 
1519. 
 
 
 
 
 
154 
 
Romero R, Espinoza J, Kusanovic JP, Gotsch F, Hassan S, Erez O, Chaiworapongsa T,  
Mazor M (2006). The preterm parturition syndrome. British Journal of Obstetrics and 
Gynaecology: An International Journal of Obstetrics and Gynaecology.; 113, 17–42. 
 
Romero R, Kadar N, Hobbins JC, Duff GW (1987a). Infection and labor: the detection of 
endotoxin in amniotic fluid. American Journal of Obstetrics and Gynecology; 157,815–819. 
 
Romero  R, Lafreniere D, Duff GW, Kadar N, Durum S, Hobbins JC (1987b) . Failure of 
endotoxin to cross the chorioamniotic membranes in vitro. American Journal of Perinatology; 
4, 360–362. 
 
Rosebury T (1962). Microorganisms indigenous to man. New York: McGraw-Hill, pp. 1-380. 
 
Rosenstein IJ, Morgan D J, Lamont RF,Sheehan M, Dore  CJ, Hay PE, Taylor-Robinson D 
(2000). Effect of intravaginal clindamycin cream on pregnancy outcome and on abnormal 
vaginal microbial flora of pregnant women. Infectious Diseases in Obstetrics and 
Gynecology; 8, 158-165. 
 
Russell A L (1966). World epidemiology and oral health. Environmental variables in oral 
disease. (Kreshover S J & McClure F J, eds.) Washington. DC: American Association for the 
Advancement of Science; 21-39. 
 
Sant'Ana AC,  Campos MR, Selma CR, Maria LR, Sebastião LA, Passanezi E (2011). 
Periodontal treatment during pregnancy decreases the rate of adverse pregnancy outcome: a 
controlled clinical trial. Journal of Applied Oral Science; 19(2), 130-136. 
 
Sadatmansouri S, Sedighpoor N, Aghaloo M (2006). Effect of periodontal treatment phase I 
on birth term and birth weight. J Indian Soc Pedod Prev Dent.; 24:23–6. 
 
 
 
 
155 
 
Saigal S, Burrows E, Stoskopf BL, Rosenbaum PL, Streiner D (2000a).  Impact of extreme 
prematurity on families of adolescent children. Journal of Pediatrics. ; 137,701–706. 
 
Saigal S, Hoult LA, Streiner DL, Stoskopf BL, Rosenbaum PL (2000b). School difficulties at 
adolescence in a regional cohort of children who were extremely low birth weight. Pediatrics; 
105, 325–331. 
 
Santos-Pereira SA, Giraldo PC, Saba-Chujfi E et al. (2007) Chronic periodontitis and pre-
term labour in Brazilian pregnant women: an association to be analysed. J Clin Periodontol.; 
34(3):208-13. 
 
Saunders, Mark NK, Lewis P, Thornhill A (2000). Research Methods for Business Students. 
2ndEdition:Financial Times/Prentice Hall, Harlow, England. 
 
Scannapieco FA (2005). Systemic effects of periodontal diseases. Dent ClinNorth Am.; 
49:533-550. 
 
Scannapieco FA, Bush RB, Paju S (2003). Periodontal disease as a risk factor for adverse 
pregnancy outcomes. A systematic review. Ann Periodontol.; 8:70–8.  
 
Schmidt EF, Bretz WA, Hutchinson RA, Loesche WJ (1988). Correlation of the Hydrolysis 
of Benzoyl-Arginine Naphthylamide (BANA) by Plaque with Clinical Parameters and 
Subgingival Levels of Spirochetes in Periodontal Patients. J Dent Res; 67:1505-09.  
 
Silva AAM, Barbieri MA, Gomes UA, Bettiol H (1998).Trends of low birth weight: a 
comparison of two birth cohorts separated by a 15 year interval in Ribeirão Preto, Brazil. Bull 
World Health Organ; 76:73-84. 
 
 
 
 
 
156 
 
Schenkein HA (2002). Finding genetic risk factors for periodontal diseases: Is the climb 
worth the view? Periodontol 2000; 30:79-90.    
 
Schieve LA, Cohen B, Nannini A, Ferre C, Reynolds MA, Zhang Z, Jeng G,Macaluso M, 
Wright VC (2007). A population-based study of maternal and perinatal outcomes associated 
with assisted reproductive technology in Massachusetts. Maternal and Child Health Journal.; 
11,517–525. 
 
Schneider H, Husslein P, Schneider KTM (2006). Die Geburtshilfe. In: Obstetrics, 3rd 
edition, p. 1136. Springer Medizin Verlag, Heidelberg.  
 
Sconyers JR, Crawford JJ, Moriarty JD (1973). Relationship of bacteraemia to toothbrushing 
in patients with periodontitis. J Am Dent Assoc.; 87: 616–22.  
 
Sembene M, Moreau JC, Mbaye MM, et al (2000). Periodontal infection in pregnant women 
and low birth weight babies. Odontostomatol Trop.; 23(89):19-22. 
 
Seymour RA and Steele JG (1998). Is there a link between periodontal disease and coronary 
heart disease? Dent J.; Jan 10; 184(1):33-8. 
 
Shennan AH and Bewley S (2006). Why should preterm births be rising? BMJ.;  
332, 924–925. 
 
Silness P and Löe H (1964). Periodontal disease in pregnancy. II. Correlation between oral 
hygiene and periodontal condition. Acta Odontol Scand. 22: 121-124. 
 
 
 
 
 
157 
 
Simhan HN and Canavan TP (2005). Preterm premature rupture of membranes: diagnosis, 
evaluation and management strategies. British Journal of Obstetrics and Gynaecology.; 112 
(Suppl. 1), 32–37.  
 
Sjoberg I and Hakansson S (1991). Endotoxin in vaginal fluid of women with bacterial 
vaginosis. Obstetrics and Gynecology; 77, 265–266. 
 
Slade GD, Ghezzi EM, Heiss G, Beck JD, Riche E, Offenbach (2003) . Relationship between 
periodontal disease and Creative protein among adults in the atherosclerosis risk in 
Communities study. Arch Intern Med.; 163(10):1172-9. 
 
Smith LK, Draper ES, Manktelow BN, Field DJ (2009). Socioeconomic inequalities in 
survival and provision of neonatal care: population based study of very preterm infants. BMJ; 
339:b4702.  
 
Socransky SS and Haffajee AD (2005).  Periodontal microbial ecology. Periodontology 2000; 
38:135-187. 
 
Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr. (1998). Microbial complexes 
in subgingival plaque. J Clin Periodontol.; 25(2):134-44. 
 
Sooriyamoorthy M and Gower DB (1989). Hormonal influences of gingival tissue 
relationship to periodontal disease. J Clin Periodontol.; 16:201-208. 
 
Spahr A, Klein E, Khuseyinova N, et al (2006). Periodontal infections and coronary heart 
disease: role of periodontal bacteria and importance of total pathogen burden in the Coronary 
Event and Periodontal Disease (CORODONT) study. Arch Intern Med.; 166(5):554-9. 
 
 
 
 
 
158 
 
Srinivas S, Sammel M, Stamilio DM, Clothier B, Jeffcoat M, Parry S, Macones G, Elovitz M, 
Metlay J (2009) . Periodontal disease and adverse pregnancy outcomes: is there an 
association? Am J Obstet Gynecol.; May; 200(5):497.e1-8. 
 
Stamilio DM, Chang JJ, Macones GA (2007). Periodontal disease and preterm birth: do the 
data have enough teeth to recommend screening and preventive treatment? Am J Obstet 
Gynecol.; 196:93–4. 
 
Stavros P and Ziyah M et al (2003). The impact of preterm birth on hospital inpatient 
admissions and costs during the first 5 years of life. Pediatrics; 112:1290-1297. 
 
Strebel R and Bucher HU (1994). Improved chance of survival for very small premature 
infants in Switzerland. Schweizerische Medizinische Wochenschrift.; 124, 1653–1659. 
 
Sunita Bamanikar and Liew Kok Kee (2013).Knowledge, Attitude and Practice of Oral and 
Dental Healthcare in Pregnant Women. Oman Med J.; Jul; 28(4): 288–291.  
 
Swartz L and Roux N (2004). A study of local government HIV/AIDS projects in South 
Africa. Journal of social aspects of HIV/AIDS.; 1(2):99-106. 
 
Taani DQ, Habashneh R, Hammad MM, Batieha A (2003). The periodontal status of 
pregnant women and its relationship with socio-demographic and clinical variables. J Oral 
Rehabil;30(4): 440-445. 
 
Tarannum F and Faizuddin M (2007). Effect of periodontal therapy on pregnancy outcome in 
women affected by periodontitis. J Periodontol; 78:2095–103. 
 
 
 
 
 
159 
 
Tatakis D and Kumar P (2005). Etiology and pathogenesis of periodontal diseases. Dent Clin 
North Am.;Jul; 49(3):491-516. 
 
Taylor HG, Klein N, Minich NM, Hack M (2001). Long-term family outcomes for children 
with very low birth weights. Archives of Pediatrics and Adolescent Medicine.; 155, 155–161. 
 
Terry SD, Jones JE, Brown HR (1994). Dental care experiences of people living with 
HIV/AIDS in Aotearoa New Zealand. New Zealand Dental Journal; 90:49 -55. 
 
Tilakarantne  A, Soory  M, Ranasinghe AW, Crea  SMX, Ekanayake SL, De Silva  M (2000). 
Periodontal disease status during pregnancy and 3 months postpartum, in a rural population 
of Sri-Lankan women. J Clin Periodontol.; 27:787-792. 
 
Thomas KM, Jared HL, Boggess K, Lee J, Moos M, Wilder RS (2008). Prenatal Care 
Providers’ Oral Health and Pregnancy Knowledge Behaviors. J Dent Res.; 87(Spec Iss A). 
 
Thomas JG and Nakaishi LA (2006) .Managing the complexity of a Dynamic biofilm. J Am 
Dent Assoc.; 137(supp):10S- 15S. 
 
Tracy SK, Tracy MB, Dean J, Laws P, Sullivan E (2007). Spontaneous preterm birth of live 
born infants in women at low risk in Australia over 10 years: a population based study. 
British Journal of Obstetrics and Gynaecology.; 114, 731–735. 
 
Tran SD. and Rudney JD (1999). Improved Multiplex PCR Using Conserved and Species-
Specific 16S rRNA Gene Primers for Simultaneous detection of Actinobacillus 
actinomycetemcomitans, Bacteroides forsythus, and Porphyromonas gingivalis. Journal of 
Clinical Microbilogy; 37(11): 3504-3508. 
 
 
 
 
 
160 
 
Ugwumadu A, Manyonda I, Reid F, Hay P (2003). Effect of early oral clindamycin on late 
miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and 
bacterial vaginosis: a randomised controlled trial. Lancet.; 361, 983–988. 
 
Vergnes JN and Sixou M (2007).  Preterm low birth weight and maternal periodontal status: a 
meta-analysis. Am J Obstet Gynecol.; 196:135–47. 
 
Vettore MV, Lamarcagde A, Leao AT, Thomaz FB, Sheiham A, Leal MC (2006). 
Periodontal infection and adverse pregnancy outcomes: a systematic review of 
epidemiological studies. Cadernos de Saude Publica.; 22, 2041–2053. 
 
 von Dadelszen P and Magee LA (2002). Could an infectious trigger explain the differential 
maternal response to the shared placental pathology of preeclampsia and normotensive 
intrauterine growth restriction? Acta Obstet Gynecol Scand.; 81: 642–8.  
 
Walker BR, McConnachie A, Noon JP, et al (1998). Contribution of parental blood pressures 
to association between low birth weight and adult high blood pressure: cross sectional study. 
BMJ; Mar 14; 316(7134):834-7. 
 
Watson M, Bretz W, Loesche W (1994). Presence of Treponema denticola and 
Porphyromonas gingivalis in Children Correlated with Periodontal Disease of Their Parents. J 
Dent Res.; 73(10):1636-1640, October. 
 
Wilder R, Robinson C, Jared HL, Lieff S, Boggess K (2007). Obstetrician's knowledge and 
practice behaviors concerning periodontal health and preterm delivery and low birth weight. J 
Dent Hyg; 81(4):81. 
 
 
 
 
 
161 
 
Williams CE, Davenport ES, Sterne JA, Sivapathasundaram V, Fearne JM, Curtis MA 
(2000).Mechanisms of risk in preterm low-birthweight infants. Periodontology 2000; 23:142-
150. 
 
Wimmer G and Pihlstrom B (2008). A critical assessment of adverse pregnancy outcome and 
periodontal disease. J Clin Periodontol.; 35(Suppl. 8): 380–397.  
 
Witkin SS, Vardhana S, Yih M, Doh K, Bongiovanni AM, Gerber S (2003). Polymorphism 
in intron 2 of the fetal interleukin-1 receptor antagonist genotype influences mid-trimester 
amniotic fluid concentrations of interleukin-1beta and interleukin-1 receptor antagonist and 
pregnancy outcome. Am J Obstet Gynecol.; 2003 Nov; 189(5):1413-7. 
 
WHO (2005). ICD-10 International Statistical Classification of Diseases and Related Health 
Problems, 2nd edition. WHO; Geneva. 
 
WHO (2006). Neonatal and Perinatal Mortality: Country, Regional and Global Estimates. 
Geneva: World Health Organization; Geneva. 
 
World Health Organization (1987). Oral health surveys: Basic methods. Geneva: World 
Health Organization.; Geneva. 
 
WHO (2013). The 8th Global Conference on Health Promotion. WHO; Helsinki, Finland10–
14 June. 
 
WHO (2005). ICD-10 International Statistical Classification of Diseases and Related Health 
Problems, 2nd edition.WHO; Geneva 
 
 
 
 
 
162 
 
Xiong X,  Buekens P, Fraser W,  Beck J, Offenbacher S (2006). Periodontal disease and 
adverse pregnancy outcomes: a systematic review BJOG: An International Journal of 
Obstetrics & Gynaecology. ; Volume 113, Issue 2: 135–143. 
 
Zachariasen RD (1993). The affect of elevated ovarian hormones on periodontal health: oral 
contraceptives and pregnancy. Women health; 20(2):21-30. 
 
Yalcin F, Eskinazi E, Soydine M, Basegmez  C, Issever H, Isik G, Berber L, Has R, Sabuncu 
H,  Onan U (2002). The effect of sociocultural status on 
Periodontal conditions in pregnancy. J Periodontol; 73(2):178-182. 
 
Yeo A, Smith MA, Lin D, et al (2005). Campylobacter rectus mediates growth restriction in 
pregnant mice. J Periodontol; 76(4):551-7. 
 
Yokoyama M, Hinode D, Yoshioka M, Fukui M, Tanabe S, Grenier D, Ito HO (2008). 
Relationship between Campylobacter rectus and periodontal status during pregnancy. Oral 
Microbiol Immunol.; 23(1):55-9. 
 
 
 
 
 
 
 
 
 
 
 
 
 
163 
 
APPENDICES 
 
Appendix 1: Consent Form 
 
INFORMED CONSENT TO PARTICIPATE IN STUDY 
 
Dear………………………………………………. 
 
I am a doctoral student in the department of medical biosciences from the Faculty of 
Sciences, University of the Western Cape. I would like to ask you a few questions about 
yourself and do a clinical examination which will take about 15 to 20 minutes. The purpose 
of the research project is to check for gum disease in the mouths of pregnant women in order 
to establish whether the presence of gum disease in the mouths of pregnant women can be 
used as an indicator for pre-term delivery or delivery of babies with low birth weights.  
 
The clinical procedure will entail the measurement of oral clinical indices for use in making a 
clinical diagnosis of pregnancy gingivitis and the removal of plaque samples from selected 
teeth for laboratory investigation. The clinical measurements and sample collection are non-
invasive and safe and will be carried out with the utmost care to ensure the comfort of the 
patient. You will be identified with a code number and your name will not appear on any 
form all the information you give us about yourself will be strictly confidential. You are 
completely free to take part or not to take part in the study. If you decide that you do not want 
to be part of the study, this will not be held against you. If you would like to take part in the 
study, please sign the form below to allow us to proceed with the interview. If you would like 
to withdraw from the study at any point for any reason, please feel free to do so and no 
questions will be asked. 
 
 
 
 
 
164 
 
If you have any questions or queries or would like more information about the study please 
contact Dr M Turton on telephone number (033) 3946 486; fax (033) 3946487; e-mail 
8403619 @ uwc.ac.za or after hours on (084 7760436). 
 
Thank you for your cooperation 
 
Yours sincerely 
Dr Mervyn Turton. 
 
 
I understand what the study is about and agree to participate in the study. 
 
My consent is subject to the following: 
• The results will in no way disclose the identity of the participants.  
• The results can be used or published for benefits in the oral health field.  
 
Name:........................................................   Signature:................................................ 
(In block letters)  
Date:............................................................................................................................................. 
Witness:........................................................................................................................................ 
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Appendix 2A: Data Capture Sheet: Part 1 
 
     Part 1 
 
Data Capture Sheet of Clinical Examination and BANA Analysis 
 
Date of examination: _________________ Site: ________________ 
 
Demographic  
 
File 
number  
 Number of 
previous 
pregnancies 
 
 
Name  Pregnancy 
stage 
 
 
Age  Race group BLK CLRD ASIAN WHITE 
1 2 3 4 
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Clinical assessment 
Smoking No 
1 
Yes 
2 
Sometimes 
3 
History of adverse pregnancy outcomes No  
1 
Yes 
2 
 
Weight Under 
1 
Moderate 
2 
Over 
3 
Alcohol None 
1 
Daily 
2 
Weekly 
3 
Level of Education Primary 
1 
Secondary 
2 
Tertiary 
3 
 
 
DMFT 
   
Decayed Missing Filled Total 
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Plaque index (PI) 
 
  M D Tot 
16       
21       
24       
36       
41       
44       
  Score   
 
 
Gingival Index (GI) 
 
  M D Tot 
16       
21       
24       
36       
41       
44       
  Score   
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Probing Depth (PD 
 
None 
1 
Mild  
2 
Moderate 
3 
Severe 
4 
 
 
Clinical attachment Loss (CAL) 
 
None 
1 
Mild  
2 
Moderate 
3 
Severe 
4 
 
 
Calculus  
 
None 
1 
Mild  
2 
Moderate 
3 
Severe 
4 
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Oral Lesions 
 
No 1 
Yes  2 
 
 
Periodontal Disease 
 
None 1 
Mild 2 
Moderate 3 
Severe 4 
 
 
BANA Analysis 
 
No 1 
Yes  2 
 
 
 
 
 
 
 
 
 
 
170 
 
 
Appendix 2B: Data Capture Sheet Part 2  
   Part 2 
Data Capture Sheet of Pregnancy Outcomes      
 
Date of examination:……………………… Site: ………………………………… 
Demographic  
 
File number   
Mothers Name  
Age  
 
Pregnancy Outcomes 
Birth weight (kg)  
  
Gestational Age (weeks)  
  
Weight for Gestational Age  
  
Gender of Baby Female Male 
1 2 
  
AGPAR score  
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Appendix 3: Approval of Research Study by UWC Human Subjects Ethics Committee 
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Appendix 4: Adverse pregnancy outcomes that have been linked to periodontal disease 
 
Adverse pregnancy outcomes that have been linked to periodontal disease include: 
• Preterm low 
• birthweight 
• Preterm birth  
• Low birthweight  
• Pre-eclampsia  
• Miscarriage  
• Stillbirth 
(McCormick 2003; Bobetsis, 2006). 
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Appendix 5: List of MOU's 
 
List of MOU's where research was undertaken 
• Edendale  
• Hlengisizwa  
• Cato Manor   
• Ntseleni   
• Empangeni 
• Mbalenhle 
• Caluza  
• Embo 
• Eastboom 
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Appendix 6:  Definitions  
 
This study used terminology from the World Health Organization International Statistical 
Classification of Diseases and Related Health Problems to ensure consistent with universally 
accepted definitions (WHO, 2005). 
 
1. Birth: Complete expulsion or extraction of foetuses X500 g or X25 cm (if weight or length 
is unavailable, 22 weeks’ gestation are considered equal to 500 g) (WHO, 2005).   
 
2. Live birth: Complete expulsion or extraction from its mother of a product of conception, 
irrespective of the duration of the pregnancy, which, after such separation, breathes or shows 
any other evidence of life, such as beating of the heart, pulsation of the umbilical cord, or 
definite movement of voluntary muscles, whether or not the umbilical cord has been cut or 
the placenta is attached; each product of such a birth is considered live born (WHO, 2005). 
 
3. Still birth: Complete expulsion or extraction from its mother of a product of conception, 
of at least 22 weeks gestation or 500 g, which after separation did not show any signs of life 
(WHO, 2005). 
 
4. Foetal death: Death before the complete expulsion or extraction from its mother of a 
product of conception, irrespective of the duration of pregnancy; the death is indicated by the 
fact that after such separation the foetus does not breathe or show any other evidence of life, 
such as beating of the heart, pulsation of the umbilical cord or definite movement of 
voluntary muscles (WHO, 2005).  
 
5. Birth weight: First weight of infant obtained afterbirth (WHO, 2005). 
 
6. Duration of gestation: Time from the first day of the last normal menstrual period (LMP) 
(WHO, 2005).  
 
7. Gestational age: Gestational age is expressed in completed days or completed weeks after 
first day of LMP (WHO, 2005). 
 
 
 
 
 
175 
 
8. Perinatal period: Time that commences at 22 completed weeks of gestation (the time 
when birth weight is normally 500 g), and ends at one completed week after birth (WHO, 
2005).  
 
9. Perinatal mortality rate: Number of deaths of foetuses weighing at least 500 g (or, when 
birth weight is unavailable, after 22 completed weeks of gestation or with a crown–heel 
length of 25 cm or more), plus the number of early neonatal deaths per 1000 total births 
(WHO, 2005).  
 
10. Neonatal death: Death of a live-born infant during the first 28 completed days of life. 
May be subdivided into early neonatal death, occurring during the first 7 days of life, and late 
neonatal death, occurring after the seventh day but before 28 completed days of life (WHO, 
2005).  
 
11. Pre-term birth: Birth under 37 week’s, gestational age (Martin et al., 2007).  
 
12. Late pre-term birth: Birth at 34-36 week’s, gestational ages (Martin et al., 2007). 
 
13. Very pre-term birth: birth under 32 week’s, gestational age (Martin et al., 2007). 
 
14. Extremely pre-term birth: birth under 28 week’s, gestational age (Martin et al., 2007).  
 
15. Low birth weight (LBW) i.e. birth weight under 2500 g (up to and including 2499 g); 
very low birth weight (VLBW) i.e. under 1500 g (up to and including 1499 g); extremely low 
birth weight (ELBW) i.e. under 1000 g (up to and including 999 g) (WHO, 2005). 
 
16. Pre-term labour: Regular uterine contractions accompanied by cervical change at under 
37 weeks gestation (Goldenberg et al., 2008). 
 
17. Pre-term premature rupture of membranes (PPROM): Spontaneous rupture of the 
membranes as under 37 weeks gestation at least 1 hour before the onset of contractions 
(Goldenberg et al., 2008). 
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